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Abstract
Coronary collaterals are pre-formed connections that provide an alternative route
when regular antegrade blood flow to the heart muscle is compromised. In response
to a coronary obstruction, coronary collaterals undergo gradual enlargement, vari-
ably compensating for impaired antegrade blood flow. As natural bypasses, suffi-
ciently large coronary collaterals can preserve myocardial perfusion and viability in
the acute and chronic phases of coronary artery disease.
In chronic stable coronary artery disease, medical therapy is complemented by es-
tablished interventional therapies such as percutaneous coronary intervention and
surgical coronary artery bypass grafting. However, new therapeutic options are
needed for patients who are not candidates for conventional revascularization due
to severe and/or diffuse obstructive coronary artery disease. Promotion of coro-
nary collaterals represents such an alternative treatment option. However, while a
multitude of interventions has been shown to be effective in collateral growth pro-
motion, the effect of current interventions is only temporary and therefore recurrent
application of the arteriogenic stimulus is necessary to sustain the level of collat-
erals. Historically, attempts to induce durable improvement of coronary collateral
flow have already been made. Experimental and clinical studies examined the effi-
cacy of distal ligation of the internal mammary artery (IMA) to augment blood flow
to the coronary circulation. The basis of these studies was the clinical structural
and experimental functional documentation of pre-formed connections between the
internal mammary arteries and the coronary circulation - extracardiac collaterals.
With the advent of coronary artery bypass grafting, the procedure was, however,
abandoned. Notably, the clinical studies were based on crude outcome measures,
such as symptomatic improvement. The function and in-vivo prevalence of inter-
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nal mammary-to-coronary-anastomoses was therefore investigated in a clinical study
(Project I) for the first time. 120 patients referred for elective coronary angiog-
raphy for suspected or established coronary artery disease (CAD) underwent 180
pairs of coronary artery balloon occlusions, the first with and the second without
simultaneous distal IMA occlusion (thought to augment flow via IMA-to-coronary
connections). Collateral function was assessed during coronary balloon occlusion by
collateral flow index (CFI), which is the ratio of coronary occlusive to aortic (effec-
tive perfusing) pressure, accounting for the back pressure (central venous pressure).
Regional myocardial ischemia was assessed by the intracoronary electrocardiogram
(ECG). With simultaneous distal IMA occlusion CFI was significantly higher during
left IMA with left anterior descending coronary artery (LAD) occlusion and right
IMA with right coronary artery (RCA) occlusion than during LAD or RCA occlu-
sion alone. Conversely, during contralateral IMA occlusion, ie RCA with left IMA
or LAD or left circumflex coronary artery (LCX) with right IMA occlusion, CFI
was not different. Concordantly, myocardial ischemia by intracoronary ECG was
lower during LAD or RCA occlusion with simultaneous ipsilateral IMA occlusion
and was not different during contralateral IMA occlusion or with LCX occlusion. In
conclusion, it could be demonstrated that there was functional, ischemia-reducing
collateral supply from the ipsilateral IMA to the right coronary and the left anterior
descending coronary artery.
The effect of permanent distal right IMA on coronary collateral function was investi-
gated for the first time in an open-label clinical trial (Project II). 50 patients with
stable CAD underwent distal right IMA closure at baseline and determination of
right and left coronary function (LAD or LCX) by CFI at baseline and at follow-up
6 weeks after right IMA device closure. CFI in the untreated RCA increased signifi-
cantly from baseline to follow-up, while CFI in the untreated left coronary remained
unchanged. Concordantly, regional myocardial ischemia determined by intracoro-
nary ECG was reduced during a 1-minute coronary balloon occlusion in the RCA
but not in the left coronary. In conclusion, permanent distal right IMA closure in
this non-randomized study appeared to augment extracardiac right coronary collat-
eral supply.
With acute myocardial ischemia, the mainstay of therapy lies in the antegrade tech-
nique of prompt percutaneous revascularization. However, a reopened epicardial
conduit artery does not guarantee reperfusion of myocardial tissue, which can be
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impaired by microvascular dysfunction. In this situation of a failed antegrade ap-
proach, retrograde treatment approach has been proposed by an intervention in the
coronary venous system - intermittent coronary sinus occlusion (CSO). Although the
ischemia-relieving effect of CSO is thought to depend on coronary collaterals, its role
of coronary collaterals has so far not been clearly defined in humans.
The role of coronary collaterals in the anti-ischemic effect of CSO was therefore inves-
tigated in a clinical study (Project III) and in a computer simulation (Project IV).
In the clinical study, 35 patients with stable coronary artery disease underwent two
2-minute balloon occlusions of a major coronary artery to induce controlled ischemia.
CSO was performed randomized to the first or second coronary balloon occlusion.
Collateral function was assessed by CFI and regional myocardial ischemia was as-
sessed by the ST-segment shift in the intracoronary ECG. Intermittent coronary
sinus occlusion was shown to reduce myocardial ischemia depending on the extent of
collateral function. With minimal collateral function, no ischemia-reducing effect of
CSO was demonstrated. An anti-ischemic effect of CSO was seen with intermediate
collateral function. High collateral function prevented myocardial ischemia in the
first place and therefore, no additional effect of CSO was demonstrated.
The computer simulation (Project IV) consisted of a lumped-parameter model of
a two-branch left coronary system circuit with arterial, capillary and venous com-
partments. As a key point, arterial collateral connections were an integral part of
the model, in contrast to prior computer models. Importantly, the salient features
of coronary pressure and flow during non-ischemic and ischemic conditions, as well
as during CSO could be reproduced. In particular, the proposed main mechanism
of CSO - retrograde flow from the venous to the venular and capillary compart-
ment was reproduced by the model. As a key point, the model predicted retrograde
flow to be dependent on the extent of collateral blood flow and contractility. With
minimal collateral function, retrograde flow to an ischemic region was low, while it
progressively increased with higher collateral function. Accounting for the combina-
tion of reduced contractility during ischemia and the level of collateral function, the
effect on retrograde flow was much increased. Retrograde flow was predicted to be
very low at zero to minimal collateral function and concomitantly severely reduced
contractility. Conversely, retrograde flow increased steeply with increasing collateral
function and more preserved contractility. In essence, the mathematical model pro-
vided a reasonable explanation for the findings from the clinical study (Project III)
14
and could, for the first time, provide an explanation for the role of collaterals in the
anti-ischemic effect of CSO.
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Abbreviations
CABG coronary artery bypass grafting.
CAD coronary artery disease.
CEP cavity-induced extracellular pressure.
CFI collateral flow index.
CS coronary sinus.
CSI coronary sinus intervention.
CSO coronary sinus occlusion.
CSP coronary sinus pressure.
CTO chronic total occlusion.
ECG electrocardiogram.
ECP extravascular compressive pressure.
ICSO intermittent coronary sinus occlusion.
IMA internal mammary artery.
L1 first left coronary branch.
L2 second left coronary branch.
LAD left anterior descending coronary artery.
LCX left circumflex coronary artery.
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LPM lumped parameter model.
LV left ventricle.
LVP left ventricular pressure.
MI myocardial infarction.
pao aortic pressure.
pRA right atrial pressure.
PCI percutaneous coronary intervention.
PIV posterior interventricular vein.
RC Resistor-Capacitor.
RCA right coronary artery.
STEMI ST-segment elevation myocardial infarction.
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1. Introduction
1.1 Impact of the Coronary Collateral Circulation in
Coronary Artery Disease
Despite considerable advances in medicine, cardiovascular diseases remain the num-
ber one cause of death globally - primarily as a consequence of myocardial infarction
due to acute coronary occlusion. Compromise of blood flow is, however, lessened
by coronary collaterals, which provide an alternative source of blood flow to my-
ocardium jeopardized by ischemia. Coronary collaterals represent pre-existing inter-
arterial anastomoses and as such are the natural counter-part of surgically created
bybasses. The extent of coronary collaterals has been shown to vary widely between
individuals, both in the absence and and in the presence of coronary narrowings.[1]
When sufficient, coronary collaterals have been shown to confer a significant benefit
in terms of overall mortality and cardiovascular events.[2, 3]
Current treatment modalities for CAD comprise medical treatment and revascu-
larization, either by percutaneous coronary intervention (PCI) or coronary artery
bypass grafting (CABG). Although widely used, PCI has not been shown to reduce
the incidence of myocardial infarction or death in patients with stable CAD com-
pared to medical therapy. In contrast, CABG significantly reduced rates of death
and myocardial infarction compared to PCI. Conceptually, the advantage of CABG
over PCI with more severe CAD relates to the protective effect of bypasses, provid-
ing an alternative source of blood flow in the event of coronary occlusion. Similarly,
coronary collaterals serve as natural as opposed to artificial surgical bypasses.
In this regard, the concept of augmenting coronary collateral function as an alterna-
tive treatment strategy to alter the course of CAD, as well as to control symptoms,
18
is attractive.
A multitude of interventions has been shown to be efficacious in collateral growth
promotion. Apart from delivery of arteriogenic agents,[4, 5, 6, 7, 8] several means for
physical collateral growth promotion have been shown to be effective.[9, 10, 11, 12, 13]
However, so far, the effect of current interventions of both these modalities is only
temporary and therefore recurrent application of the arteriogenic stimulus is neces-
sary to sustain the level of collaterals. Notwithstanding, there have been historical
attempts to induce durable improvement of coronary collateral flow.
1.2 Extracardiac Collaterals
Colloquially, coronary collaterals are synonymously used with the term intracardiac
coronary collaterals, ie they are implicitly understood to originate from and connect
to coronary arteries. However, pathological and experimental studies have confirmed
the existence of collaterals connecting the coronary circulation with an extracardiac
vessel - extracardiac collaterals.[14, 15, 16]
In contrast to the extensively studied coronary collateral circulation within the
heart,[17, 18] limited data exist on extracardiac-to-coronary anastomoses.[16] Fur-
thermore, existing data rely on visual methods insensitive for the adequate detection
of structurally present but poorly functional anastomoses. Most of the knowledge
comes from pathological studies, which are summarized in Table 1.1. The first
demonstration of anastomoses between coronary arteries and mediastinal vessels was
by von Haller in 1803.[19]
A potential merit for further investigation are the prior clinical data supporting
a role for extracardiac anastomoses as a target for durable promotion of coronary
collateral function. Such a therapeutic approach appears especially attractive with
regard to connections between the IMA and the coronary circulation, which have
been documented macroscopically in one tenth of patients with CAD.[20]
1.2.1 Anatomical Background
In the absence of pericardial adhesions, blood supply from extracardiac collaterals
to the heart is possible via the pericardial reflections, located posterior to the heart
between the roots of the great vessels.[20] This is consistent with Hudson, who re-
ported the most extensive anastomoses between cardiac and extracardiac vessels to
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be around the ostia of the pulmonary veins.[15] The (parietal) pericardium receives
blood supply from the IMAs (via the pericardiophrenic arteries) and the bronchial
arteries (to the posterior part of the pericardium).[21] Given their proximity to the
pericardial reflections, either the IMAs or the bronchial arteries therefore usually
give rise to extracardiac coronary collaterals.[14, 22, 20]
Apart from the vasa vasorum of the aorta, a possible pathway between the IMA
or the bronchial artery and the coronary circulation is represented by the atrial
coronary branches (Figure 1.1).[20, 14] While the atrial coronary branches show
high anatomical variability, the most constant (and largest) atrial branches are those
supplying the sinus node and atrioventricular node, respectively.[23] Regularly the
largest atrial coronary branch, the sinus node artery arises slightly more frequently
from the RCA than the from the LCX, usually within its first few centimeters. The
atrioventricular node artery, typically smaller than the sinus node artery, originates
from the RCA in the majority of cases.[23] Numerous, but smaller and variable atrial
branches can be designated simply as right (from RCA) or left atrial arteries (from
LCX).
On anatomical grounds, atrial coronary branches would conceivably mediate an ex-
tracardiac connection to the coronary artery it originates from, e.g. a sinus node
coronary artery arising from the right coronary artery would therefore provide a po-
tential route for an extracardiac source to the right coronary artery. However, grossly
visible anastomoses exist between the atrial coronary branches of the right and left
coronary arteries, implying a potential route for direct communication between the
right and left coronary arteries.[24] As a corollary, an extracardiac connection me-
diated by a particular atrial branch would also be conceivable to communicate with
a major coronary branch via atrial anastomoses irrespective of the origin of the
mediating atrial branch.
1.2.2 Internal Mammary Artery-to-Coronary Collaterals
With respect to a therapeutic intervention aiming at promotion of extracardiac anas-
tomoses, the connections from the internal mammary arteries have become the sub-
ject of interest.
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Figure 1.1: Atrial coronary branches
Source: [14]
Anatomical background
The IMA of both sides originate proximally from the subclavian artery and run
caudally within a few centimeters laterally of the sternum. At the sixth-to-seventh
intercostal space they divide into their terminal branches, the musculophrenic artery
(laterally) and superior epigastric artery (medially). The superior epigastric artery,
in turn, anastomoses with the inferior epigastric artery, which arises from the external
iliac artery.
With respect to an extracardiac connection to the coronary circulation, the most
important branch of the IMA is the pericardiophrenic artery, which branches off the
IMA near its upper end and runs with the phrenic nerve to reach the diaphragm.
The pericardiophrenic artery provides blood supply to the parietal pericardium,
which highlights its potential to form anastomoses with the coronary circulation via
the pericardial reflection. Other arteries supplying the pericardium are pericardial
branches from bronchial, esophageal or superior phrenic arteries.
21
Author Origin of extracardiac collateral Frequency
Moberg 1967 IMA 19/49 (38.8%)
Moberg 1967 bronchial arteries 45/45 (100%)
Bjo¨rk 1967 bronchial arteries 73/200 (36.5%)
Hudson 1932 branches of aorta (incl. bronchial
arteries), IMA (via pericardio-
phrenic branches
NA
Table 1.1: Post-mortem angiography studies on extracardiac coronary collaterals.
IMA, internal mammary artery.
Post-mortem angiography studies
The only detailed and comprehensive study regarding IMA-to-coronary anastomoses
is the one by Moberg, who also examined bronchial-to-coronary anastomoses.[20, 14]
Post-mortem, contrast agent was injected directly into the right IMA with the ex-
ception of two patients, where contrast injection was performed into the left IMA.
Contrast filling of the IMA contralateral to the injected one was deemed to occur suf-
ficiently through inter-IMA-anastomoses (via retrosternal branches).[25] Radiograms
were then assessed for contrast filling in the coronary arteries on atrial or ventricular
level. A total of 49 subjects were investigated, in none of which pericardial adhesions
were observed, therefore excluding the possibility of extracardiac anastomoses to be
facilitated by this condition.[26, 27] By this angiographic method, an extracardiac,
IMA-to-coronary anastomoses could be documented in 19 (38.8%) of patients. Table
1.2 gives the details of his study.
Subjects - n (%) Terminal coronary branch filled Connecting branch
15/49 (30.6) atrial coronary branch NA
4/49 (8.2) ventricular branch
RCA (1 case) sinus node artery
LCX (3 cases) left atrial artery
Table 1.2: Post-mortem angiography study on IMA-to-coronary anastomoses.
LAD, left anterior descending. LCX, left circumflex. RCA, right coronary artery.
Source: [20]
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Angiographic case reports
In-vivo, the structural existence of IMA-to-coronary artery connections has rarely
been demonstrated, exclusively in the context of coronary angiography for the eval-
uation of CAD. Table 1.3 gives an overview of the angiographic case reports on
IMA-to-coronary connections. A constant in these cases was severe obstruction of
the collateral-receiving coronary artery. In contrast to the post-mortem study by
Moberg, the in-vivo angiographic cases allow to evaluate from which side of the IMA
the extracardiac collateral originates from. With one exception, the anastomoses
between the IMA and the coronary circulation were documented to be ipsilateral,
ie, left IMA to a branch of the left coronary artery (LCX or LAD), or right IMA to
RCA. In 2 of the cases, a prior CABG had been performed, which may have enabled
the development of the observed connection to have occurred by transpericardial
vascularization secondary to pericardial adhesions.[26]
Origin Coronary Connecting branch Prior heart surgery Reference
LIMA LAD pericardial branch yes, saphenous vein
bypass grafting
Salachas [28]
LAD NA yes, coronary artery
bypass grafting
Knight [29]
LAD NA yes, coronary artery
bypass grafting,
aneurysmectomy
Aras [30]
LIMA LCX pericardial branch,
left atrial branch
no Yamamoto [31]
RIMA RCA pericardial branch,
sinus node artery
no Singh [32]
RCA pericardial branch,
sinus node artery
no Kajinami [33]
RIMA LCX pericardial branch no Numata [34]
Table 1.3: Angiographic case reports of natural IMA-to-coronary anastomoses.
LAD, left anterior descending. LCX, left circumflex. LIMA, left internal mammary artery. RCA, right coronary artery.
RIMA, right internal mammary artery.
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Promotion of IMA-to-coronary collaterals
Before the advent of CABG, several experimental and clinical studies set out to
investigate the promotion of coronary collateral flow via IMA-to-coronary anasto-
moses. In the majority of cases, ligation of the IMA distal to the take-off of the
presumptive donor branch (the pericardiophrenic branch) was performed, with the
idea to redirect blood flow and thus enhance the naturally pre-existing anastomoses.
Experimental studies
Table 1.4 summarizes the major experimental studies investigating the efficacy to
promote IMA-to-coronary flow. With the exception of a subgroup in Chatterjee’s
study,[35] IMA ligation distal to the pericardiophrenic branch was performed as a
means of IMA-to-coronary collateral promotion. Mostly, mortality was assessed,
which has to be regarded as an insensitive endpoint in light of several methodical
shortcomings.
Instructive to the interpretation of the data are the studies by Blair[36, 37] and a
substudy by Bogedain.[38] Both assessed the effect of acute IMA ligation on coro-
nary blood flow, albeit by different methods. In response, a small, but consistent
increase in coronary blood flow was found. Furthermore, Blair et al. found that the
observed increase was reversed by clamping of the IMA at their origin. Collectively,
therefore, these studies provide a proof of principle for IMA ligation as a means to
promote extracardiac collateral function.
In contrast to other investigations related to (intracardiac) collaterals, a constant
of the experimental studies on extracardiac collateral promotion was that coronary
occlusion was always acute. However, a sizeable enlargement of any collateral con-
nection in response to coronary constriction takes (days to) weeks. Consequently,
any additional blood flow by IMA-to-coronary anastomoses was likely small given
that enlargement of pre-existing, but minute extracardiac connections could not oc-
cur. In some of the studies, there was a time interval between ligation of the IMA
and the coronary artery, which may have lead to an enlargement of the pre-existing
anastomoses. However, a potential arteriogenic effect of IMA ligation was likely to
be small in the absence of a significant pressure gradient between the donor (IMA)
and the recipient artery, such as would have been the case with severe coronary
narrowing. Taken together, the experimental findings are consistent with the proof
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of principle that IMA ligation can additionally contribute to augment extracardiac
coronary collateral flow, but that its recruitable extent is ineffective in reducing mor-
tality secondary to acute coronary occlusion in the absence of additional promoting
factors (i.e. a coronary narrowing).
Author IMA Intervention Coronary Intervention Result
Blair
1957 [36]
IMA ligation, bilat-
eral
none increase in coronary
flow (avg 9.6 ml/min)
Blair
1960 [37]
IMA ligation, bilat-
eral
none increase in coronary
flow (avg 7.3 ml/min)
Glover
1957 [39]
treatment: IMA
ligation, bilateral
coronary ligation 93% mortality
control: none coronary ligation 42% mortality
Chatterjee
1963 [35]
IMA ligation, bilat-
eral
LAD ligation, acute 100% mortality
IMA arteriovenous
shunt, bilateral
LAD ligation, acute 16.7% mortality
Vansant
1959 [40]
control: none LAD ligation, acute 90% mortality,
60% with irreversible
ventricular fibrillation
IMA ligation, bilat-
eral
LAD ligation, acute 70% mortality,
50% with irreversible
ventricular fibrillation,
infarct size not different
IMA ligation, bilat-
eral
LAD ligation, 2 weeks
after IMA ligation
Katznelson
1960 [41]
control: none none no radiographic evidence of
anastomoses betweeen
pericardiophrenic and
coronary arteries
IMA ligation, bilat-
eral
none
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Author IMA Intervention Coronary Intervention Result
Rueger
1960 [42]
IMA ligation, bilat-
eral, pleural cavity
left closed
LAD ligation, 3 weeks
after IMA ligation
27% mortality
IMA ligation, bilat-
eral, pleural cavity
opened
LAD ligation, 3 weeks
after IMA ligation
30% mortality
none: sham IMA
ligation
LAD ligation, 3 weeks
after sham IMA ligation
40% mortality
none: anesthesia LAD ligation, 3 weeks
after anesthesia
40% mortality
none LAD ligation, acute 55% mortality
IMA ligation, bilat-
eral
LAD ligation, acute 70% mortality
Sabiston
1958 [43]
IMA ligation, bilat-
eral
LAD ligation, acute 78% mortality
IMA ligation, bi-
lateral; ligation of
the other branches
of the subclavian
artery
LAD ligation, 33 days
after IMA ligation
93% mortality
IMA ligation, left;
ligation of the other
branches of the sub-
clavian artery
LAD ligation, 46 days
after IMA ligation
92% mortality
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Author IMA Intervention Coronary Intervention Result
Bogedain
1962 [38] control: none
LAD ligation, acute 78% mortality
LCX ligation, acute 100% mortality
LAD and LCX ligation,
acute
67% mortality
IMA ligation,
bilateral
LAD ligation, 3 weeks
after IMA ligation
25% mortality
LCX ligation, 3 weeks
after IMA ligation
67% mortality
LAD and LCX ligation,
3 weeks after IMA liga-
tion
100% mortality
IMA ligation, bilat-
eral
none 15% increase in coro-
nary flow
Table 1.4: Major experimental studies on promotion of IMA-to-coronary anasto-
moses
IMA, internal mammary artery. LAD, left anterior descending. LCX, left circumflex.
Clinical studies
Based on anatomical considerations, bilateral IMA ligation was first proposed by
the Italian surgeon Fieschi and the first clinical case was performed in in 1939.[44]
The procedure could be performed under local anesthesia via a small incision in an
intercostal space. Two major clinical, but uncontrolled studies in several hundreds
of patients showed subjective improvement in symptoms in most patients after the
procedure, while objective measures by electrocardiography were observed to a lesser
extent.[45, 46] However, two randomized, controlled trials showed similar improve-
ment in symptoms in the group undergoing the sham procedure.[47, 48] Notably, a
major limitation of both randomized studies was the small sample size (17 and 18
patients, respectively). Nevertheless, with the introduction of the cardiopulmonary
bypass technique enabling CABG, the procedure was abandoned.
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1.3 Coronary Sinus Interventions
Coronary artery reperfusion is the mainstay of therapy in acute myocardial ischemia.
Persisting myocardial ischemia can, however, occur even after desobstruction of the
culprit epicardial conduit artery, as effective reperfusion of myocardial tissue de-
pends also on the coronary microvasculature, the function of which can be impaired
especially after prolonged ischemia. Myocardial tissue hypoperfusion that persists
despite a reopened conduit artery is known as the no-reflow phenomenon, the cause
of which has been attributed to a dysfunction of the coronary microcirculation. Clin-
ically, the no-reflow phenomenon is relevant due to its being a strong predictor for
long-term mortality in patients with acute myocardial infarction.
Current treatment approaches for no-reflow have so far been disappointing and high-
light the need for alternative management strategies. As an alternative to the con-
ventional antegrade approach, a retrograde approach has been investigated in clinical
and experimental studies of acute myocardial ischemia. Conceptually, the retrograde
approach, also termed retroperfusion, relates to manipulation of the coronary venous
system to improve regional myocardial blood flow in ischemic territories. The tech-
nique has found a regular application in retrograde cardioplegia during cardiopul-
monary bypass, where distribution of the cardioplegic solution can be impaired in
the setting of severe CAD when infused by the antegrade approach.[49] In acute coro-
nary syndrome, its use is investigated as an adjunct to PCI, whereas in chronic stable
CAD, it is investigated as an alternate therapy for patients with refractory angina
who are not candidates for conventional revascularization procedures.[50, 51, 52]
Regardless of the employed retroperfusion method, a reduction in myocardial infarct
size has been observed after coronary occlusion in experimental models compared to
a control group.[53]
Several mechanisms have been proposed to underlie the anti-ischemic effect of coro-
nary sinus pressure elevation. While the concept of effective retrograde perfusion
from the coronary veins to the ischemic region is appealing, several considerations
have to be taken into account. In particular, this relates to the coronary venous
anatomy and the role of coronary collaterals, which has not been investigated so far
in humans.
With regard to the acute application of retrograde perfusion methods in acute my-
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ocardial ischemia, the observed hemodynamic reactions reflect functional changes of
the coronary arterial and venous system. Conversely, a structural adaptation could
be imagined with chronic elevation of coronary sinus pressure. In this respect, a
clinical study has recently investigated the safety and efficacy of a coronary sinus
reducer stent in patients with chronic refractory angina pectoris not amenable to
conventional therapy.
1.3.1 Coronary Venous Anatomy
The efficacy of coronary venous intervention to result in effective retroperfusion is
critically determined by the anatomy of the coronary network, in particular the car-
diac venous anatomy (Figure 1.2). [54] Two major distinct drainage pathways for
coronary flow exist. The majority of coronary flow returns via large epicardial veins
to the right atrium, most of them via the coronary sinus (CS), while some veins open
directly into the right atrium.[55] These connections are known as the greater (ma-
jor) cardiac venous drainage system. Conversely, the thebesian vessels (or smaller
(minor) cardiac drainage system) are small vessels originating from the subendocar-
dial region and connecting directly to the ventricular cavities.
Myocardium drained by non-coronary sinus pathways
It is reasonable that CSO may not reperfuse myocardium draining by pathways other
than the CS. Non-coronary sinus drainage is the rule for the myocardium of the right
ventricle, which is illustrated by its ineffective perfusion by retrograde cardioplegia
via the CS.[57, 58]. Most of the right ventricle is perfused by the RCA. With respect
to the left ventricle (LV), the RCA perfuses the inferior and infero-posterior territory
(with right coronary dominance, which is the usual case). The major cardiac vein
draining the part of the LV supplied by the RCA is the posterior interventricular
vein (PIV), also known as the middle cardiac vein.[59] While the PIV opens into
the CS in the majority of cases, it does so typically near its end. Placement of the
occluding balloon is therefore likely to exclude the PIV due to its more proximal
placement in the CS. On anatomical grounds and experimental observations, CSO
is therefore ineffective in the case of RCA ischemia.
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Figure 1.2: Distribution patterns of the major cardiac veins and their mode of ter-
mination.
AIV, anterior interventricular vein; CS, coronary sinus. GCV, great cardiac vein. PIV, posterior interventricular vein. SCV,
small cardiac vein.
Source: [56]
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1.3.2 Hemodynamic Effects of (Intermittent) Coronary Sinus Oc-
clusion
Elevation of coronary sinus pressure
CSO is typically performed by inflating a balloon in the coronary sinus. Occlusion is
released periodically, as permanent occlusion would result in myocardial injury.[60]
Coronary sinus pressure (CSP) increases with CSO with a typical pattern, (Figure
1.3).
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Figure 1.3: Typical pattern of coronary sinus pressure during coronary sinus occlu-
sion (starting at 30 seconds). Recording from a patient from a clinical study.[61]
Coronary inflow reduction
If the coronary circulation were a single-route system, blockage of the outflow would
eventually result in total cessation of antegrade blood flow. However, drainage of
myocardium occurs not only via the coronary sinus, but also via the thebesian vein
system from the subendocardial region to the ventricular cavities and via smaller
collecting epicardial veins directly to the right atrium. The extent of these alternative
drainage pathways therefore dictate the effective resistance to inflow. The findings
from experimental studies are consistent with these considerations.
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Right coronary inflow is principally unaltered during CSO, owing to its predominant
drainage directly to the right atrium.[62, 63, 64] With respect to left coronary inflow,
a reduction has been observed in experimental studies during CSO in dogs.[62, 65,
66, 64] Elevation of the CSP did, however not significantly influence left coronary
inflow in sheep.[67] The differential effect is likely explained by the greater extent of
draining pathways alternative to the CS, especially the thebesian vein system. In
other words, a greater extent of left coronary drainage via thebesian connections in
sheep provides an explanation for the lack in inflow reduction during CSP elevation.
Redistribution of venous outflow
With increasing CSP, CS outflow is redistributed to alternative draining pathways.[68]
On an anatomical basis, these are principally the thebesian vessels draining to the
ventricular chambers and the anterior cardiac veins draining directly to the right
atrium. The anterior cardiac veins provide an alternative drainage pathway by virtue
of its frequent communication with the coronary sinus vessel, representing epicardial
veno-venous connections.[69]
1.3.3 Influence of Coronary Collaterals on Intermittent Coronary
Sinus Occlusion
The extent of collaterals per se is an important determinant of the magnitude of
ischemia in a dependent myocardial region.[70, 71] If well-developed, coronary col-
laterals not only lessen but prevent myocardial ischemia at rest and even during
exercise.[72] In animals, the extent of coronary collaterals varies significantly be-
tween species.[73, 74] Pigs[75] and sheep[76] have a minimal collateral circulation,
while dogs[77] show relatively well-developed coronary collaterals. Experimental
studies on CSO have been conducted in different species, which permits to gain in-
sight of the role of coronary collaterals in the anti-ischemic effect of CSO.
A compelling argument for the role of coronary collaterals would be the demonstra-
tion of increased myocardial salvage by CSO in species with well-developed collaterals
relative to control, as compared to species with poor collaterals. Such a comparison
is, however, precluded by the heterogenous study protocols employed even within
the same type of coronary sinus intervention.[53] In other words, differences in my-
ocardial salvage could be attributed to a particular study protocol, rather than to a
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differential effect mediated by the extent of collateral connections.
In an experimental study in dogs, regional myocardial blood flow in the ischemic
region produced by coronary occlusion increased in response to CSO.[78] Mean col-
lateral flow was 25% of normal in this experiment. It was hypothesized that CSO
would increase outflow resistance (via an increase in CSP) in the collateral-donor
vessel, thereby mediating a flow diversion through the collateral channels. Regional
myocardial blood flow was more increased with higher CSP, consistent with the no-
tion of increased flow diversion via collaterals by increased outflow impedance in the
collateral donor. Conversely, in an animal model without significant collateral circu-
lation (in pigs), CSO did not improve regional myocardial blood flow or mechanical
function of the ischemic bed induced by acute coronary occlusion.[79]
Another argument in favour of a mediating role of coronary collaterals in the anti-
ischemic effect of CSO can be gained by comparing its effect to selective coronary
vein occlusion. While with CSO, sizeable reductions in myocardial infarction (MI)
size compared to control were observed in dogs,[80, 81, 82] selective vein occlusion
did not reduce MI size.[83] Selective occlusion of the vein draining the ischemic re-
gion does not lead to outflow impedance in a collateral donor vessel, in contrast to
occlusion of the large collecting vein such as the coronary sinus vessel, which might
serve as a possible explanation for the disparate findings.
Of note, regional myocardial blood flow in the above mentioned studies was invari-
ably measured by the microsphere method. The microsphere technique is suitable
for measurement of collateral blood flow, but fails to detect retrograde blood flow
from the venous system.[84, 85] The reduction of MI size by CSO in animals with
minimal collateral circulation[86, 87, 88] and in the absence of an increase in (an-
tegrade) myocardial blood flow might therefore be explained by effective retrograde
blood flow from the venous compartment.
Given the multiple variables implicated in the effect of CSO, a computer simulation
presents a possibility to estimate the influence of each factor independently.
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2. Hypotheses and Aims of the
Thesis
Project I
Objective: To determine of the in vivo prevalence and functional distribution of nat-
ural internal-mammary to coronary artery connections.
Hypothesis: Natural internal-mammary to coronary artery connections are function-
ally prevalent in a majority of patients.
Project II
Objective: To determine the safety and efficacy of permanent right distal internal
mammary occlusion on coronary collateral function.
Hypothesis: Permanent right distal internal mammary artery closure is safe and
effective in promoting right coronary collateral function.
Project III
Objective: To determine the influence of coronary collaterals on the effect of inter-
mittent coronary sinus occlusion on acute myocardial ischemia in humans.
Hypothesis: the effect of intermittent coronary sinus occlusion on acute myocardial
ischemia is modulated by the extent of the collateral circulation.
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Project IV
Objective: To develop a lumped parameter mathematical model of the hemodynamic
reactions of intermittent coronary sinus occlusion during acute coronary occlusion,
with a special regard of the influence of coronary collaterals.
Hypothesis: The direct or indirect influence of coronary collaterals can be elucidated
in a mathematical model.
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3. Results
3.1 Project I
Function of Natural Internal Mammary-to-Coronary Artery
Bypasses and Its Effect on Myocardial Ischemia
The first project aimed at determining the functional prevalence of natural bypasses
between the internal mammary arteries and the coronary circulation and its ischemia-
abating effect in humans.
My contributions were the conception and design of the project, acquiring, analyz-
ing and interpreting the data, assisting in statistical analysis, handling funding of
the project and making critical revision of the manuscript for important intellectual
content.
The paper was published in Circulation in June 2014, journal ranking was #2 ac-
cording to impact factor and #2 according to SCImago Journal Rank (SJR)[89] in
the year of publication in Cardiology and Cardiovascular Medicine.
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In patients with chronic coronary artery disease (CAD), prog-nosis is adversely affected by ischemia.1 Likewise, the extent 
of ischemia and necrosis is the main determinant of outcome 
after acute myocardial infarction.2 Both the degree of myocar-
dial ischemia and the resulting infarct size can be estimated 
by ECG ST-segment shift, in particular and very sensitively 
by intracoronary ECG.3,4 The absence of intracoronary ECG 
ST-segment shift during a brief coronary balloon occlusion 
has been demonstrated to be a beneficial prognosticator of sur-
vival.5 Myocardial ischemia in the event of coronary occlusion 
is influenced by the duration of occlusion, the size of the myo-
cardial area at risk for infarction, the lack of collateral supply 
to the ischemic zone, the absence of ischemic preconditioning 
before vascular occlusion, and the level of myocardial oxygen 
consumption at the time of occlusion.6 The beneficial effect on 
survival of a well-functioning intercoronary collateral circula-
tion in chronic stable CAD has been well documented.7–9
Clinical Perspective on p 2652
Anatomically, extracardiac coronary collateral  supply via 
internal mammary artery (IMA) branches to the pericardium 
was described >80 years ago.10,11 In the advent of coronary 
bypass surgery, bilateral IMA ligation in patients with CAD 
has been suggested to alleviate angina pectoris and ECG signs 
of ischemia,12–16 although this finding has been challenged by 
2 very small sham-controlled trials.17,18 Using angiographic 
techniques, a total of 3 case reports have described the struc-
tural existence of in vivo naturally occurring anastomoses 
between one of the IMAs and the coronary circulation.19–21 
Very recently, an experimental study in 8 dogs undergoing 
coronary artery constriction and IMA ligation failed to reveal 
myocardial microsphere perfusion via IMA in the single ani-
mal that survived the entire study protocol.22
Hence, the prevalence, functional relevance, and effect on 
myocardial ischemia of extracardiac coronary collateral sup-
ply via natural IMA bypasses are unknown. The present study 
in patients without and with CAD tested the hypotheses that 
coronary collateral function increases in the presence versus 
the absence of distal IMA balloon occlusion and that the for-
mer is reflected by reduced myocardial ischemia.
Methods
Study Design and Patients
This was a prospective, observational study in 120 patients undergoing 
coronary angiography for diagnostic purposes in the context of chest 
pain. The primary study end point was collateral flow index (CFI; see 
Background—The function of naturally existing internal mammary (IMA)–to–coronary artery bypasses and their quantitative 
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below for calculation) obtained in 180 instances during two 1-minute 
coronary artery balloon occlusions (a total of 360 measurements), the 
first with and the second without simultaneous distal IMA balloon 
occlusion (Figure 1). Half of the patients with half of the measure-
ments underwent assessment of ipsilateral IMA–to–coronary artery 
anastomoses (left IMA to left coronary artery and right IMA to right 
coronary artery), and half of the patients with half of the measure-
ments underwent assessment of contralateral IMA–to–coronary artery 
anastomoses. Secondary study end points were the quantitatively 
determined intracoronary ECG ST-segment elevation and angina pec-
toris during the same 1-minute coronary occlusions. Criteria for study 
inclusion were age >18 years, written informed consent to participate 
in the study, and 0- to 3-vessel chronic stable CAD. Exclusion criteria 
were acute coronary syndrome, previous myocardial infarction in the 
vascular region undergoing CFI measurement, and severe hepatic or 
renal failure (creatinine clearance <15 mL·min−1·1.73 m−2).
The study was approved by the ethics committee of the Kanton 
of Bern, Switzerland, and all patients gave written informed consent 
to participate.
Cardiac Catheterization and Coronary 
Angiography
Patients underwent left heart catheterization and coronary angiogra-
phy for diagnostic purposes from the right femoral artery approach. 
Biplane left ventriculography was performed, followed by coronary 
angiography. Coronary artery stenoses were determined quantita-
tively as percent diameter reduction with the guiding catheter used 
for calibration. Aortic pressure (P
ao
) was obtained with a 6F coronary 
artery guiding catheter. Central venous pressure (CVP) was measured 
via the right femoral vein.
Invasive Coronary Assessment
Primary Study End Points
Coronary occlusive collateral flow relative to normal antegrade flow 
through the nonoccluded coronary artery (CFI) was determined from 
coronary pressure measurements. A 0.014-in pressure-monitoring 
angioplasty guide wire (Pressure Wire, St. Jude Medical, Eschborn, 
Germany) was set at zero, calibrated, advanced through the guiding 
catheter, and positioned in the distal part of the vessel of interest. CFI 
was determined by simultaneous measurement of mean P
ao
 (mm Hg), 
the distal coronary artery pressure during balloon occlusion (P
occl; 
mm Hg), and the CVP (mm Hg; Figure 2) obtained during the last 
30 seconds of the 1-minute coronary balloon occlusions. CFI was 
calculated as (P
occl−CVP) divided by (Pao−CVP).23 The accuracy of 
pressure-derived CFI measurements compared with ECG signs of 
myocardial ischemia during occlusion and with absolute myocardial 
perfusion measurements has been documented previously.5,24,25
Secondary Study End Points
Signs of myocardial ischemia were assessed simultaneously with 
CFI measurement as quantitatively determined intracoronary ECG 
ST-segment elevation (mV; Figure 2); the intracoronary ECG lead was 
obtained from the angioplasty guide wire via a cross-clamp to lead 
V1.3,5 Myocardial ischemia during the 1-minute coronary occlusions 
was also characterized by the presence or absence of angina pectoris.
Study Protocol
Before the diagnostic examination, 2 puffs of oral isosorbide dinitrate 
were given. After diagnostic coronary angiography and at the start 
of the invasive study procedure, all patients received 5000 U heparin 
intravenously. The left or right IMA was intubated via a second 5F 
right femoral artery introducer sheath using a 5F mammary artery 
guiding catheter. IMA angiography was performed (Figure 1). A 2.5-
mm angioplasty balloon catheter (20 mm long) was placed distally 
at or slightly below the level of the heart. The coronary artery subse-
quently undergoing CFI measurements was chosen on the basis of the 
presence of a stenotic lesion requiring percutaneous coronary inter-
vention or on the basis of ease of access in case of a nonstenotic ves-
sel. A 6F coronary guiding catheter was used in all cases. Fractional 
flow reserve was obtained before CFI. Fractional flow reserve was 
determined with the pressure guide wire positioned distally in the 
nonoccluded vessel of interest with the use of an intracoronary bolus 
of ≈70 μg adenosine for hyperemia induction: Fractional flow reserve 
equals distal coronary pressure divided by P
ao
. Shortly before the first 
CFI measurement, the IMA angioplasty balloon was inflated at a 
pressure of 5 to 7 atm, and complete occlusion was established by 
angiography. For CFI measurement, an adequately sized angioplasty 
balloon catheter (diameter ranging from 2.5–4 mm) was positioned 
in the proximal part of the vessel while the pressure guide wire 
remained distally, and balloon inflation occurred at a pressure of 1 
to 2 atm. Complete coronary occlusion was established by angiogra-
phy (Figure 1). During this vessel occlusion, simultaneous P
occl, Pao, 
and CVP were obtained for the calculation of CFI (Figure 2). During 
the entire procedure, the intracoronary ECG obtained from the guide 
wire was recorded. At the end of the first 1-minute balloon occlusion, 
the IMA and the coronary artery angioplasty balloons were released 
in this sequence. Immediately after CFI measurement, the patient was 
asked about the occurrence of angina pectoris during the 1-minute 
coronary artery balloon occlusion. A few minutes after the combined 
occlusion of the IMA and coronary artery, the second coronary artery 
occlusion was performed with the angioplasty balloon at the identical 
location as in the first occlusion. The sequence of coronary occlu-
sions remained unchanged throughout the study: first with and second 
without simultaneous IMA occlusion.
Statistical Analysis
Intraindividual comparison of CFI, intracoronary ECG ST-segment 
elevation, and heart rate obtained in the presence versus the absence of 
IMA occlusion was performed by a paired Student t test. A mixed lin-
ear model was used to assess the within-person correlation of repetitive 
measurements of continuous variables in >1 coronary artery. Because 
repetitive intraindividual measurements in different coronary arteries 
Figure 1. Left internal mammary artery 
(LIMA) angiographies in a patient before 
coronary angiography (left) and during 
simultaneous distal LIMA balloon occlusion 
with proximal occlusion of the left 
circumflex coronary artery (LCx; right). The 
LIMA occlusion is located at the bifurcation 
of the superior epigastric artery and the 
musculophrenic artery (arrow, left). During 
LIMA occlusion with radiographic contrast 
injection (right), the LCx is hazily imaged 
downstream of the balloon occlusion 
without delineation of a distinct vessel 
connecting the LIMA and LCx (pressure 
sensor wire positioned in a marginal 
branch).
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were not shown to be related to the study end points, between-group 
comparisons of continuous demographic, clinical, angiographic, and 
hemodynamic variables, CFI, and intracoronary ECG data were per-
formed by factorial ANOVA followed by the Bonferroni post hoc test 
(values of P<0.0033 indicating significance in the context of multiple 
testing). Study groups were established on the basis of the 6 differ-
ent combinations of IMA with coronary artery occlusion. The χ2 test 
or, when applicable, the Fisher exact test was used for comparison of 
categorical variables among the study groups. Continuous variables 
are given as mean and SD or SE or as median and interquartile range 
when applicable (nonnormal distribution of data).
Results
A total of 180 pairs of CFI measurements were performed 
among the 120 study patients, that is, 60 patients underwent 1 
and 60 patients underwent 2 CFI measurements (Table 1). The 
prevalence of a functional IMA–to–coronary artery connec-
tion as defined by a larger CFI in the presence compared with 
the absence of IMA occlusion was 123 of 180 (68%). During 
IMA occlusion, CFI was 0.110±0.074; in the absence of IMA 
occlusion, CFI was 0.096±0.072 (P<0.0001).
Patient Characteristics and Clinical Data
There were no statistically significant differences between the 
groups in terms of age, occurrence of cardiovascular risk factors, 
and intake of cardiovascular drugs (Table 1). The proportion of 
men differed significantly between the study groups (Table 1).
Hemodynamic and Coronary Angiographic Data
There was no difference between the groups in systemic 
blood pressure, left ventricular ejection fraction, and left 
ventricular end-diastolic pressure (Table 2). The number of 
coronary arteries with CAD, the total number of stenotic 
lesions, the percent diameter narrowing of the stenosis (ves-
sel undergoing CFI measurement), and the fractional flow 
reserve obtained in the same vessel did not differ statistically 
between the groups (Table 2).
IMA Occlusion and Related Changes in Study  
End Points
IMA balloon occlusion time before coronary balloon occlu-
sion was similar between the study groups (Table 3). Heart 
rate obtained during simultaneous IMA and coronary artery 
occlusion and during coronary occlusion without IMA occlu-
sion did not differ either intraindividually (P=0.29) or between 
the groups (Table 3).
Primary Study End Point
CFI obtained simultaneously with IMA occlusion was different 
between the study groups and was similar in the absence of IMA 
occlusion (Table 3). Figure 2 exemplifies an augmented CFI in 
the presence versus the absence of simultaneous IMA balloon 
occlusion. The individual changes in CFI in the presence versus 
the absence of IMA occlusion are shown in Figure 3.
The difference of CFI obtained in the presence of IMA 
occlusion minus CFI in the absence of IMA occlusion was 
highest and most consistently positive during left IMA with 
left anterior descending artery (LAD) occlusion and during 
right IMA with right coronary artery (RCA) occlusion (ipsi-
lateral occlusions): 0.033±0.044 and 0.025±0.027, respec-
tively (Table 3 and Figure 4). This CFI difference was absent 
during right IMA with LAD occlusion and during left IMA 
with RCA occlusion (contralateral occlusions): −0.007±0.034 
and 0.001±0.023, respectively (Table 3 and Figure 4). The 
respective CFI differences during either IMA with left cir-
cumflex artery (LCx) occlusion were inconsistently positive 
(Table 3 and Figure 4).
In the 60 patients undergoing 2 coronary artery measure-
ments, the mentioned CFI differences were statistically 
independent between the 2 coronary arteries: ΔCFI in the 
first vessel=0.01+0.1 ΔCFI in the second vessel; r2=0.005, 
P=0.61 (ΔCFI is CFI with IMA occlusion minus CFI without 
IMA occlusion).
LAD- with LIMA-occlusion LAD- without LIMA-occlusion
Pao
Poccl
CVP
i.c. ECG
CFI=0.166 CFI=0.085
Figure 2. Coronary collateral flow index (CFI) measurement in a patient with balloon occlusion of the proximal left anterior descending 
artery (LAD) with (left) and without (right) simultaneous distal left internal mammary artery (LIMA) occlusion. Left and Right, Simultaneous 
recordings of phasic and mean aortic pressure (Pao; red line; scale, 200 mm Hg), distal coronary occlusive pressure (Poccl; black line; scale, 
200 mm Hg), and central venous pressure (CVP; blue line; scale, 50 mm Hg). Additionally, an intracoronary (i.c.) ECG tracing is depicted at 
the bottom. The time is given at the bottom of the recording (≈4 minutes between the 2 LAD occlusions).
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Secondary Study End Points
Figure 2 exemplifies reduced intracoronary ECG ST-segment 
elevation in the presence versus the absence of simultane-
ous IMA balloon occlusion. Intracoronary ECG ST-segment 
elevation normalized for R amplitude was diminished most 
during ipsilateral left IMA with LAD occlusion and dur-
ing right IMA with RCA occlusion, whereas it remained 
unchanged or was worsened during contralateral IMA 
occlusion or during IMA with LCx occlusion, respec-
tively (Table 3 and Figure 4). Angina pectoris tended to 
be diminished during ipsilateral IMA with LAD and RCA 
occlusions (Table 3).
Discussion
The present clinical study demonstrated for the first time the 
prevalent in vivo function of natural IMA–to–coronary artery 
bypasses and their anti-ischemic effect. Functional natural 
IMA bypasses were consistently present during ipsilateral 
IMA with coronary artery occlusion (right IMA with RCA 
and left IMA with LAD); they were absent or inconsistently 
Table 2. Hemodynamic and Coronary Angiographic Data
LAD–LIMA LAD–RIMA LCx–LIMA LCx–RIMA RCA–LIMA RCA–RIMA P
CFI measurements, n 30 30 30 30 30 30
Systolic blood pressure, mm Hg 132±30 125±20 126±24 124±21 123±23 119±21 0.25
Diastolic blood pressure, mm Hg 71±18 76±13 70±12 70±13 70±13 68±13 0.33
LV ejection fraction, % 64±8 64±8 64±11 59±9 66±7 62±6 0.08
LV end-diastolic pressure, mm Hg 12±6 11±7 12±6 14±17 11±7 15±15 0.61
Diseased vessels, n (%) 0.65
  0 11 (37) 8 (27) 8 (27) 7 (23) 10 (33) 10 (33)
  1 7 (23) 7 (23) 6 (20) 4 (14) 4 (14) 4 (14)
  2 6 (20) 8 (27) 11(37) 6 (20) 11(37) 7 (23)
  3 6 (20) 7 (23) 5 (16) 13 (43) 5 (16) 9 (30)
Total stenoses, n 1.5±2.0 1.2±1.6 1.4±1.4 1.8±2.1 1.3±1.5 1.6±2.0 0.76
Percent diameter stenosis 28±24 27±20 22±22 24±26 26±19 32±28 0.67
Fractional flow reserve 0.81±0.14 0.83±0.13 0.92±0.09 0.93±0.09 0.92±0.13 0.89±0.18 0.0112
Continuous values are given as mean±SD. CFI indicates collateral flow index; LAD, left anterior descending artery; LCx, left circumflex coronary artery; LIMA, left 
internal mammary artery; LV, left ventricular; RCA, right coronary artery; and RIMA, right internal mammary artery.
Table 1. Patient Characteristics and Clinical Data
LAD–LIMA LAD–RIMA LCx–LIMA LCx–RIMA RCA–LIMA RCA–RIMA P
Patients, n 20 20 20 20 20 20
CFI measurements, n 30 30 30 30 30 30
Coronary artery–IMA 
connection
Ipsilateral Contralateral Ipsilateral Contralateral Contralateral Ipsilateral
Age, y 69±8 61±8 67±8 61±12 65±12 63±11 0.09
Male sex, n (%) 8 (40) 17 (85) 10 (50) 14 (70) 15 (75) 14 (70) 0.0150
Body mass index, kg/m2 28±8 29±5 27±6 27±6 27±6 27±5 0.90
Smoking, n (%) 3 (15) 7 (35) 7 (35) 8 (40) 4 (20) 5 (25) 0.23
Dyslipidemia, n (%) 11 (55) 12 (60) 12 (60) 12 (60) 11 (55) 13 (65) 0.81
Hypertension, n (%) 15 (75) 11 (55) 17 (85) 14 (70) 13 (65) 11 (55) 0.19
Family history of CAD, n (%) 7 (35) 8 (40) 7 (35) 8 (40) 8 (40) 7 (35) 0.99
Diabetes mellitus, n (%) 4 (20) 3 (15) 7 (35) 3 (15) 3 (15) 4 (20) 0.77
Acetylsalicylic acid, n (%) 13 (65) 12 (60) 11 (55) 12 (60) 12 (60) 11 (55) 0.71
Clopidogrel, n (%) 5 (25) 5 (25) 3 (15) 4 (20) 3 (15) 5 (25) 0.55
β-Blockers, n (%) 9 (45) 7 (35) 11 (55) 11 (55) 9 (45) 9 (45) 0.55
Nitrates, n (%) 0 0 1 (5) 0 1 (5) 0 0.45
ACE inhibitor/ARB, n (%) 11 (55) 9 (45) 12 (60) 10 (50) 12 (60) 10 (50) 0.74
Diuretics, n (%) 5 (25) 10 (50) 5 (25) 2 (10) 5 (25) 5 (25) 0.54
Statin, n (%) 11 (55) 11 (55) 12 (60) 14 (70) 12 (60) 13 (65) 0.68
Continuous values are given as mean±SD. ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blocker; CAD, coronary artery disease; CFI, 
collateral flow index; IMA, internal mammary artery; LAD, left anterior descending artery; LCx, left circumflex coronary artery; LIMA, left internal mammary artery; RCA, 
right coronary artery; and RIMA, right internal mammary artery.
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present during contralateral IMA with coronary artery occlu-
sion or during either IMA with LCx occlusion.
Extracardiac Coronary Collateral Supply
The branches of the IMAs are the pericardiacophrenic arteries 
with their high takeoff, anterior intercostal arteries, perforating 
arteries, musculophrenic arteries, and superior epigastric arteries 
(ie, the continuation of the IMAs), which finally anastomose 
with the external iliac arteries via the inferior epigastric arter-
ies. In this article, the older term IMA is used instead of the 
newer term internal thoracic artery in the context of historical 
aspects relating to IMA surgery. The anatomy of extracardiac 
coronary arterial anastomoses taking their origin from the bron-
chial or the internal thoracic arteries was alluded to as early as 
Table 3. IMA Occlusion and Related Changes in Coronary Collateral Function and Myocardial Ischemia
LAD–LIMA LAD–RIMA LCx–LIMA LCx–RIMA RCA–LIMA RCA–RIMA P
CFI measurements, n 30 30 30 30 30 30
IMA occlusion time before CFI, min 2.8±1.8 3.1±1.7 2.9±1.9 4.1±2.8 4.2±3.2 3.9±2.9 0.25
Heart rate with IMA occlusion, bpm 72±15 73±12 69±10 68±14 65±12 67±13 0.09
Heart rate without IMA occlusion, bpm 72±16 73±11 68±13 67±11 64±11 67±13 0.09
CFI with IMA occlusion 0.126±0.073* 0.070±0.043 0.122±0.070 0.125±0.086 0.102±0.074 0.116±0.079 0.0231
CFI without IMA occlusion 0.093±0.074 0.077±0.058 0.109±0.077 0.107±0.076 0.101±0.079 0.091±0.067 0.54
ΔCFI (with−without IMA occlusion) 0.033±0.04† −0.007±0.03† 0.014±0.03 0.017±0.05 0.001±0.02 0.025±0.03 0.0002
ECG ST-segment elevation with IMA occlusion‡ 0.82±1.76 0.54±0.65 0.41±0.36 0.26±0.19 1.06±2.10 1.18±2.21 0.13
ECG ST-segment elevation without IMA occlusion‡ 1.36±2.91 0.65±0.78 0.41±0.30§ 0.29±0.19§ 0.60±0.99 1.78±2.51 0.0070
ΔECG ST-segment shift (with−without IMA occlusion)‡ −0.51±1.18‖ −0.11±0.58 −0.02±0.22 −0.03±0.19 0.48±1.64‖ −0.48±1.42 0.0092
No angina pectoris with vs without IMA occlusion, n (%) 3 (10) 0 1 (3) 2 (7) 0 3 (10) 0.08
Continuous values are given as mean±SD. CFI indicates collateral flow index; IMA, internal mammary artery; LAD, left anterior descending artery; LCx, left circumflex 
coronary artery; LIMA, left internal mammary artery; LV, left ventricular; RCA, right coronary artery; and RIMA, right internal mammary artery.
*P<0.0029 for LAD–LIMA vs LAD–RIMA. †P≤0.0009 for LAD–LIMA vs LAD–RIMA, LAD_LIMA vs RCA_LIMA, and LAD_RIMA vs RCA_RIMA.
‡ECG ST-segment elevation normalized for R-wave amplitude (mV/mV).
§P≤0.0030 for LCx–LIMA vs RCA–RIMA and LCx–RIMA vs RCA–RIMA.
‖P<0.0012 for LAD–LIMA vs RCA–LIMA and RCA–LIMA vs RCA–RIMA.
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Figure 3. Individual changes in coronary collateral flow index (CFI) obtained in the 3 coronary arteries with and without simultaneous 
internal mammary artery (IMA) occlusion. The error bars indicate median values and interquartile ranges. LAD indicates left anterior 
descending artery; LCx, left circumflex coronary artery; LIMA, left IMA; RCA, right coronary artery; and RIMA, right IMA.
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1803 by Albrecht von Haller (cited in Loukas et al26). Hudson et 
al10 rediscovered them accidentally by observing the supply of 
ink injected into the coronary circulation to the pericardium and 
to extracardiac arterial regions. Hence, communication between 
the coronary circulation and pericardiacophrenic branches of 
the IMAs, but also the anterior mediastinal, phrenic, and inter-
costal arteries and the esophageal arterial branches of the aorta, 
was demonstrated.11 The bronchial arteries supply the posterior 
part of the pericardium, and extracardiac anastomoses to the 
coronary arteries are preferentially found at sites of pericardial 
reflections such as entry into the pericardium of the caval veins.27 
The most common bronchial artery–to–coronary artery commu-
nication has been documented to the left circumflex coronary 
artery.27 Structurally, this may explain why in our present study 
functional IMA bypasses to the LCx were present only incon-
sistently and why, in essence, they had no anti-ischemic effect.
Function of Natural IMA Bypasses
In the context of the first studies of bilateral IMA ligation (see 
below),12–16,28 canine experiments on the extracorporeal bypass 
have shown that the procedure as carried out in the second 
intercostal space led to an average increase in total coronary 
flow of ≈6 to 10 mL/min.29 It was thought that the hemody-
namic effect of IMA ligation was transmitted by a local pres-
sure rise of 12 to 15 mm Hg in the subclavian artery with 
unchanged systemic pressure.30 If the macroscopic arterial cir-
culation is considered a system of connecting tubes, an instan-
taneous pressure equilibration would physically be expected 
rather than the mentioned pressure difference. Conversely, the 
length of the arterial system between different sections resist-
ing the pressure transmission could serve as an explanation for 
the findings by Taber and Marchioro.30
Compared with the cited experiments,29,30 the present study 
protocol did not, for ethical reasons, temporarily block the 
entire coronary circulation but instead blocked only part of it, 
that is, 1 of the 3 coronary arteries. Myocardial ischemia was 
induced twice with and without simultaneous IMA occlusion. 
The sequence of coronary occlusions with IMA occlusion first 
was held constant as a conservative measure favoring the null 
hypothesis of the study that coronary collateral function does 
not increase in the presence versus the absence of distal IMA 
balloon occlusion. Possible coronary collateral recruitment or 
ischemic preconditioning occurring during the second (but not 
the first) occlusion could be misinterpreted as augmented CFI or 
diminishing signs of ischemia in the context of IMA occlusion 
if it occurred during the second but not the first coronary occlu-
sion. Despite this study design, CFI was higher in the presence 
versus the absence of IMA occlusion in 68% of the measure-
ments, and overall, this difference amounted to 0.025 compared 
with the absence of IMA occlusion (P<0.0001). The fact that 
the anatomic vicinity of the occluded IMA and coronary artery 
rendered this finding more consistent enhances the verification 
of the hypothesis in the case of the LAD and RCA. The variabil-
ity in response of either IMA occlusion during LCx occlusion 
increased rather than decreased, which may be seen in light of 
the variable supply of the LCx coronary territory by extracar-
diac sources other than the IMA (bronchial arteries).27
 The con-
sistency of the CFI increase during IMA occlusion was slightly 
less in the case of LAD with left IMA occlusion (25 of 30 mea-
surements) than in the case of RCA with right IMA occlusion 
(28 of 30 measurements). The most likely explanation for a 
worsening response in the context of ipsilateral IMA-to-LAD 
and IMA-to-RCA occlusions is strong collateral recruitment or 
ischemic preconditioning during the second coronary occlusion 
in nonfunctional IMA anastomoses. Theoretically, the possi-
bility of the 20-mm-long angioplasty balloon obstructing the 
takeoff of the pericardiacophrenic branch directly supplying 
the coronary system is given as an alternative explanation for a 
diminished CFI during ipsilateral IMA occlusion. However, for 
this study, it is irrelevant because the IMA occlusion site was 
always distal at the fifth or sixth intercostal space, where the 
bifurcation of the superior epigastric and the musculophrenic 
artery is located (Figure 1A). The bifurcation of the IMA and 
the pericardiacophrenic artery is, on the other hand, its first or 
second one at the level of the first or second intercostal space.
Anti-Ischemic Effect of Natural IMA Bypasses
This topography of the IMA-pericardiacophrenic bifurcation pro-
vided the rationale for the IMA ligation site chosen in the trials 
Figure 4. Top, Difference (Delta) between collateral flow index 
(CFI) obtained with internal mammary artery (IMA) occlusion and 
that obtained without IMA occlusion (vertical axis) plotted for 
the study groups (ie, according to the combination of IMA with 
simultaneous coronary artery occlusion). Bottom, Difference 
(Delta) between intracoronary ECG ST-segment elevation 
normalized for R amplitude obtained with IMA occlusion and 
that without IMA occlusion (vertical axis) plotted as in the top. 
The box plots indicate median values and interquartile ranges; 
the error signs indicate 10% and 90% confidence intervals; and 
the cross signs indicate mean values. LAD indicates left anterior 
descending artery; LCx, left circumflex coronary artery; LIMA, left 
IMA; RCA, right coronary artery; and RIMA, right IMA.
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carried out in the late 1950s among ≈500 symptomatic CAD pat
ients.15,17,18,28,31–33 IMA ligation as a treatment for angina pecto-
ris was conceived by Fieschi in 1939, and in 1954, Battezzati et 
al12 documented anew the existence of connections between both 
IMAs and the myocardium by methylene blue injection into the 
IMAs. Transthoracic surgical access to the IMAs was performed 
under local anesthesia by a small incision between the second and 
third rib. The primary end point of the clinical trials was angina 
pectoris and, inconsistently, ECG signs of myocardial ischemia. 
Battezzati and coworkers28 reported the results of their uncon-
trolled trial among 304 CAD patients in 1959. Nearly all of the 
patients improved in terms of their symptoms, and this improve-
ment was sustained during follow-up. In a further uncontrolled 
trial among 50 CAD patients, Kitchell et al31 reported similarly 
favorable results, with symptomatic relief in 68% of the patients. 
The following sham-controlled trials of bilateral IMA ligation in 
35 CAD patients coined the phrase “surgery as placebo” in the 
context of their negative results.17,18,34 Although the introduction 
of a sham-control study design in the context of surgical trials 
was seminal,35 the conclusion drawn from the negative results of 
the IMA ligation trials at hand is questionable in the context of the 
present investigation. Possibly in this context, the anti-ischemic 
concept of IMA ligation has been promoted again lately.22,36–38
In the trial by Cobb et al,17 angina pectoris relief was found 
in 5 of 8 patients (63%) after IMA ligation and in 5 of 7 patients 
(71%) after IMA sham ligation. Dimond and coworkers18 
reported 9 of 13 in the verum and 5 of 5 in the sham-operation 
group, respectively. In comparison, angina pectoris relief during 
a 1-minute ipsilateral IMA plus simultaneous coronary balloon 
occlusion in our study occurred in 6 of 60 measurements among 
40 patients; it was absent during contralateral IMA occlusion 
(P=0.08). From this perspective, the abrupt stop of bilateral 
transthoracic IMA ligation was likely caused by the advent of 
IMA bypass grafting rather than by the slim evidence against 
IMA ligation claimed by the controlled trials. The soft study 
end point of angina pectoris requires patient numbers that, for 
meaningful results, are 1 order of magnitude higher than those 
recruited for the sham-controlled IMA ligation trials. This 
is even more so in case of an inconsistently applied ischemic 
stimulus such as daily activities versus the systematically used 
1-minute coronary occlusion. In this context, the present study 
predefined intracoronary ECG ST-segment elevation during 
coronary occlusion, not angina pectoris, as the first end point for 
ischemia, the former of which was consistently reduced during 
ipsilateral IMA with RCA or LAD occlusion. Another drawback 
of the historical IMA ligation studies was that their patients did 
not undergo coronary angiography, and it is unknown how many 
in the verum group had, by chance, their culprit lesion in the 
LCx, where the effect of IMA ligation from either side is vari-
able and not anti-ischemic. Finally, the systematic IMA ligation 
at the second intercostal space may have resulted in a variable 
site of IMA occlusion proximal or distal to the pericardiaco-
phrenic artery, that is, the source of extracardiac supply to the 
coronary circulation. Occlusion proximal to the bifurcation of 
the pericardiacophrenic artery likely resulted in a much reduced 
supply to the pericardium compared with distal occlusion.
Study Limitations
The present study performed collateral function measurements 
of the IMAs themselves in only a small minority of the cases, 
which does not allow reliable estimation of their CFI for a dis-
tinction between the effect of proximal and distal IMA occlusion. 
Anatomically, there is communication between the IMAs and 
the iliac external arteries via the superior and inferior epigastric 
arteries. On the basis of the rare functional IMA CFI measure-
ments of the present study, collateral supply from the caudal side 
amounted to approximately two thirds during proximal IMA 
occlusion compared with patency. The absence of systematic 
proximal IMA occlusion implies a further study limitation, that 
is, the missing information on the effect of proximal IMA occlu-
sion together with occlusion of the pericardiacophrenic branch. 
Because the latter has been described as the extracardiac source 
of coronary arterial supply, the effects found in the present study 
would have been absent during proximal IMA occlusion at the 
site of the pericardiacophrenic artery bifurcation. Finally, IMA 
angiography during distal occlusion was systematically per-
formed, but image quality at the end of the 1-minute occlusion 
was too inconsistent to allow proper analysis of contrast medium 
supply to the coronary circulation. In fact, this could be seen in 
only 2 to 3 patients in our study (see Figure 1).
Study Implications
From the present study findings, an anti-ischemic therapeutic 
approach alternative to IMA bypass grafting (ie, distal IMA 
occlusion by invasive techniques) can be considered. In a first 
step, catheter-based IMA occlusion ought to be investigated 
conceptually in the setting of the less frequently grafted right 
IMA among patients with ischemia in the RCA territory.
Conclusion
There is a functional, ischemia-reducing extracardiac coro-
nary artery supply via ipsilateral but not via contralateral natu-
ral IMA bypasses.
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CLINICAL PERSPECTIvE
Until now, the prevalence, functional relevance, and effect on myocardial ischemia of extracardiac coronary collateral sup-
ply via natural internal mammary artery (IMA) bypasses have been unknown. The present study in patients without and 
with coronary artery disease tested the hypotheses that coronary collateral function increases in the presence versus the 
absence of distal IMA balloon occlusion and that the former is reflected by reduced myocardial ischemia. The study among 
120 patients with chronic stable coronary artery disease undergoing coronary angiography found that there is a functional, 
ischemia-reducing extracardiac coronary artery supply via ipsilateral (ie, during left IMA with left anterior descending artery 
occlusion and during right IMA with right coronary artery occlusion) but not via contralateral natural IMA bypasses. On 
the basis of the findings presented here, an anti-ischemic therapeutic approach alternative to IMA bypass grafting, that is, 
distal IMA occlusion by invasive techniques, can be considered. In a first step, catheter-based IMA occlusion ought to be 
conceptually investigated in the setting of the less frequently grafted right IMA among patients with ischemia in the right 
coronary artery territory.
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3.2 Project II
Effect of Permanent Right Internal Mammary Artery
Closure on Coronary Collateral Function and Myocardial
Ischemia
The second project aimed at determining the effect of permanent right internal mam-
mary closure on coronary collateral function and myocardial ischemia in humans.
My contributions were the conception and design of the project, acquiring, analyzing
and interpreting the data, assisting in statistical analysis and making critical revision
of the manuscript for important intellectual content.
The paper has been pubslished in Circulation: Cardiovascular Interventions in
June 2017, journal ranking was #13 according to impact factor and #8 accord-
ing to SCImago Journal Rank (SJR)[89] in 2015 in Cardiology and Cardiovascular
Medicine.
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1The prevalence of patients with stable coronary artery dis-ease (CAD) undergoing indicated but incomplete revas-
cularization is close to 30%, and all-cause mortality among 
these patients has been described elevated in comparison to 
those with complete revascularization (3-year cumulative mor-
tality rate of 14.8% versus 6.6%).1 Patients with incomplete 
revascularization and refractory angina pectoris require novel 
therapeutic strategies aimed at improving survival by reduc-
ing myocardial ischemia because in stable CAD, outcome after 
medical therapy irrespective of percutaneous coronary interven-
tion (PCI) is dependent on the amount of myocardial ischemia.2 
In the event of coronary occlusion, ischemia is influenced by 
its duration, the size of the ischemic territory, the lack of col-
lateral supply, the absence of ischemic preconditioning prior 
to occlusion, and myocardial oxygen consumption at the time 
of occlusion.3 The clinical benefit on survival of a functional 
intercoronary collateral circulation in chronic stable CAD has 
been documented.4,5 Additionally, extracardiac coronary collat-
eral supply via the internal mammary artery (IMA) has been 
described.6–8 Seven case reports have documented the existence 
of naturally occurring angiographic anastomoses between one 
of the IMAs and the human coronary circulation.9–15 Blair et 
al measured increased coronary artery blood flow after experi-
mental IMA ligation. More recently, a study in 8 dogs undergo-
ing coronary artery constriction and IMA ligation has failed to 
reveal myocardial microsphere perfusion via IMA in the single 
animal, which survived the study protocol.17 In patients with 
CAD, our group has provided evidence for a functional, isch-
emia-reducing extracardiac coronary artery collateral supply 
during temporary ipsilateral IMA balloon occlusion.18
See Editorial by Kern and Seto
Background—The objective of this study is to test the effect of permanent right internal mammary artery device closure on 
coronary collateral function and myocardial ischemia.
Methods and Results—This was a prospective, open-label clinical trial in 50 patients with coronary artery disease. The primary 
study end point was coronary collateral flow index as obtained during a 1-minute proximal right coronary artery (RCA) and left 
coronary artery balloon occlusion at baseline before and at follow-up examination 6 weeks after distal right internal mammary 
artery device closure. Collateral flow index is the ratio between simultaneously recorded mean coronary occlusive pressure 
divided by mean aortic pressure, both subtracted by central venous pressure. Secondary study end points were fractional flow 
reserve during vessel patency, the quantitative intracoronary ECG ST-segment elevation, and angina pectoris during the same 
1-minute coronary occlusion. Collateral flow index in the untreated RCA and left coronary artery changed from 0.071±0.082 
at baseline to 0.132±0.117 (P<0.0001) at follow-up examination and from 0.106±0.092 to 0.081±0.079 (P=0.29), respectively. 
RCA fractional flow reserve increased significantly (P=0.0029) from baseline to follow-up examination, despite deferral of 
coronary intervention in all patients. There was a decrease in intracoronary ECG ST-elevation during RCA occlusion from 
baseline to follow-up examination (P=0.0015); it did not change in the left coronary artery. Angina pectoris during RCA 
occlusion tended to occur in fewer patients at follow-up versus baseline examination (P=0.06).
Conclusions—Permanent right internal mammary artery device closure seems to augment extracardiac ipsilateral coronary 
supply to the effect of reducing ischemia in the dependent myocardial region.
Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT02475408.   
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2  Stoller and Seiler  RIMA Closure and Coronary Collateral Function 
Thus, the present conceptual study tested the hypotheses 
that after 6 weeks of follow-up, permanent right IMA (RIMA) 
device closure results in augmented collateral function of the 
right coronary artery (RCA), but not the left coronary artery 
(LCA), and that this is reflected by respective changes in myo-
cardial ischemia.
Methods
Study Design and Patients
This was a prospective, open-label, longitudinal interventional clini-
cal trial in 50 patients undergoing diagnostic coronary angiography in 
the context of chest pain. The primary study end point was quantitative 
coronary collateral function (collateral flow index, CFI; see below for 
calculation) as obtained during a 1-minute proximal coronary artery 
balloon occlusion at baseline before and at follow-up examination 6 
weeks after RIMA device occlusion (Figure 1). Secondary study end 
points were fractional flow reserve during vessel patency (FFR), the 
quantitatively determined intracoronary (IC) ECG ST-segment eleva-
tion, and angina pectoris during the same 1-minute coronary occlu-
sion. Study end points were obtained in the RCA and LCA. Eligibility 
criteria for study inclusion were age >18 years, angina pectoris under 
conventional medical therapy, written informed consent to participate 
in the study, and 1- to 3-vessel chronic stable CAD. Exclusion criteria 
were acute coronary syndrome, previous myocardial infarction in the 
vascular region undergoing CFI measurement, and severe hepatic or 
renal failure (creatinine clearance <15 mL/min per 1.73 m2).
The study was approved by the ethics committee of the Kanton of 
Bern, Switzerland, and all patients gave written informed consent to 
participate (in accordance with the author guidelines of this journal).
Cardiac Catheterization and Coronary 
Angiography
Patients underwent left heart catheterization and coronary angiogra-
phy for diagnostic purposes from the right femoral artery approach via 
a 6F introducer sheath. Biplane left ventriculography was performed 
followed by coronary angiography. Coronary artery stenoses were 
assessed quantitatively as percent diameter reduction using the guid-
ing catheter for calibration. Aortic pressure (P
ao
) was acquired via a 6F 
guiding catheter. Central venous pressure (CVP) was measured by a 
5F pigtail catheter as right atrial pressure via the right femoral vein.
Study End Points
Primary Study End Point
Coronary occlusive collateral flow relative to normal antegrade flow 
through the nonoccluded coronary artery (CFI) was determined using 
coronary pressure measurements. A 0.014-inch pressure monitoring 
angioplasty guidewire (Pressure Wire; St Jude Medical, Eschborn, 
Germany) was set at zero, calibrated, advanced through the guid-
ing catheter, and positioned in the distal part of the vessel of interest 
(identical position at baseline and follow-up examination). CFI was 
determined by simultaneous measurement of mean aortic pressure (P
ao
, 
mm Hg), the mean distal coronary artery pressure during balloon occlu-
sion (P
occl, mm Hg), and the mean CVP (mm Hg; Figure 2) as measured 
during the last 30 seconds of the 1-minute coronary balloon occlusions. 
CFI was calculated as (P
occl−CVP) divided by (Pao−CVP).19 The ac-
curacy of pressure-derived CFI measurements in comparison to ECG 
signs of myocardial ischemia during occlusion and to absolute myo-
cardial perfusion measurements has been documented previously.5,19–21
Secondary Study End Points
Coronary pressure–derived FFR measurements were obtained. Signs 
of myocardial ischemia were assessed simultaneously to CFI mea-
surement as quantitatively determined IC ECG ST-segment elevation 
in millivolt (Figure 2); the IC ECG lead was obtained from the angio-
plasty guidewire via a cross-clamp to a precordial lead.22 Myocardial 
ischemia during the 1-minute coronary occlusions was also character-
ized by the presence or absence of angina pectoris.
Study Protocol
Before the diagnostic examination, 2 puffs of oral isosorbidedinitrate 
were given. After diagnostic coronary angiography and at the start of 
the invasive baseline and follow-up study procedure, all patients re-
ceived 5000 U of heparin intravenously. End point measurements were 
first obtained in the LCA, followed by the RCA. FFR was performed 
prior to CFI and in the same vessels as those undergoing CFI mea-
surement. FFR was determined with the pressure guidewire positioned 
distally in the nonoccluded main vessel of interest using intravenous 
adenosine at 140 μg/min per kg for hyperemia induction: FFR=distal 
coronary pressure divided by P
ao
. The LCA (left anterior descending 
artery, LAD, and left circumflex coronary artery) undergoing CFI mea-
surements was chosen on the basis of the presence of a stenotic lesion 
requiring PCI or on the basis of ease of access in case of a nonstenotic 
vessel. For CFI, an adequately sized angioplasty balloon catheter was 
positioned in the ostial part of the vessel while the pressure guidewire 
remained distally. Before imminent coronary balloon occlusion, the 
patient was asked not to talk and to breath normally for the following 
1.5 minutes (prevention of CVP variability). Coronary balloon infla-
tion occurred at a pressure of 1 to 2 atmospheres. Complete coronary 
occlusion was ascertained by angiography. During the 1-minute oc-
clusion, simultaneous P
occl, Pao, and CVP were recorded for the cal-
culation of CFI (Figure 2). During the entire procedure, the IC ECG 
obtained from the guidewire was recorded. Immediately after CFI 
measurement, the patient was asked about the occurrence of angina 
pectoris during coronary artery balloon occlusion. At an FFR>0.75, 
PCI of the LCA was deferred to the end of the invasive follow-up 
examination (ie, after all end point measurements), which took place 
at 6 weeks after the baseline examination; at an FFR≤0.75, PCI of the 
LCA occurred at baseline before end point measurements in the RCA. 
End point measurements in the RCA were repeated as just described.
At the end of the baseline examination, permanent RIMA device 
occlusion was performed using a 4F IMA catheter and a Radiofocus 
0.032-inch, 260-cm stiff guidewire (Terumo, Eschborn, Germany), the 
latter of which was placed with its tip below the diaphragm. The IMA 
catheter was then exchanged for a 4F multipurpose catheter, which was 
engaged in the IMA until its tip reached the level of the right atrium 
WHAT IS KNOWN
• A recent investigation in patients with stable coro-
nary artery disease has shown that temporary balloon 
occlusion of the internal mammary artery induces a 
functional, ischemia-reducing extracardiac coronary 
artery supply via ipsilateral natural internal mam-
mary artery bypasses.
WHAT THE STUDY ADDS
• The new finding of the present study is that over the 
course of 6 weeks, permanent right internal mam-
mary artery occlusion by a vascular closure device 
augments extracardiac right coronary artery but not 
left coronary artery supply and reduces myocardial 
ischemia during a 1-minute ostial right coronary ar-
tery balloon occlusion.
• Permanent internal mammary artery device closure 
deserves further evaluation as a potential treatment 
option for alleviation of myocardial ischemia in pa-
tients with chronic coronary artery disease not ame-
nable to conventional revascularization or refractory 
to medical therapy.
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(anteroposterior projection). Subsequently, an Amplatzer vascular plug 
4 (St Jude Medical, Eschborn, Germany) was inserted via the multipur-
pose catheter into the RIMA at the level of the right atrium (Figure 1). 
Invasive follow-up examinations at 6 weeks after RIMA device occlu-
sion consisted of identical measurements as described earlier.
Statistical Analysis
Sample size calculation was based on values for the primary end 
point CFI found in the previous work by Stoller et al,18 which had 
means±standard deviations of 0.116±0.079 and 0.091±0.067 with 
and without RIMA balloon occlusion, respectively, measured cross-
sectionally. Using a 1-sided paired Student’s t test for intraindividual 
changes and a correlation of 0.65 between the matched data pairs 
(baseline and 6-week follow-up RCA CFI), an alpha level of 0.05, and 
a power of 0.80, the calculated sample size was 40 using the GPower 
program. For the purpose of data presentation, 2 study groups were 
established based on the absence or presence of percent diameter RCA 
stenosis ≤ or >50% as determined quantitatively. Intraindividual com-
parison of CFI, FFR, IC ECG ST-segment elevation, and heart rate 
obtained at baseline versus follow-up examination was performed by 
a paired Student’s t test. Between-group comparison of continuous 
demographic, clinical, angiographic, hemodynamic variables, CFI, 
FFR, and IC ECG data was performed by unpaired Student’s t test. 
A χ2 test was used for comparison of categorical variables among the 
study groups. Statistical significance was defined at a P level <0.05. 
Continuous variables are given as mean and standard deviation.
Results
Thirty-seven patients belonged to the group with an RCA lesion 
≤50% in diameter, and 13 patients were in the group with at 
least 1 stenosis >50% (Table 1). PCI of the RCA was postponed 
to after follow-up end point measurements or not performed 
(n=40) in all 50 patients; in case of the LCA, PCI was deferred 
in 33 patients, and it was performed at baseline in 11 patients. 
In 6 patients, no LCA end point measurement at baseline and 
follow-up was performed, that is, it occurred only in the RCA.
Patient Characteristics and Clinical Data at 
Baseline
There were no statistically significant differences between the 
groups regarding age, sex, body mass index, Canadian Cardio-
vascular Society class of angina pectoris, cardiovascular risk 
factor prevalence, and cardiovascular medication (Table 1).
Figure 1. A, Anteroposterior angiogram of the truncus brachiocephalicus (site of the catheter tip) depicting the right internal mammary 
artery (RIMA) with its pericardiophrenic branch (arrow) taken at the baseline examination. B, RIMA angiography of the same patient as 
in A taken during follow-up examination. Simultaneous occlusion of the distal RIMA (by vascular occlusion device) and the ostial right 
coronary artery (RCA, by angioplasty balloon). The pericardiophrenic branch (arrow) and the other RIMA branches are larger than those at 
baseline (A).
Figure 2. Left, Simultaneous recording of phasic and mean aortic pressure (Pao, red curve), ostial right coronary artery (RCA) occlusive 
pressure (Poccl, black curve), central venous pressure (CVP, blue curve), and intracoronary ECG (bottom, black curve) as obtained during 
baseline examination. Coronary balloon occlusion starts at ≈2 seconds on the time scale (horizontal axis) and lasts until 79 seconds (up-
slope of Poccl). Pao, Poccl, and CVP are taken as temporal mean values between the arrowheads: collateral flow index, CFI=(Poccl−CVP)/ 
(Pao−CVP)=(18.8−12.5)/(92.6−12.5)=0.079. Right, Simultaneous recording of phasic and mean Pao, ostial RCA Poccl, CVP, and intracoronary 
ECG during follow-up examination in the same patient as in the left panel. CFI=0.190.
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Hemodynamic and Coronary Structural and 
Functional Data at Baseline
There were no statistical differences between the groups 
in heart rate, left ventricular ejection fraction and end-dia-
stolic pressure, and mean arterial venous pressure and CVP 
(Table 2). The number of coronary arteries with stenotic 
lesions >50% was similar between the groups. Study end 
points were determined in all patients in the RCA and with 
similar frequency among the groups in the LAD or left cir-
cumflex coronary artery (in 44 LCA vessels at baseline). RCA 
percent diameter stenosis and FFR differed according to the 
group definition (Table 2). FFR of the LCA was significantly 
higher in the group with no or irrelevant RCA stenosis than in 
the group with significant RCA stenosis.
Changes of Coronary Function and Myocardial 
Ischemia During Follow-Up
Primary Study End Point
Overall, CFI in the RCA changed from 0.071±0.082 at base-
line to 0.132±0.117 (P<0.0001) at follow-up examination 
(Figure 3 and Table 2). CFI in the untreated LCA changed 
from 0.106±0.092 to 0.081±0.079 (P=0.29). Absolute CFI 
change in the RCA over the 6-week course of follow-up 
was +0.067±0.094, and it was −0.012±0.112 in the LCA 
(P<0.0001; Figure 3). There was a trend to higher CFI increase 
in the group of patients with relevant RCA stenosis (Table 2).
Secondary Study End Points
FFR in the RCA increased significantly from baseline to fol-
low-up examination (Figure 4), and it remained unchanged 
in the LCA (PCI deferred until after FFR measurement in all 
vessels). There was a decrease in IC ECG ST-elevation during 
Table 1. Patient Characteristics and Clinical Data at Baseline
RCA % Diameter 
Reduction ≤50%
RCA % Diameter 
Reduction >50% P Value
Number of patients 37 13  
Age, y 67±10 60±13 0.06
Male sex, % 31 (84) 13 (100) 0.17
Body mass index, kg/m2 28±5 27±2 0.40
CCS class of angina at 
baseline 0/i/ii/iii
0/12/18/7 0/5/4/4 0.44
Current smoking, % 9 (24) 5 (38) 0.47
Dyslipidemia, % 35 (95) 12 (92) 0.98
Hypertension, % 28 (76) 10 (77) 0.95
Family history for CAD, % 15 (41) 3 (23) 0.49
Diabetes mellitus, % 12 (32) 1 (8) 0.14
Acetylsalicylic acid (ASA; %) 34 (92) 12 (92) 0.79
Platelet inhibitors other 
than ASA, %
14 (38) 6 (46) 0.34
Beta-blockers, % 23 (62) 6 (46) 0.52
Calcium antagonists, % 5 (14) 0 0.37
ACE inhibitor/ARB, % 28 (76) 10 (77) 0.82
Diuretics, % 7 (19) 2 (15) 0.80
Nitrates, % 3 (8) 0 0.56
Statins, % 33 (89) 12 (92) 0.60
ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor 
blocker; CAD, coronary artery disease; CCS, Canadian Cardiovascular Society; 
and RCA, right coronary artery.
Table 2. Hemodynamic Data at Baseline and Coronary 
Structural and Functional Data
 
RCA % Diameter 
Reduction ≤50%
RCA % Diameter 
Reduction >50%
P Value
Number of patients 37 13  
Heart rate, bpm 72±12 73±15 0.92
Left ventricular ejection 
fraction, %
60±11 59±9 0.56
Left ventricular end-
diastolic pressure, mm Hg
14±4 14±7 0.80
Mean arterial pressure, 
mm Hg
95±17 91±17 0.41
Mean central venous 
pressure, mm Hg
9±4 10±3 0.40
Number of coronary 
arteries diseased
2.3±0.7 2.4±0.7 0.58
Coronary artery for 
collateral flow index (CFI)
  0.45
  Right coronary artery 
(RCA), %
All All  
  Left anterior 
descending artery 
(LAD), %
13 (35) 6 (46)  
  Left circumflex artery 
(LCX), %
21 (57) 4 (31)  
Right coronary artery PCI, 
%; all deferred
1 (3) 9 (69) 0.0001
Left coronary artery (LCA) 
PCI, %
34 (92) 10 (77) 0.61
Percent diameter stenosis 
RCA at baseline
28±18 65±23 <0.0001
Percent diameter stenosis 
LCA at baseline
44±18 53±26 0.19
Fractional flow reserve 
RCA at baseline
0.89±0.12 0.75±0.26 0.0304
Fractional flow reserve 
LCA at baseline
0.84±0.10 0.66±0.24 0.0047
Collateral flow index RCA 
at baseline
0.063±0.073 0.090±0.111 0.36
Collateral flow index RCA 
at follow-up
0.116±0.082 0.146±0.143 0.39
CFI difference (follow-up 
minus baseline)
+0.053±0.065 +0.094±0.128 0.14
IC ECG ST-segment shift 
RCA at baseline, mV
+0.56±0.52 +0.42±0.59 0.53
CCS class of angina at 
follow-up 0/i/ii/iii
16/8/9/4 6/5/1/1 0.37
CCS indicates Canadian Cardiovascular Society; IC, intracoronary; and PCI, 
percutaneous coronary intervention.
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5  Stoller and Seiler  RIMA Closure and Coronary Collateral Function 
RCA occlusion from baseline to follow-up examination (Fig-
ure 4); IC ECG ST-elevation did not change significantly in 
the LCA. There was a trend to fewer events of angina pectoris 
during RCA occlusion at follow-up versus baseline examina-
tion and in comparison to LCA occlusion irrespective of the 
examination (Figure 5).
Canadian Cardiovascular Society class of angina pecto-
ris class 0 at follow-up was observed more frequently than at 
baseline examination (Tables 1 and 2).
Procedural Feasibility of RIMA Closure
RIMA device closure was successful in all patients. In 12 
patients, the right femoral artery access had to be switched 
to right radial artery or right brachial artery (n=2) access 
to achieve procedural success. Except for 2 cases of proxi-
mal RIMA dissection, no procedure-related complications 
occurred. The dissections were left untreated. During the 6 
weeks of follow-up, all patients remained asymptomatic with 
regard to the RIMA device closure. Angiographic control of 
the RIMA at follow-up revealed incomplete occlusion at the 
site of the device in 11 of 50 cases.
Discussion
The present conceptual clinical trial found that permanent 
RIMA device closure results in augmented right (but not left) 
coronary collateral function (CFI), which was reflected by 
improved coronary hemodynamics as obtained during vessel 
patency (FFR) and by reduced signs of myocardial ischemia 
during vessel occlusion.
Treatment Options for Refractory Angina Pectoris
Refractory angina pectoris is defined as a chronic condi-
tion (>3 months) characterized by the presence of angina 
caused by coronary insufﬁciency in the presence of CAD, 
which cannot be controlled by a combination of medical 
therapy, angioplasty, and coronary bypass surgery.23 There 
are numerous treatment options aiming at alleviating myo-
cardial ischemia using angiogenic therapeutic approaches 
(by the so-called myocardial laser revascularization,24 
external shock wave therapy,25 and myocardial stem cell 
application26), diastolic coronary pressure augmentation by 
external counterpulsation,27 coronary arteriogenesis with 
induction of large collateral artery remodeling,28 coronary 
sinus venous backpressure augmentation,29,30 and ischemic 
preconditioning.31,32 The latter represents the default therapy 
applied by any primary or secondary prevention program 
because physical exercise with myocardial ischemia is its 
cornerstone. The only potentially useful treatment option 
exerting a permanent and not just temporary effect is cor-
onary sinus pressure augmentation using a venous caliber 
reducer stent.33 All the other modalities require repetitive 
applications for a lasting effect, the fact of which substan-
tially reduces the tolerability of a procedure, especially if it 
Figure 3. Individual values of collateral flow index (CFI, vertical 
axis) as obtained at baseline and follow-up examination in the 
right and left coronary artery. Error bars indicate mean values and 
standard deviation.
Figure 4. Left, Individual values of fractional flow reserve (FFR, vertical axis) as obtained at baseline and follow-up examination in the 
right and left coronary artery. Error bars indicate mean values and standard deviation. Right, Individual values of intracoronary ECG ST-
segment shift (i.c. ECG ST-segment shift, vertical axis; ST-elevation as positive values) as obtained at baseline and follow-up examination 
in the right and left coronary artery. Error bars indicate mean values and standard deviation.
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is as strenuous and time-consuming as, for example, exter-
nal counterpulsation with its daily 1-hour sessions.
In comparison, the anatomic connections between the 
IMAs and the coronary circulation represent the basis for a 
sustainably improved extracardiac myocardial supply source.8 
Essentially, this applies also to the extracardiac source of col-
lateral connections between the bronchial artery and the RCA, 
respectively, the left circumflex coronary artery.34 However, 
these circulatory anastomoses are even less explored than the 
IMA coronary artery network.
Extracardiac Coronary Artery Supply via the IMAs
Anatomically, the IMAs on each side and the coronary circu-
lation are connected via the second IMA branch, that is, the 
pericardiophrenic or pericardiacophrenic artery, which takes 
off proximally at the second intercostal space and supplies the 
pericardium.8 During IMA angiography, the pericardiophrenic 
branch is recognizable as the only IMA branch moving with 
the heart beat. At the follow-up examination of our study, 
enlargement of this IMA branch could be observed often (see 
Figure 1). The pericardiophrenic artery with its pericardial 
branches finds access to atrial branches of the epicardial coro-
nary circulation via the sites of pericardial reflections located 
at the entry into the pericardium of the caval veins.35 This 
well-documented anatomic knowledge6–8,35,36 led to the first 
surgical attempt of myocardial revascularization. More than 
20 years before the first clinical coronary artery bypass graft-
ing in 1960,37 the ligation of the IMAs aiming at redirecting 
blood flow to the pericardiophrenic branch was introduced as 
a treatment concept for angina pectoris by Fieschi.38 In the 
course of this procedure, transthoracic surgical access to the 
IMAs was gained under local anesthesia by a small incision 
between the second and third rib, and they were ligated via this 
entry site. The primary end point of the first clinical IMA liga-
tion trials was angina pectoris and, inconsistently, ECG signs 
of myocardial ischemia. Battezzati et39 reported the results of 
their uncontrolled trial in 304 CAD patients, with only half of 
them having angina pectoris: the symptoms of nearly all of 
them had improved sustainably. In a further uncontrolled trial 
among 50 CAD patients (2/3 with angina pectoris), Kitchell 
et al40 reported similarly favorable results with symptomatic 
relief in 68% of the patients.
Surgical bilateral IMA ligation has not gained historical 
stature because of its success, but because of its failure. The 
latter was—apparently—exposed by the then introduced new 
research design tool of a sham control group. The small, but 
sham-controlled negative trials by Cobb et al41 and by Dimond 
et al42 (totaling 35 patients) coined the term surgery as pla-
cebo.43,44 The fraction of trial participants (based on single 
digit numbers) experiencing relief of angina pectoris dur-
ing long-term follow-up was similar between the really and 
sham-operated group.41,42 To infer IMA ligation inefficacious 
on the basis of those trials was unwarranted, but desirable for 
the inauguration of an essential scientific element into clinical 
research; this must be the current conclusion because of their 
low power in connection with a soft primary clinical end point 
(chest pain).
Furthermore, a recent clinical investigation in 120 CAD 
patients undergoing temporary distal IMA and simultaneous 
ostial coronary artery balloon occlusion has found an isch-
emia-reducing, enhanced extracardiac coronary artery supply 
via ipsilateral (but not contralateral) natural IMA bypasses.18 
Specifically, the CFI difference as obtained with versus with-
out IMA occlusion was highest and most consistently positive 
during left IMA with LAD occlusion and during RIMA with 
RCA occlusion: +0.033±0.04 and +0.025±0.03.18
Permanent IMA Closure
Permanent distal IMA device occlusion is the logical conse-
quence of the above observations collected during temporary 
IMA balloon occlusion. The concept had to be tested in the 
setting of the less frequently grafted RIMA in order not to 
waste an arterial graft for future use. At our institution, RIMA 
coronary artery bypass grafts account for 5% to 8% of all cor-
onary grafts. In addition, the distal occlusion site at the height 
of the right atrium in most cases still allows the RIMA to be 
used as a graft artery because its length may be sufficient to 
be anastomized to the RCA. The site of RIMA device closure 
in the present study was identical to temporary balloon occlu-
sion in the investigation by Stoller et al.18 This location was 
Figure 5. Number of patients with and 
without angina pectoris (vertical axis) dur-
ing the 1-minute proximal right coronary 
artery (RCA) and left coronary artery (LCA) 
balloon occlusions at baseline and follow-
up examination, which were performed for 
simultaneous pressure and intracoronary 
ECG measurements (see also Figure 2).
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chosen because it ought to be safely distal of and certainly not 
on the bifurcation of the pericardiophrenic branch. In all of 
the 4 cases, in whom the pericardiophrenic branch was inad-
vertently occluded by an IMA dissection or the device itself, 
no CFI increase was observed at follow-up examination. 
Because the IMA connects directly to the ipsilateral external 
iliac artery, the CFI of this vessel during ostial balloon occlu-
sion amounts to ≈0.75 to 0.8, and thus, an effect, though a 
lower one, on coronary CFI could also be expected in case of 
ostial as opposed to distal IMA device occlusion. Certainly, 
this functional connection of the IMA between the upper and 
lower extremities is primarily responsible for the safety of the 
procedure in our study population; the risk of tissue necrosis 
in the RIMA-dependent territory is most likely low, which can 
also be expected, because no IMA side branches are affected 
by IMA device closure as opposed to IMA bypass grafting.
The amount of CFI increase in response to permanent 
RIMA occlusion observed in this study exceeds the above 
described +0.025 during temporary occlusion by a factor of 2.7 
(+0.067±0.094). In (an informal) comparison to other, clini-
cally tested coronary arteriogenic treatment options, such as 
granulocyte–macrophage colony-stimulating factor,45 granu-
locyte colony–stimulating factor,46 ivabradine,47 a 3-month 
physical exercise training,48 and 90 hours of external counter-
pulsation,27 permanent right IMA occlusion reached the largest 
CFI increase. The intraindividual comparison of CFI change 
between the right and left coronary territory in response 
to RIMA closure showed no effect on LCA CFI, the fact of 
which is in agreement with the ipsilateral anatomic connection 
between the IMA and the coronary circulation. The plausibil-
ity of the primary end point results (CFI) is enhanced by their 
coherence with the study’s secondary end points. The effect 
of RIMA device closure on CFI of the RCA is reflected by a 
decrease in functional stenosis severity, that is, an increased 
FFR in the absence of direct RCA intervention; RCA PCI 
was performed only after follow-up end point measurements. 
Finally, IC ECG signs of myocardial ischemia during the 
1-minute ostial RCA occlusion were quantitatively diminished 
at follow-up examination, and there was a trend toward fewer 
events of angina pectoris during the same procedure.
Study Limitations
This conceptual and feasibility study of permanent RIMA clo-
sure was not a controlled trial, with randomized allocation to 
device closure or no closure. Thus, the results of this study 
should be confirmed in a larger, randomized controlled trial, 
possibly with a sham-control design and the presently used 
surrogate, as well as clinical end-points. In the above context, 
the important goal of technical feasibility and initial safety 
of the procedure could be determined more swiftly than by 
selecting a controlled study design. IMA device closure may, 
theoretically, carry a risk for ischemia in the dependent ter-
ritories. None of our patients reported symptoms associable 
with IMA closure during the 6 weeks of follow-up or later. In 
comparison to the surgical use of an IMA for bypass grafting, 
IMA device occlusion does not affect IMA side branches by 
ligation. The RIMA was not entirely occluded at follow-up in 
22% of the patients. Because this was a situation more likely 
favoring the null hypothesis than that of CFI augmentation, 
it rather supports than weakens the study findings. LCA PCI 
was not deferred in all, but only in 33 patients. In theory, LCA 
revascularization on its own could have augmented RCA CFI 
in this minority of patients. A subanalysis of the population 
with total PCI deferral (n=33) revealed effects of RIMA clo-
sure, consistent with those of the entire study cohort.
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3.3 Project III
Effects of Coronary Sinus Occlusion on Myocardial Is-
chaemia in Humans: Role of Coronary Collateral Func-
tion
The third project was a clinical study aimed at determining the role of coronary col-
laterals in the effect of intermittent coronary sinus occlusion on myocardial ischemia.
My contributions were parts of the conception and design of the project, acquiring,
analyzing and interpreting the data, assisting in statistical analysis and making crit-
ical revision of the manuscript for important intellectual content.
The paper was published in Heart in January 2013, journal ranking was #10 accord-
ing to impact factor and #22 according to SCImago Journal Rank (SJR)[89] in the
year of publication in Cardiology and Cardiovascular Medicine.
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ABSTRACT
Objective This study tested the hypotheses that
intermittent coronary sinus occlusion (iCSO) reduces
myocardial ischaemia, and that the amount of ischaemia
reduction is related to coronary collateral function.
Design Prospective case-control study with
intraindividual comparison of myocardial ischaemia
during two 2-min coronary artery balloon occlusions
with and without simultaneous iCSO by a balloon-tipped
catheter.
Setting University Hospital.
Patients 35 patients with chronic stable coronary
artery disease.
Intervention 2-min iCSO.
Main outcome measures Myocardial ischaemia as
assessed by intracoronary (i.c.) ECG ST shift at 2 min of
coronary artery balloon occlusion. Collateral ﬂow index
(CFI) without iCSO, that is, the ratio between mean
distal coronary occlusive (Poccl) and mean aortic pressure
(Pao) both minus central venous pressure.
Results I.c. ECG ST segment shift (elevation in all) at
the end of the procedure with iCSO versus without iCSO
was 1.33±1.25 mV versus 1.85±1.45 mV, p<0.0001.
Regression analysis showed that the degree of i.c. ECG
ST shift reduction during iCSO was related to CFI, best
ﬁtting a Lorentzian function (r2=0.61). Ischaemia
reduction with iCSO was greatest at a CFI of 0.05–0.20,
whereas in the low and high CFI range the effect of
iCSO was absent.
Conclusions ICSO reduces myocardial ischaemia in
patients with chronic coronary artery disease. Ischaemia
reduction by iCSO depends on coronary collateral
function. A minimal degree of collateral function is
necessary to render iCSO effective. ICSO cannot manifest
an effect when collateral function prevents ischaemia in
the ﬁrst place.
ClinicalTrials.gov Identiﬁer: NCT01625832.
INTRODUCTION
Myocardial infarct size is the main determinant of
outcome following acute coronary artery occlusion.1
It is the product of coronary occlusion time, the lack
of collateral supply to the ischaemic territory, the size
of the area at risk for myocardial necrosis, the
absence of preconditioning ischaemic episodes prior
to the occlusion, and the myocardial oxygen con-
sumption during occlusion (the product of heart rate,
contractility and ventricular wall stress).2 3 The
amount of ECG ST segment elevation as obtained
during coronary occlusion is a well known and
accurate surrogate marker for infarct size.4 Heart rate
and myocardial contractility reduction by β-blockers
have been used for decades as a measure to limit
infarct size. Nowadays, the therapeutic mainstay of
reducing infarct size is to conﬁne coronary occlusion
time by primary percutaneous coronary intervention
(PCI). In approximately one-third of the patients
with coronary artery disease (CAD), infarct size is
effectively limited by a pre-existing collateral supply
to the area at risk sufﬁcient to prevent ischaemia in
the event of acute coronary occlusion.5 In the other
two-thirds of CAD patients, the time window
between coronary occlusion and completion of col-
lateral growth beyond functional recruitment is too
narrow for myocardial salvage.6 Theoretically, reduc-
tion of the area at risk could be imagined as a means
to limit infarct size in the context of its close and
inverse relationship to collateral supply. In such a
scenario, the area at risk would not be expected to be
reduced in the absence of minimally functional anas-
tomoses between the ischaemic and non-ischaemic
territory.
In this context, coronary sinus occlusion (CSO)
can be imagined to reduce ischaemic myocardium
at risk for necrosis by retroperfusion, and its collat-
eral supply has been hypothesized but not tested to
be a crucial element in the action of augmented
coronary venous back pressure.7 8 However in
patients with CAD, the effect of CSO on myocar-
dial ischaemia has not been directly examined,9 10
and the role of collaterals in transmitting regionally
unbalanced back pressure augmentation, thereby
altering adjacent area at risk sizes has not been
studied so far. Therefore, the present investigation
in patients with chronic stable CAD tested the
hypotheses that intermittent CSO (iCSO) reduces
the amount of myocardial ischaemia as quantiﬁed
by intracoronary (i.c.) ECG ST segment elevation
during a 2-min coronary occlusion, and that the
decrease of ischaemia is dependent on the amount
of collateral supply to the ischaemic territory with
no effect in the absence of any and in the presence
of abundant collateral supply.
METHODS
Patients and study design
Thirty-ﬁve patients with chronic stable one-vessel
to three-vessel CAD were included in the study.
Coronary angiography was performed for diagnos-
tic purposes in the context of chest pain. Criteria
for study inclusion were as follows: (1) no previous
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Q-wave myocardial infarction in the myocardial area undergo-
ing temporary ischaemia, (2) no baseline ECG ST segment
abnormalities and (3) absence of acute myocardial infarction or
unstable angina pectoris.
This was a prospective study with randomisation for the
sequence of iCSO during the ﬁrst or second of two 2-min cor-
onary balloon occlusions. The rationale of the randomised cor-
onary occlusion sequence relates to the occurrence of collateral
recruitment in the context of repetitive occlusions.11 The study
population was divided in a group of patients who underwent
iCSO ﬁrst (n=17), and in one with iCSO as the second of the
two 2-min occlusions (n=18). As the primary study endpoint,
i.c. ECG ST segment shift (depression or elevation in mV)
during the last 10 s of coronary occlusion was determined. The
main secondary endpoint was collateral ﬂow index (CFI) as
obtained during the 2-min coronary occlusion without iCSO.
The study was approved by the ethics committee of the
Kanton of Bern, Switzerland, and all included patients gave
written informed consent to participate.
Cardiac catheterisation and coronary angiography
Patients underwent left heart catheterisation and coronary angi-
ography for diagnostic purposes from the right femoral artery
approach. Biplane left ventriculography was performed followed
by coronary angiography. Coronary artery stenoses were deter-
mined quantitatively as per cent diameter reduction using the
guiding catheter for calibration. Aortic pressure was obtained
via a 6F coronary artery guiding catheter. Central venous pres-
sure (CVP=unobstructed coronary sinus pressure) was measured
via the right femoral vein.
Coronary sinus intubation and occlusion
An 8F transseptal sheath was inserted into the right femoral vein
and advanced to the hepatic veins. Coronary sinus intubation was
performed either by direct access using the JR 5F diagnostic cath-
eter or an AL2 5F diagnostic catheter and a hydrophilic probing
guide wire. Alternatively and in most cases, the coronary sinus
was intubated retrogradely using a multipurpose 6F diagnostic
catheter with the hydrophilic guide wire (ﬁgure 1). After posi-
tioning the diagnostic catheter within the coronary sinus, the
hydrophilic guide wire was exchanged to a non-hydrophilic long
exchange guide wire, and the transseptal sheath was advanced
towards and if possible slightly into the coronary sinus. The diag-
nostic catheter was then exchanged for a Swan Ganz 7F balloon-
tipped catheter, which was placed 2–3 cm upstream of the
coronary sinus entrance into the right atrium. During the study
protocol, iCSO was performed at this site.
Figure 1 Panel A: Visualisation of the coronary sinus (lateral view) during the venous phase of a left coronary angiography. Far downstream, that
is, shortly before the coronary sinus drainage into the right atrium, the entry of the right coronary vein into the coronary sinus is visible (arrow).
Panel B: Visualisation of the hydrophilic guide wire placed in the coronary sinus. Panel C: Direct injection of contrast medium into the coronary sinus
via a 6F multipurpose diagnostic catheter. Panel D: Simultaneous balloon occlusion of the proximal left circumﬂex coronary artery and the coronary
sinus by the balloon-tipped 7F Swan Ganz catheter (arrow).
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Intracoronary ECG
For the quantitative assessment of myocardial ischaemia, an uni-
polar i.c. ECG was obtained during coronary occlusion with
and without iCSO from the angioplasty guide wire (ﬁgure 2).
For that purpose, an alligator clamp was attached close to the
end of the pressure sensor wire (see below) and connected to
ECG lead V1.12 13 In addition, a three-lead surface ECG was
recorded.
Coronary collateral assessment
Coronary pressure-derived (CFI, mm Hg/mm Hg; ﬁgure 2):
During the coronary occlusion sequence without iCSO, collateral
ﬂow during a 2-min vascular balloon occlusion relative to normal
antegrade ﬂow through the non-occluded coronary artery was
determined using coronary pressure measurements. A 0.014 inch
ﬁbre-optic pressure monitoring wire (RadiWire, Radi, Upsala,
Sweden) was set at zero, calibrated, advanced through the
guiding catheter and positioned distal to the site of coronary
occlusion. CFI was determined by simultaneous measurements of
mean aortic pressure (Pao, mm Hg, via the angioplasty guiding
catheter), distal coronary occlusive pressure (Poccl, mm Hg) and
(CVP=unobstructed coronary sinus pressure): CFI=(Poccl−CVP)/
(Pao−CVP) (ﬁgure 2; CFI calculation at the end of the 2-min
balloon occlusion). Sensor-derived CFI measurements have been
previously validated,14–16 and are regarded as the gold-standard
for collateral assessment in humans.
Study protocol
Following diagnostic coronary angiography, the coronary sinus
was intubated as described. At the start of the protocol, 5000
units of heparin were given intravenously. Two puffs of oral
nitroglycerin spray were applied immediately thereafter. The
angioplasty pressure sensor guide wire was positioned distal to
the site of the imminent angioplasty balloon occlusion. During
the entire protocol, the i.c. ECG obtained from the pressure
guide wire and a three-lead surface ECG were recorded.
Simultaneous recording of Pao, Poccl, CVP and the i.c. ECG was
started before and continued throughout the 2-min balloon
occlusions (ﬁgure 3). The iCSO occlusion sequence was selected
at random, and accordingly, CFI was determined during the
second or during the ﬁrst of two 2-min occlusions. During the
iCSO sequence, all the signals described above were recorded
identically (ﬁgure 3). Coronary occlusion was performed using
an appropriately sized angioplasty balloon. If indicated, PCI for
treatment of the stenotic lesion was performed following the
two study-related occlusions.
Statistical analysis
Between-group comparisons of continuous demographic, clin-
ical, angiographic, haemodynamic, ECG and collateral ﬂow data
were performed by a two-sided unpaired Student’s t test. A
χ2-test (2×2 table) was used for comparison of categorical vari-
ables among the study groups. Intraindividual comparison of
ECG ST segment elevations during the two coronary occlusions
was performed by a paired Student’s t-test. Curvilinear regres-
sion analysis was performed between CFI as the independent
variable and i.c. ECG ST shift change without minus that with
iCSO as the dependent variable; the summed least square
method was applied for determining the best ﬁt of several curvi-
linear functions: third and fourth order polynomial function,
Gauss and Lorentz function.
RESULTS
Patient characteristics and clinical data
There were no statistically signiﬁcant differences between the
two groups regarding age, gender, prior myocardial infarction
in a remote area, body mass index and frequency of cardiovas-
cular risk factors as well as the use of cardiovascular drugs
(table 1).
Figure 2 Upper panel: Original
simultaneous recording without
intermittent coronary sinus occlusion of
mean and phasic aortic pressure (Pao,
scale: 200 mm Hg), central venous
pressure (CVP, scale: 50 mm Hg), distal
coronary occlusive pressure (Poccl, scale:
200 mm Hg) and intracoronary ECG (i.c.
ECG, 0.5 mV/10 mm). Collateral ﬂow
index is calculated from mean pressure
values as follows: (Poccl−CVP)/
(Pao−CVP). Lower panel: Original
simultaneous recording with
intermittent coronary sinus occlusion of
the tracings just described; coronary
sinus (CS) pressure as obtained
upstream of the occlusive Swan Ganz
balloon catheter.
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Coronary angiographic data
In the 35 study patients, the coronary arteries subjected to the
two 2-min occlusions with and without iCSO were similarly dis-
tributed among the groups (table 2). There was no difference
between the groups in the number of coronary arteries diseased
and in the vascular site of occlusion. Average per cent diameter
stenosis at the occlusion site and the fractional ﬂow reserve of
the lesion were similar (table 2). The total ﬂuoroscopy time of
the entire study protocol plus PCI amounted on average to 25
min and 31 min in the two groups (range 9–56 min),
respectively.
Haemodynamic, myocardial ischaemia and collateral
circulation data
Before the start of the study protocol, heart rate, arterial blood
pressure, left ventricular ejection fraction, left ventricular end-
diastolic pressure and CVP were similar between the groups
(table 3).
Indicative of the action of iCSO on coronary venous back
pressure (see also ﬁgure 3), coronary sinus pressure as obtained
upstream of and during the phases of iCSO rose by 15 mm Hg
in comparison with CVP (p<0.0001 for intraindividual, paired
comparison), and it was not statistically different between the
groups (table 3). Distal coronary occlusive pressure (Poccl) was
elevated by 3 mm Hg during iCSO (p=0.0437 for intraindivi-
dual comparison); mean Poccl in the absence of iCSO amounted
on average to approximately 20 mm Hg in both groups (table
3). Mean Pao during coronary occlusion with and without iCSO
was similar. Heart rate with and without iCSO was similar
between the groups as well as intraindividually. I.c. ECG ST
shift at 2 min of coronary occlusion manifested as ST elevation
in all measurements, and it amounted to approximately 1.5 mV
in the group with iCSO 1st, and to approximately 1.2 mV in
Table 1 Patient characteristics and clinical data
Intermittent
coronary sinus
occlusion 1st
Intermittent
coronary sinus
occlusion 2nd
p
Value
Number of study patients 17 18
Age (years) 67±8 66±7 0.80
Male gender (%) 12 (71) 15 (83) 0.37
Prior myocardial infarction
in remote area (%)
8 (47) 6 (33) 0.32
Body mass index (kg/m2) 29±6 30±7 0.57
Smoking (%) 2 (12) 2 (11) 0.77
Dyslipidemia (%) 17 (100) 18 (100) –
Hypertension (%) 16 (94) 17 (89) 0.91
Family history for coronary
artery disease (%)
4 (24) 4 (22) 0.81
Diabetes mellitus (%) 3 (18) 1 (6) 0.48
Acetylsalicylic acid (%) 14 (82) 18 (100) 0.12
β-blockers (%) 8 (48) 11 (61) 0.51
Nitrates (%) 1 (6) 1 (6) 0.93
ACE inhibitor (%) 11 (61) 11 (61) 0.64
Statin (%) 12 (12) 16 (89) 0.29
Figure 3 Upper panel: Original simultaneous recording during 2 min of coronary occlusion with intermittent coronary sinus occlusion of the
following curves: mean and phasic aortic pressure (Pao, scale: 200 mm Hg), coronary sinus (CS) pressure as obtained upstream of the occlusive Swan
Ganz balloon catheter (scale: 50 mm Hg), distal coronary occlusive pressure (Poccl, scale: 200 mm Hg) and intracoronary ECG (i.c. ECG, 0.5 mV/
10 mm). Lower panel: Original simultaneous recording without intermittent coronary sinus occlusion during 2 min of coronary occlusion of the
following curves: mean and phasic aortic pressure (Pao, scale: 200 mm Hg), central venous pressure (CVP, scale: 50 mm Hg), distal coronary occlusive
pressure (Poccl, scale: 200 mm Hg) and intracoronary ECG (i.c. ECG, 0.5 mV/10 mm).
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the group with iCSO 2nd (table 3). Figure 4 shows the overall
difference in the i.c. ECG ST shift (without minus with iCSO)
between the two coronary occlusions. It was signiﬁcantly less in
the group with iCSO 1st, that is, the group without collateral
recruitment before iCSO, than in the group with iCSO 2nd (table
3 and ﬁgure 5). Accordingly and indicative of absent and present
collateral recruitment in the group with iCSO 1st and iCSO 2nd,
respectively, CFI at 1 min and at 2 min of coronary occlusion was
0.132±0.130, respectively 0.130±0.115 (p=0.82 for paired
comparison) in the former group, and 0.109±0.126, respectively
0.123±0.127 (p=0.0485) in the latter group. Figure 6 illustrates
that a decrease of i.c. ECG ST shift (maximum=2.14 mV, 95%
CI=1.52 to 2.75 mV) in response to iCSO during coronary occlu-
sion occurred at a CFI between approximately 0.05 and 0.20 (cen-
treline of the ﬁtted curve=0.108).
DISCUSSION
In humans with chronic stable CAD, iCSO diminishes myocar-
dial ischaemia during coronary occlusion. The amount of
ischaemia reduction during two 2-min coronary occlusions is
less pronounced if iCSO is applied during the ﬁrst versus the
second occlusion, the latter of which goes along with recruit-
ment of collateral function. Myocardial ischaemia is not dimin-
ished by iCSO in the presence of collateral ﬂow sufﬁcient to
prevent it in the ﬁrst place as well as in patients with poor col-
lateral function.
Coronary sinus occlusion: data from the literature
The concept of venous retroperfusion as a way of delivering
nutrients to a coronary artery territory at risk for infarction had
been already introduced by Pratt at the end of the 19th
century.17 The same principle led the surgeons to perform cor-
onary venous bypass grafting as an arterial revascularisation pro-
cedure, and almost 30 years ago, CSO was introduced to
provide retroperfusion by transient augmentation of coronary
venous pressure.7 8 Subsequently, the vast majority of the
studies on the topic has been performed in approximately 220
dogs and pigs undergoing acute coronary artery ligation.18 An
infarct size reduction between 29–39% has been observed
depending on whether iCSO alone or iCSO plus retroperfusion
of arterialised blood was applied (no statistical difference
between the effect of the two methods).18
Notwithstanding the high consistency of the effect of iCSO
on infarct size irrespective of the animal model, the concept has
been evaluated during the last three decades in only 30 patients
with CAD undergoing coronary bypass grafting,9 19 in 34
patients with ECG ST elevation myocardial infarction undergo-
ing thrombolysis10 and in 15 patients with chronic stable CAD
receiving a coronary sinus reducer stent for the treatment of
Table 3 Haemodynamic, myocardial ischaemia and coronary collateral circulation data
Intermittent coronary sinus occlusion 1st Intermittent coronary sinus occlusion 2nd p Value
Heart rate (beats/min) 78±11 73±20 0.39
Systolic blood pressure (mm Hg) 137±31 133±25 0.69
Diastolic blood pressure (mm Hg) 68±19 70±11 0.68
LV ejection fraction (%) 58±9 63±3 0.0138
LV end-diastolic pressure (mm Hg) 13±7 13±8 0.85
Central venous pressure (mm Hg) 8±4 8±4 0.62
Myocardial ischaemia and collateral circulation
Coronary sinus pressure during iCSO (mm Hg) 22±10 23±8 0.75
Poccl during iCSO (mm Hg) 23±10 21±11 0.40
Pao during iCSO (mm Hg) 84±26 90±23 0.53
Poccl without iCSO (mm Hg) 20±9 19±12 0.73
Pao without iCSO (mm Hg) 89±23 89±22 0.96
Heart rate during iCSO (beats/min) 71±10 65±18 0.28
Heart rate without iCSO (during CFI; beats/min) 70±13 69±19 0.95
I.c. ECG ST shift* at 20 of occlusion (mV) 1.526±1.418 1.154±1.088 0.39
Change of i.c. ECG ST shift at 20 occl.† (mV) 0.273±0.466 0.730±0.752 0.0409
Collateral flow index (CFI) at 20 of occlusion 0.130±0.115 0.123±0.127 0.86
*‘shift’ corresponded to ST elevation in all measurements.
†i.c. ECG ST shift at 2 min (20) of occlusion without minus with iCSO.
I.c., intracoronary; iCSO, intermittent coronary sinus occlusion; LV, left ventricular; Pao, mean aortic pressure during coronary occlusion; Poccl, mean distal coronary occlusive pressure.
Table 2 Coronary angiographic data
Intermittent
coronary sinus
occlusion 1st
Intermittent
coronary sinus
occlusion 2nd
p
Value
Number of study patients 17 18
Vessel undergoing occlusion 0.72
Left anterior descending
artery (%)
9 (52) 8 (45)
Left circumflex coronary
artery (%)
4 (24) 4 (22)
Right coronary artery (%) 4 (24) 6 (33)
Number of vessels diseased 0.95
1 (%) 6 (35) 6 (33)
2 (%) 4 (24) 4 (22)
3 (%) 7 (41) 8 (45)
Site of occlusion 0.23
Proximal segment (%) 17 (100) 15 (83)
Mid-segment (%) 0 3 (17)
% diameter stenosis at
occlusion site
74±24 70±23 0.63
Fractional flow reserve
(mm Hg/mm Hg)
0.73±0.16 0.76±0.17 0.66
Total fluoroscopy time (min) 25±11 31±11 0.12
Stoller M, et al. Heart 2013;0:1–8. doi:10.1136/heartjnl-2012-303305 5
Coronary artery disease
 group.bmj.com on January 26, 2013 - Published by heart.bmj.comDownloaded from 
refractory angina pectoris.20 The study endpoints employed in
the mentioned clinical trials have been left ventricular wall
motion abnormalities, creatine kinase levels, major adverse
cardiac events during 48 months of follow-up (as obtained in 34
patients!), and severity of angina pectoris. Though there has
been a trend in these clinical studies in favour of an effect of
iCSO, it has been far less consistent than in the animal studies,
the fact of which may be due to their insufﬁcient power and/or
to the rather blunt study endpoints employed. At this paradoxic-
ally early stage of clinical efﬁcacy testing of iCSO, a study
design using a chronic stable ‘model’ of acutely and systematic-
ally induced ischaemia with a very precise surrogate measure of
infarct size (i.c. ECG) is likely more adequate than the setting of
acute coronary syndrome. In the present study involving 35
stable CAD patients, the overall effect of iCSO on i.c. ECG ST
elevation during exactly 2 min of coronary occlusion was statis-
tically highly relevant. However, this overall effect is only an
apparent effect of iCSO, because factors aside from iCSO con-
tributing to tolerance against ischaemia, and thus, ﬁnally smaller
infarct size were active in this as in the other mentioned studies.
Mechanisms of tolerance to myocardial ischaemia
The apparent effect of iCSO found in this study is considerably
larger than the real one. This is explained by pre-existing,
constituent and by developing tolerance against myocardial ischae-
mia, both of which were variably present in this study. It has been
documented previously that the left coronary artery territory is
constituently less tolerant to ischaemia than the right coronary
artery region.13 Accordingly, the effect of iCSO was more pro-
nounced when the ischaemia was induced in the former than in
the latter region (maximum ST elevation reduction of approxi-
mately 1 mV vs 2.2 mV in the left anterior descending artery
(LAD) region; data not shown). Possibly in the same context,
Mohl et al10 included only patients with infarction in the LAD ter-
ritory in their study. Additionally and/or alternatively, iCSO was
less effective in the right than the left coronary artery because of
the frequent distal anatomic right coronary artery (RCA) drainage
site into the coronary sinus, which was probably not always
occluded by the more upstream balloon catheter (see also ﬁgure 1).
Two factors of developing tolerance to ischaemia contributed to
the apparent effect of iCSO, that is, ischaemic preconditioning
and collateral recruitment.11 In comparison with all other clinical
and many experimental studies on the subject, the present one can
distinguish between apparent and real effects of iCSO: the average
decrease of i.c. ECG STelevation was about 40% when iCSO was
applied during the ﬁrst as compared with the second of two coron-
ary occlusions (0.27 mV vs 0.73 mV; p=0.04). In other words,
60% of the apparent iCSO effect was due to naturally developing
tolerance against ischaemia and not to iCSO. The importance of
ischaemic preconditioning in this context was probably of minor
importance, since it was a constant in all patients who had been
selected for coronary angiography because of angina pectoris. The
principle effect of the two 2-min coronary occlusions on i.c. ECG
ST elevation was likely due to recruitment of collateral function.
However, this can only be deduced from the fact that there was
intraindividual, signiﬁcant CFI increase between 1 and 2 min of
occlusion in the group randomised to iCSO during the second
occlusion. In patients undergoing iCSO during the ﬁrst coronary
occlusion, no intraindividual collateral recruitment between 1 min
and 2 min of the second occlusion could be observed. Based on a
canine study by Ido et al,21 it can be speculated that collateral ﬂow
in this group was already recruited by iCSO during the ﬁrst occlu-
sion and remained, therefore, unchanged during the second.
Anti-ischaemic effect of iCSO: proposed mechanism
This possible association between collateral recruitment during
the ﬁrst occlusion and the effect of iCSO suggests a role of the
Figure 5 Individual changes of intracoronary (i.c.) ECG ST segment
shift (=elevation in all cases) during the 2-min coronary occlusion with
and without (horizontal axis) intermittent coronary sinus occlusion
(iCSO) in the group with iCSO as the ﬁrst of two coronary occlusions
(left side), and in the group with iCSO as the second of two coronary
occlusions (right side). Error bars: mean±SD.
Figure 6 Curvilinear regression analysis between the change (Δ) in
intracoronary (i.c.) ECG ST segment shift in response to intermittent
coronary sinus occlusion (iCSO) and (collateral ﬂow index ; horizontal
axis) as obtained during the 2-min coronary occlusion without iCSO.
The best curve ﬁt according to the summed least square method is a
bell-shaped Lorentzian function (bold black line). The red line indicates
the centreline of the function. r,: regression coefﬁcient.
Figure 4 Individual changes of intracoronary (i.c.) ECG ST segment
shift (=elevation in all cases) during the 2-min coronary occlusion with
and without (horizontal axis) intermittent coronary sinus occlusion.
Error bars: mean±SD.
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collateral circulation in the way how iCSO affects myocardial
ischaemia. Experimental work in the porcine animal model void
of coronary collaterals supports this notion by revealing no
effect of iCSO on the ligation-induced fall of perfusion in the
LAD from 1.5 to <0.1 ml/min/g.22 Conversely, the canine
model with a coronary artery anastomotic network similar to
that in humans23 has shown an increase in the ischaemic LAD
territory from 0.17–0.19 without iCSO to 0.23–0.33 ml/min/g
with iCSO.21 24 In both the referenced canine studies, the effect
of iCSO on myocardial perfusion was predominant in the pen-
umbra and not the core of the ischaemic zone, thus indicating
the transmit function of collaterals between adjacent supply
areas and their role in diminishing the area at risk.
In this context and in light of the speciﬁc ﬁndings of the
present study, the following mechanisms of absent or present
anti-ischaemic effects of iCSO are proposed:
▸ There is no effect of iCSO in the high range of collateral
supply to the ischaemic region sufﬁcient to prevent ischae-
mia for the obvious reason that it cannot be detected even by
the sensitive tool of i.c. ECG. A CFI sufﬁciently high to
prevent ischaemia during a 1-min coronary occlusion is 0.2–
0.25 and occurs in approximately 33% of the CAD popula-
tion.5 23 In the present study, there was absent or only
minimal i.c. ECG STelevation in the upper range of CFI.
▸ There is no effect of iCSO in the very low range of collat-
eral supply to the ischaemic region, because its function is
insufﬁcient to convey the effect of augmented venous back
pressure to the area at risk thereby reducing it (see below).
The prevalence of CFI in the low range between 0–0.05 in
a population with CAD is approximately 17%.5
▸ There is an anti-ischaemic effect of iCSO in the range of CFI
(as obtained in the absence of iCSO) between 0.05–0.2. The
collateral pathways between the non-ischaemic and the
ischaemic region transmit the regionally unbalanced venous
back pressure induced by iCSO. The venous back pressure as
applied in the coronary sinus is regionally balanced in the
venous but not in the vascular bed upstream of the microcir-
culation. Myocardial ischaemia results in two counteracting
responses of the microcirculation, that is, maximal vasodila-
tion and increased myocardial compressive forces in the
context of diminished myocardial thickness with augmented
ventricular wall stress. It is likely that in the presence of a
large ischaemic territory as with proximal LAD occlusion,
enhanced ventricular wall stress with heightened microcircu-
latory resistance prevails over ischaemia-induced maximal
vasodilation. As a consequence, there is a regional imbalance
in microvascular resistance with a downward gradient
between the ischaemic and the non-ischaemic area. In turn,
the venous back pressure augmentation by iCSO is able to
reach the non-ischaemic microcirculation more easily than
the ischaemic one, thereby increasing the microcirculatory
resistance in the non-ischaemic zone. This leads to a ﬂow
diversion of arterialised blood to the ischaemic area at risk
under the necessary but not always sufﬁcient condition (see
ﬁgure 6) of functionally present collateral connections ori-
ginating from the non-ischaemic area.
Study limitations
As just outlined and alternatively, the prevailing consequence of
ischaemia could be an initially lowered instead of heightened
microcirculatory resistance, which would tip the regional balance
during iCSO to a lower resistance in the non-ischaemic region,
because of a better transmission of the increased back pressure to
the ischaemic bed. In this scenario, a steal phenomenon of blood
via collaterals away from the ischaemic to the non-ischaemic
region is conceivable, and could explain the considerable number
of pro-ischaemic responses to iCSO in the CFI range around 0.05
(see ﬁgure 6). The present study was not designed and equipped
to assess regional myocardial perfusion and resistance (eg, by
myocardial contrast echocardiography) as part of the protocol,
which would have allowed testing the validity of the proposed
mechanism of action of iCSO. However in case of the LAD, the
variability of the effect of iCSO on ischaemia was explained by
factors other than CFI only to 10% (r2=0.91 for curvilinear ﬁt
analogous to ﬁgure 6). As a consequence, the more important study
limitation than that just mentioned is the low power in regard to the
examined vessels RCA and left circumﬂex artery (LCX).
As a technical limitation, the site of iCSO was often selected
too far upstream in order to gain catheter stability and not as
far downstream as possible with obstruction of all venous tribu-
taries. Thus, the far downstream entrance of the right coronary
vein into the coronary sinus may have been excluded from
iCSO. The long time for intubation of the coronary sinus and
placement of the balloon catheter is a further technical short-
coming, which, most likely, did not affect the outcome of this
study, but which would have to be substantially lowered in the
setting of acute myocardial infarction.
Due to its size, the balloon-tipped 7F catheter in the coronary
sinus possibly obstructed it already in the absence of iCSO. This
would have, however, resulted in a smaller effect of iCSO versus
no iCSO, and thus, would have counteracted the study hypoth-
esis or would have conserved the null hypothesis.
Study implications
ICSO can be expected to have an anti-ischaemic effect in
approximately half the CAD patients. Most likely and addition-
ally, the population with an ischaemia in the RCA territory has
to be subtracted from that. In the setting of acute myocardial
infarction, iCSO has a potential to salvage myocardium follow-
ing revascularisation of the culprit lesion by PCI. Considering
the relevance of a certain degree of collateral supply to the area
at risk as a necessary condition for the effect of iCSO, the con-
sequences of the expected fall of collateral supply in response to
PCI remains uncertain. In the setting of acute myocardial infarc-
tion, the time for access to the coronary sinus and placement of
a balloon catheter has to be minimised by the use of steerable
catheters. Considering the costs for such equipment plus those
for a customised balloon catheter capable of applying iCSO for
an extended period, the net gain of the procedure for the
patient has to be carefully taken into account.
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3.4 Project IV
A Lumped Parameter Mathematical Model of Intermit-
tent Coronary Sinus Occlusion: Role of Coronary Collat-
erals
Experimental and clinical studies, as well as pathophysiological considerations imply
an important role of the coronary collateral circulation in the anti-ischemic effect of
intermittent coronary sinus occlusion. In the in-vivo human model (Project III),
characterization of the hemodynamics during intermittent coronary sinus occlusion
was limited to easily accessible compartments of the heart. A mathematical model
might therefore provide insight in compartments inaccessible to measurement. Al-
though several models of intermittent coronary sinus occlusion have been published,
the influence of the coronary collateral circulation has not been clearly defined.
Therefore, the aim of this project was to develop a mathematical model of inter-
mittent coronary sinus occlusion with a special regard to the coronary collateral
circulation. The hypothesis was that the direct or indirect influence of coronary
collaterals could be elucidated in a mathematical model.
As the results of this project are not yet published, the methods and results are
summarized in the following sections.
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3.4.1 Methods
A 0D cardiovascular model was developed consisting of three major parts: a heart,
systemic vasculature and coronary circulation (Figure 3.1).[90]
Left Ventricle Systemic Circulation
C
or
on
ar
y
C
irc
ul
at
io
n
Figure 3.1: Principal structure of lumped parameter model
The systemic vasculature is represented by a four-element Windkessel [91] as a mono-
compartment model. The heart is represented by an LV, modeled as a single node
with a prescribed flow (see appendix 1 for details).
3.4.1.1 Coronary model
The scheme of the electrical equivalent for the coronary circulation is given in Fig-
ure 3.2. The modeled coronary circulation consists of two symmetric left coronary
vascular beds, which are connected by arterial collaterals. Drainage occurs via a
common pathway (the coronary sinus) and via separate non-coronary sinus path-
ways, representing smaller shunting veins to the ventricles (thebesian connections)
and the right atrium.
Each coronary vascular bed is represented by an arterial epicardial, an intramyocar-
dial and a venous epicardial compartment. Myocardial mass is set at 100g for each
coronary vascular bed.
The arterial epicardial compartment is modeled as an Resistor-Capacitor (RC) seg-
ment, with the boundary condition of aortic pressure (pao). By increasing the epi-
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cardial resistance element, an epicardial coronary stenosis can be simulated.
The intramyocardial compartment is represented by two RC segments, arteriolar
and capillary/venular. The interaction between the intramyocardial vasculature and
the myocardium is modeled similar to the intramyocardial pump model.[92] The
arteriolar compartments are connected by arterial collaterals, represented by a simple
resistance.
The epicardial venous compartments are each represented by an RC segment. They
connect to the same outflow point, reflecting the CS, which connects to the boundary
condition of right atrial pressure (pRA).
Non-coronary sinus drainage via smaller shunting veins to the right atrium and thebe-
sian veins to the left ventricle are represented by extra-outlet resistances connecting
to their respective pressure boundary conditions (left ventricular pressure (LVP) and
pRA).
3.4.1.1.1 Extravascular compressive pressure
The interaction between the myocardium and the coronary vessel is modeled through
the extravascular compressive pressure (ECP). The ECP is assumed to be determined
by the LVP (as the cavity-induced extracellular pressure (CEP) [93, 94]) and my-
ocardial contractility.[95, 93] The ECP therefore acts on the arteriolar and capillary
compliance.
CEP = αLV P (3.1)
ECP = γCEP (3.2)
with α = 0.75, reflecting a value typical of the mid- to subendocardium.[96]. To
account for contractility γ was chosen as a proportionality factor, reflecting normal
contractility with γ = 1 and reduced contractility with values below 1, such as during
ischemia-induced dysfunction.[95]
3.4.1.1.2 Extra outlets
Non-coronary sinus drainage principally occurs through thebesian connections into
the ventricles, and veins draining directly into the atria without connecting to the
CS.[97]. Therefore, the model incorporated extra outlets for non-coronary sinus
drainage at the capillary/venular and at the venous level. At the capillary/venular
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level, the thebesian connections were modeled as simple resistances connecting to the
boundary condition of LVP, given that the model represented a left coronary system.
At the venous level, the veins bypassing the coronary sinus were also represented by
simple resistances, but connecting to the boundary condition of pRA. Constant
positive pressure offsets were added to the node pressures for the pressure-flow rela-
tionship of the extra outlets. On the capillary level, this was done to account for the
fact that the pressure at the site of thebesian drainage, i.e. at the inner subendocar-
dial layer is larger than the actual node pressure. For the venous level, the pressure
offset accounted for the spectrum of pressure gradients existing for the pathways
originating within the myocardium, the lower bound equal to the difference between
node pressure and right atrial pressure.[98]
3.4.1.1.3 Collateral connections
Connections between the two left coronary vascular beds were implemented at the
arteriolar level, represented by a simple resistor.[99] Veno-venous collaterals were
accounted for in the extra outlet at the venous level.[98]
3.4.1.2 Model inputs
Inputs to the system consisted of the LVP and pao (Figure 3.2), derived from a
separate lumped parameter model (LPM) based on a four-element Windkessel model
[91] with a prescribed left ventricular flow rate (see appendix, Figure 1, code 2 and
input to code 3 for details). Right atrial pressure was set constant at 700 Pa (5.25
mmHg).
3.4.1.3 Model parameters
Initial parameters for the model were extracted from the literature. Parameters were
then adapted to achieve quantitative and qualitative pressure and flow targets.
The heart rate was set at 60 beats per minute, i.e. the heart cycle was 1s. Systolic
duration was 0.4s, i.e. 40% of the heart cycle.
Normal perfusion
Values for resistances and compliances during normal perfusion are shown in Table
3.1, values for compartmental volumes in Table 3.2.
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Figure 3.3: Inputs for the lumped parameter model.
pLV , left ventricular pressure. pao, aortic pressure.
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Parameter LPM Source Value * Unit
Arterial epicardial compartment
Arterial epicardial resistance Raepi [100], adapted for stenosis 1.33× 108 Pa s m−3
Arterial epicardial compliance Caepi [92] 3.00× 10−11 m3 Pa−1
Intramyocardial compartment
Arteriolar resistance Rai assumed as half of Rcap 1.69× 109 Pa s m−3
Arteriolar compliance Cai [92] 1.73× 10−10 m3 Pa−1
Capillary/venular resistance Rcap inflow of 1 ml/min/g over
Raepi
3.44× 109 Pa s m−3
Capillary/venular compliance Ccap [98], adapted for venous pres-
sure during coronary sinus oc-
clusion
3.00× 10−9 m3 Pa−1
Thebesian resistance Rex assumed 4.9× 109 Pa s m−3
Venous epicardial compartment
Venous resistance Rvepi [98] 1.33× 108 Pa s m−3
Venous compliance Cvepi [98], adapted for venous pres-
sure during coronary sinus oc-
clusion
2.98× 10−9 m3 Pa−1
Coronary sinus resistance RCS [98] 1.33× 108 Pa s m−3
Extra outlet resistance Rex2 [98], adapted for venous pres-
sure during coronary sinus oc-
clusion and target outflow of
10% of inflow
3.00× 109 Pa s m−3
Collaterals
Arteriolar collateral resistance Rcai set at 5 times the arteriolar
resistance[99]
8.45× 109 Pa s m−3
Table 3.1: Resistances and compliances for coronary circulation during normal per-
fusion
* mean over 5 heart beats
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Ischemia
Coronary occlusion was modeled by increasing the epicardial resistance to 1× 1020
Pa s m−3 in one coronary branch. Arteriolar resistance in the ischemic bed was set to
one hundredth of normal to simulate vasodilation. Flow over the arteriolar collateral
resistance was then varied in intervals of 0.05 ml/min/g, from 0-0.4 ml/min/g. A
reduction in contractility was modeled by varying γ from 0-1 (equation (3.2)).
Coronary sinus occlusion
Coronary sinus occlusion was modeled by increasing the coronary sinus resistance to
1× 1020 Pa s m−3. Occlusion was released after 10 seconds.
3.4.1.4 Model equations
The following equations were introduced for the model (for parameters see Table
3.2).
3.4.1.4.1 Variable resistances
Resistances connecting to nodes with intramyocardial and venous compliances were
modified to prevent emptying of compartments.
Capillary resistance
for a positive pressure gradient (pai − pcap > 0), Figure 3.2
Rcap = R0cap + (20Vai)−2 (3.3)
for a negative pressure gradient (pai − pcap < 0), Figure 3.2
Rcap = R0cap + (20Vcap)−2 (3.4)
Venous epicardial resistance
for a positive pressure gradient (pcap − pven > 0), Figure 3.2
Rvepi = R0vepi + (20Vcap)−2 (3.5)
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for a negative pressure gradient (pcap − pven < 0), Figure 3.2
Rvepi = R0vepi + (20Vven)−2 (3.6)
Extra outlet resistance at capillary/venular level
for a positive pressure gradient (pcap − pLex > 0), Figure 3.2
RLex = R0Lex (3.7)
for a negative pressure gradient (pcap − pLex < 0), Figure 3.2
RLex = R0Lex + (20Vcap)−2 (3.8)
Extra outlet resistance at venous level
for a positive pressure gradient (pven − pex2 > 0), Figure 3.2
Rex2 = R0ex2 (3.9)
for a negative pressure gradient (pven − pex2 < 0), Figure 3.2
Rex2 = R0ex2 + (20Vven)−2 (3.10)
3.4.1.4.2 Venous compliance
Venous compliance was defined as volume-dependent, according to Schreiner.[98]
Cven(Vven) = C0ven(1 + σven)−1exp(−σven[Vven(t)− V 0ven]) (3.11)
where Cven is the instantaneous venous compliance, Vven the instantaneous (stressed)
venous volume, C0ven the reference venous compliance, σven the slope of change in
venous compliance and V 0ven the reference venous volume.
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Variable Parameter Value
Arterial epicardial compartment
V 0aepi Reference arterial epicardial volume 1.5 ml
Intramyocardial compartment
C0cap Reference capillary compliance 2.66× 10−8 m3Pa−1
V 0cap Reference capillary volume 1 ml
Venous epicardial compartment
C0ven Reference venous compliance 2.66× 10−8 m3Pa−1
σven Slope of change in venous compliance 0.3
V 0ven Reference venous volume 25 ml
Table 3.2: Parameter values for compartment volumes and variable compliances
3.4.1.5 Numerical solution
For the electrical analogue of the coronary circulation (Figure 3.2), a system of differ-
ential equations was formulated by setting up the balances for the pressures nodes
(flow balances according to Kirchhhoff’s current law) and volumes in the capaci-
tances. The resulting system of differential equations was then solved in MATLAB
(Release 2015a, The MathWorks, Inc., Natick, Massachusetts, United States) using
the solver ode15s (see appendix 1 for the full code). The simulation was run for 30s.
The condition of a closed coronary sinus was applied from 15s to 25s. Steady-state
with the coronary sinus open was reached after 10s at the start of simulation and
within 2s (2 beats) after coronary sinus release.
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3.4.2 Results
3.4.2.1 Normal perfusion without coronary sinus occlusion
The lumped parameter model of the coronary circulation reproduced physiologic
pressure (Figure 3.4) and flow curves (Figure 3.5) for the first left coronary branch
(L1) and second left coronary branch (L2). During systole, arterial flow was ret-
rograde due to the high values chosen for the ECP, while venous flow was high-
est. Conversely, arterial flow reached a maximum during early diastole and declined
thereafter, in parallel to the aortic pressure.
3.4.2.2 Normal perfusion with coronary sinus occlusion
Figure 3.6 shows the increase in venous pressure during occlusion of the coronary
sinus during normal perfusion. The pattern predicted by the model matched the
characteristic form from the clinical and experimental trials. With release of the
occlusion, baseline pressures were reached within 1-2 heart beats, also in agreement
with the in-vivo observations.
Inflow reduction during CSO reached the specified target with 9.9%. Non-coronary
sinus drainage without CSO was 7.6% of total outflow, slightly below the target
chosen by Schreiner and colleagues.[98] As expected, the model predicted increasing
retrograde flow from the venous epicardial to the lumped venular/capillary compart-
ment and increasing non-coronary sinus drainage during CSO (Figure 3.7).
Volume during CSO increased markedly for the venous epicardial compartment,
while it increased also in the lumped capillary/venular compartment. No significant
changes were seen in the arteriolar and arterial epicardial compartment (Figure 3.8).
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Figure 3.4: Pressure curves during normal perfusion.
Pressures shown for L1 (symmetric for L2). Systole from 10.0-10.4s, diastole from
10.4-11s.
L1, first left coronary branch. L2, second left coronary branch. paepi, arterial epicardial pressure. pai, arteriolar
pressure. pao, aortic pressure. pcap, capillary/venular pressure. pra, right atrial pressure. pvepi, venous epicardial
pressure.
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Figure 3.5: Flow curves during normal perfusion.
Flows shown for L1 (symmetric for L2). Systole from 10.0-10.4s, diastole from 10.4-
11s.
L1, first left coronary branch. L2, second left coronary branch. Iaepi, arterial epicardial flow. Iai, arteriolar flow.
Icap, capillary/venular flow. ICS , coronary sinus flow. Iex1, extra-outlet flow (thebesian veins). Iex2, extra-outlet flow
(non-coronary sinus). Ivepi, venous epicardial flow.
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Figure 3.8: Volumes during normal perfusion with coronary sinus occlusion.
Coronary sinus is occluded from 15s to 25s.
Vaepi, arterial epicardial volume. Vai, arteriolar volume. Vcap, capillary/venular volume. Vven, venous epicardial
volume.
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3.4.2.3 Ischemia without coronary sinus occlusion
During occlusion of L1, antegrade arterial epicardial flow in L1 was reduced to zero.
Consequently, flow over the lumped capillary/venular compartment in L1 varied with
the prescribed collateral flow (Figure 3.9). When ECP in L1 was decreased via the
proportionality factor gamma (Eq. (3.2)), the shape of the flow curve varied as
a function of ECP (Figure 3.10), but capillary/venular flow was still a function of
collateral flow (Figure 3.11), given that collateral flow was kept constant for each
gamma by variation of collateral resistance.
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Figure 3.9: Capillary/venular flow curves during ischemia without coronary sinus
occlusion as a function of collateral flow.
Single beat resolution, with collateral flow varied from zero to 0.40 ml/min/g in intervals
of 0.05 ml/min/g. Normal perfusion for comparison. Extravascular compressive pressure
(ECP) is set to normal.
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Figure 3.10: Capillary/venular flow curves during ischemia without coronary sinus
occlusion as a function of ECP in L1.
Collateral flow is 0.15 ml/min/g. Normal perfusion for comparison. Flow curve
varies as a function of gamma (Eq. (3.2)), the proportionality factor for ECP.
ECP = extravascular compressive pressure. L1 = first left coronary branch (ischemic region).
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Figure 3.11: Mean capillary/venular flow during ischemia without coronary sinus
occlusion as a function of ECP and collateral flow. Collateral flow is kept constant
by variation of collateral resistance.
ECP = extravascular compressive pressure.
3.4.2.4 Ischemia with coronary sinus occlusion
Coronary sinus occlusion reduced coronary sinus flow to zero. With CSO, flow from
the capillary/venular to the venous compartment became bidirectional in both the
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ischemic (L1) and non-ischemic region (L2), with retrograde flow during diastole.
Retrograde flow in L1 increased with increasing duration of CSO and varied as a
function of collateral flow: it increased with increasing collateral flow (Figure 3.12).
For the same collateral flow, retrograde flow in L1 decreased with decreasing ECP
in L1 up to gamma = 0.1 and increased again with gamma = 0 (Figure 3.13). Ret-
rograde flow became apparent also during later systole with lower ECP, at gamma
approximately 0.25.
Collectively, mean retrograde flow during CSO increased with increasing collateral
flow and was greater at higher ECP in the ischemic region L1 (Figure 3.12). Of
note, with decreasing ECP in the ischemic region, retrograde flow was increasingly
similar for different levels of collateral flow. In other words, lower ECP increasingly
attenuated the effect of collateral flow on retrograde flow (Table 3.3).
Peak CSP (Figure 3.15) and mean CSP (Figure 3.16) also varied as a function of
collateral flow and ECP, increasing with greater collateral flow and higher ECP. Col-
lateral flow was uniformly reduced with CSO: reduction was greater with increasing
collateral flow and showed a curvilinear (U-shaped) relationship with ECP (Figure
3.17), which was more marked at lower collateral flows.
84
0
0.
5
1
1.
5
2
2.
5
3
3.
5
4
4.
5
5
5.
5
6
6.
5
7
7.
5
8
8.
5
9
9.
5
10
−1
4
−1
2
−1
0−8−6−4−202468101214
no
rm
al
pe
rfu
sio
n
0.
00
m
l/
m
in
/g
co
lla
te
ra
lfl
ow
0.
10
m
l/
m
in
/g
co
lla
te
ra
lfl
ow
0.
20
m
l/
m
in
/g
co
lla
te
ra
lfl
ow
0.
30
m
l/
m
in
/g
co
lla
te
ra
lfl
ow
0.
40
m
l/
m
in
/g
co
lla
te
ra
lfl
ow
Fi
gu
re
3.
12
:
C
ap
ill
ar
y
to
ve
no
us
flo
w
cu
rv
es
du
rin
g
w
ho
le
cy
cl
e
of
co
ro
na
ry
sin
us
oc
cl
us
io
n
as
a
fu
nc
tio
n
of
co
lla
te
ra
lfl
ow
.
N
or
m
al
pe
rfu
sio
n
fo
r
co
m
pa
ris
on
.
EC
P
is
co
ns
ta
nt
w
ith
g
a
m
m
a
=
1.
N
eg
at
iv
e
va
lu
es
re
pr
es
en
t
re
tr
og
ra
de
flo
w
fro
m
th
e
ve
no
us
to
th
e
lu
m
pe
d
ca
pi
lla
ry
/v
en
ul
ar
co
m
pa
rt
m
en
t.
E
C
P
=
ex
tr
av
as
cu
la
r
co
m
pr
es
si
ve
pr
es
su
re
.
85
0
0.
5
1
1.
5
2
2.
5
3
3.
5
4
4.
5
5
5.
5
6
6.
5
7
7.
5
8
8.
5
9
9.
5
10
−1
2
−1
0−8−6−4−202468
T
im
e
[s]
Capillarytovenousflow[ml/min/g]
ga
m
m
a
=
1
ga
m
m
a
=
0.
75
ga
m
m
a
=
0.
50
ga
m
m
a
=
0.
25
ga
m
m
a
=
0.
10
ga
m
m
a
=
0.
00
Fi
gu
re
3.
13
:
C
ap
ill
ar
y
to
ve
no
us
flo
w
cu
rv
es
du
rin
g
w
ho
le
cy
cl
e
of
co
ro
na
ry
sin
us
oc
cl
us
io
n
as
a
fu
nc
tio
n
of
EC
P.
C
ol
la
te
ra
l
flo
w
is
se
t
at
0.
15
m
l/
m
in
/g
.
EC
P
is
va
rie
d
w
ith
g
a
m
m
a
fro
m
ze
ro
to
1.
N
eg
at
iv
e
va
lu
es
re
pr
es
en
t
re
tr
og
ra
de
flo
w
fro
m
th
e
ve
no
us
to
th
e
lu
m
pe
d
ca
pi
lla
ry
/v
en
ul
ar
co
m
pa
rt
m
en
t.
E
C
P
=
ex
tr
av
as
cu
la
r
co
m
pr
es
si
ve
pr
es
su
re
.
g
a
m
m
a
=
pr
op
or
ti
on
al
it
y
fa
ct
or
fo
r
E
C
P
.
86
0 0.2 0.4 0.6
0.8 10
0.1
0.2
0.3
0.4
0.2
0.4
0.6
0.8
Scaling factor for ECP
in L1
Collateral flow
[ml/min/g]
R
et
ro
gr
ad
e
flo
w
[m
l/
m
in
/g
]
Figure 3.14: Mean flow from venous to capillary/venular compartment (retrograde
flow) during ischemia with coronary sinus occlusion as function of ECP in L1 and
collateral flow. Mean values over 10s of coronary sinus occlusion.
ECP = extravascular compressive pressure. L1 = first left coronary branch.
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Table 3.3: Mean retrograde flow as a function of collateral flow and ECP in L1.
Mean values [ml/min/g] over whole CSO cycle of 10s.
CSO = coronary sinus occlusion, ECP = extravascular compressive pressure, gamma = proportionality factor for
ECP, L1 = first left coronary branch (ischemic region).
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Figure 3.15: Peak coronary sinus pressures during ischemia with coronary sinus
occlusion as a function of ECP in L1 and collateral flow.
ECP = extravascular compressive pressure, L1 = first left coronary branch (ischemic region).
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Figure 3.16: Mean coronary sinus pressures during ischemia with coronary sinus
occlusion as a function of ECP in L1 and collateral flow.
ECP = extravascular compressive pressure, L1 = first left coronary branch (ischemic region).
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Figure 3.17: Reduction of collateral blood flow during ischemia with coronary sinus
occlusion as a function of ECP in L1 and collateral flow.
Reduction in collateral blood flow expressed as percentage of collateral blood flow
without coronary sinus occlusion (delta collateral flow).
ECP = extravascular compressive pressure. L1 = first left coronary branch (ischemic region).
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4. Discussion and Outlook
The main aims of this study were to investigate the extracardiac coronary collateral
circulation (Projects I and II) and the role of coronary collaterals in the anti-ischemic
effect of CSO (Projects III and IV).
Extracardiac Collaterals
In a first-in-man study, we could demonstrate evidence for functional, ischemia-
reducing collateral supply from the internal mammary artery to the coronary cir-
culation (Project I). In the clinical study, the augmentative effect of distal IMA
occlusion on collateral function and consequently a reduction in regional myocardial
ischemia could be demonstrated for the ipsilateral coronary branch, ie left IMA to
LAD and right IMA to RCA. In the case of the LCX, the findings were equivocal,
with a variable response of collateral function to ipsi- or contralateral distal IMA
occlusion. As a continuation of the preliminary trial, we could further provide ev-
idence in favour of structural growth of anastomoses between the right IMA and
the RCA in response to distal right IMA occlusion, whereas overall no effect was
demonstrated on collateral function in the left coronary artery (Project II).
Clinical vs anatomic findings
The pathology studies demonstrated IMA-to-coronary anastomoses only for the RCA
and LCX, but not for the LAD. Furthermore, the few angiographic case reports in
vivo of IMA-to-LAD anastomoses[28, 29, 30] were documented exclusively in patients
with prior heart surgery. Prior heart surgery and inflammatory conditions of the peri-
cardium are known to cause adhesions between the pericardial layers, which might
have enabled these connections to occur not primarily but secondarily.[26]. Moreover,
on anatomical grounds and consistent with the pathological findings, atrial coronary
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branches conceivably mediate connections between the IMA and a ventricular coro-
nary branch via an atrial coronary branch. Most atrial coronary branches have been
described to arise from the RCA and the LCX, with a minority originating from
the left main coronary artery.[23] However, consistent atrial branches have not been
described for the LAD. At variance with these observations, our clinical study pro-
vided evidence also for left IMA to LAD anastomoses. A possible explanation might
be the methodical difference between the qualitative angiography in the pathology
studies and the arguably more sensitive quantitative functional assessment in our
study.
With respect to contralateral distal IMA occlusion, no effect on collateral function
or regional myocardial ischemia could be detected for the LAD or the RCA, which
is consistent with the findings from angiographical case reports and the pathology
studies. For the LCX, CFI was higher with ipsilateral IMA balloon occlusion and
trended to be higher with contralateral IMA occlusion (p=0.08), however, regional
myocardial ischemia was not different with either ipsi- or contralateral IMA occlu-
sion. Anatomically, however, connections to the LCX are conceivable via left atrial
and also the largest atrial branch, the sinus node artery.[20] Moreover, angiograph-
ically, IMA anastomoses to the LCX from both the ipsilateral[34] and contralateral
side[31] have been documented. Taken together, the findings from our clinical study
are at variance with these considerations. On balance, it seems reasonable that ex-
tracardiac anastomoses to the LCX exist from both the right and the left IMA, but
that the clinical study lacked in statistical power to detect their prevalence.
Promotion of extracardiac collaterals
In our first-in-man study we provided evidence for the proof of concept to promote
right coronary collateral function by distal right IMA closure. Compared to other
trials on the promotion of collateral function, this study method is among the first
that could provide a durable promotion of collateral growth. The method could be
likened to a model of physical coronary arteriogenesis,[11] although the mechanism
by which the presumed augmentative effect of distal IMA closure is exerted, remains
speculative. Whereas the acute effect of distal IMA occlusion by balloon in the
preliminary study[70] can be interpreted as a functional recruitment of IMA-to-
coronary anastomoses, [101, 102] the chronic effect by permanent distal IMA closure
92
in the exploratory therapeutic study can be regarded as a structural adaptation.
Prior studies necessitated recurrent application of the arteriogenic stimulus to sustain
the effect of collateral growth promotion. Repetitive application of an arteriogenic
treatment is, however, cumbersome,[12] dependent on patient compliance[13, 10, 12]
and may have unwanted side effects.[8, 103] Comparing the effect size of the different
interventions is difficult, given the differences in patient characteristics. Neverthe-
less, the increase in CFI attributed to a response to permanent right IMA closure
(+0.067± 0.094) is among the largest compared to other clinically tested collateral
promotion trials.
The study hypothesis postulated a differential effect of right IMA closure on collat-
eral function in the right vs the left coronary artery. Specifically, we hypothesized
that right coronary collateral function would improve, whereas no change would be
seen for the left coronary artery. This hypothesis was based on the study findings
from the preliminary trial.
The positive study results of an augmenting effect on right coronary collateral func-
tion from right IMA closure have to be interpreted in light of a lack in randomization
of the intervention. Therefore, confirmation in a randomized study design is manda-
tory to derive more definite conclusions regarding the efficacy of the intervention. In
case of confirmation, distal right IMA closure appears most suitable as an alternative
adjunct to established revascularization procedures in patient subsets with coronary
lesions not amenable to conventional therapy. Mainly, this applies to patients with
ischemia in the RCA territory, specifically chronic total occlusion (CTO) of that
artery. Chronic total occlusions are commonly found during coronary angiography,
[104] but due to lower procedural success rates and a higher complication rate com-
pared to non-CTO interventions,[105] a conservative approach is not unusual for
these lesions.[106] From an anatomical point of view, it appears reasonable that the
occlusion should be situated before the sinus node artery, given that it has been
implicated to mediate the extracoronary collateral connection.
Reluctance seems justified to perform distal left IMA occlusion as a means to im-
prove collateral function of the LAD, given that it might preclude its utilization
for CABG, where it is almost universally used. On the other hand, the practice of
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bilateral IMA grafting is infrequent,[107, 108] which places less restriction on right
IMA interventions in the context of arteriogenic trials. Nevertheless, given its distal
position, occlusion of the IMA might not entirely exlude its use in future CABG.
Coronary Sinus Intervention
The clinical trial on intermittent CSO in patients with stable CAD was consistent
with an important contribution of the coronary collateral circulation in the anti-
ischemic effect of this intervention (Project III). With very low collateral function,
regional myocardial ischemia during a 2-minute coronary balloon occlusion was not
different with or without CSO. Similarly, an additional anti-ischemic effect of CSO
was not demonstrated with high collateral function, given that signs of myocardial
ischemia were practically prevented by sufficient collaterals in the first place. In
comparison, in the intermediate range of collateral function, there was a pronounced
effect of CSO in reducing electrocardiographic signs of ischemia.
Given the multitude of influencing factors and variables not accessible to measure-
ment, a lumped parameter computer model was also developed.
Role of coronary collaterals: clinical vs experimental findings
In experimental trials, a reduction in myocardial infarct size by CSO was demon-
strated regardless of the collateral status of the examined species. Thus, salvage of
myocardium could be observed also in the pig, which is notorious for its minimal col-
lateral circulation. A differential effect on infarct size with CSO in species with good
versus poor collaterals is hampered by the heterogeneity in the study protocols.[53]
Notably, key influencing factors for infarct size, such as the duration of coronary
occlusion and the timing of CSO differed significantly between the experiments. A
difference in effectiveness of CSO as a function of the collateral status can there-
fore not be drawn on the basis of the extent of infarct size reduction. However, the
demonstration of infarct size in species practically devoid of arterial collaterals impli-
cates mechanisms in reducing myocardial ischemia also functioning in the absence of
coronary collaterals. In this context, the model of selective coronary vein occlusion
as opposed to occlusion of the major collecting vein is instructive.
Occlusion of the CS results in an increase in CSP which is transmitted back to its
tributaries, mainly, the venous branches of the left coronary arteries. Thus, the
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outflow pressure is increased to both ischemic and non-ischemic regions, assuming
ischemia in the territory of one of the left coronary branches. Consequently, owing to
a decreased perfusion pressure in the ischemic region, the impedance to outflow may
favour a redistribution of flow from the non-ischemic to the ischemic region.[78, 79]
This flow redistribution could conceivably be mediated by coronary collaterals. The
extent of flow redistribution would then be dependent on the size of the pre-existing
collateral connections. With minute collateral connections, little capacity could be
expected, whereas larger increases would be imaginable with more sizeable collat-
erals. The provisions to this hypothesis would for the collateral donor to originate
from the left coronary artery, eg from the LCX in the case of LAD occlusion, given
that the RCA is unaffected by CSO. In pigs, microsphere-measured regional my-
ocardial blood flow in the ischemic region was practically zero and was not enhanced
by CSO.[79] Measuring regional myocardial perfusion by the microsphere method
equates to collateral blood flow.[84] In dogs, regional myocardial blood flow in the
ischemic region was enhanced by CSO in one study in dogs.[78] However, an aug-
mentation of collateral function by CSO was not found in other studies in dogs
[63, 109, 64]. Collectively, these data indicate that collateral flow is not typically
augmented by CSO.
With selective occlusion of the vein draining an ischemic region, the resulting out-
flow impedance is limited and will not affect drainage in non-ischemic regions.[79] In
fact, an inhibitory effect on any antegrade flow in the region drained by the occluded
epicardial vein is likely, given the greater restriction on outflow with more upstream
vein occlusion.[79] Selective intermittent vein occlusion in dogs did not reduce in-
farct size,[83], an observation consistent with a lack of effectiveness of that method in
the absence of flow diversion from non-ischemic zones. Selective vein retroperfusion
with arterial blood, however, lead to significant reductions in infarct size compared
to control.[83] In this situation, effective retroperfusion of the ischemic region is the
likely mechanism of ischemia reduction. Qualitatively, it was proven by dye staining
that retroperfusate injected selectively in a coronary vein reached the capillary level
in ischemic (but not in non-ischemic) myocardium.[110]
The effectiveness of coronary sinus intervention (CSI) with well- vs poorly-functioning
collaterals can be appreciated in comparing retroperfusion trials in pigs with the ex-
perimental findings of CSO in dogs. Retroperfusion and CSO in pigs was effective in
preserving myocardial viability, but only retroperfusion at high flow rates and high
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counter-pressures (80-120mmHg) was effective in restoring myocardial function.[111,
112] In contrast, CSO alone was effective in (partial) restoration of myocardial func-
tion in dogs.[113]
Role of coronary collaterals: findings from mathematical model
Several computer models of coronary sinus occlusion have been published, notably
by Schreiner,[114, 115, 98, 116, 117], Neumann[118] and Beyar[119] and colleagues.
The models invariably simulated a two-branch left coronary system, given the fact
that the right coronary system is practically unaffected by CSO. Schreiner and Neu-
mann and colleagues extensively investigated the modulating influence of variable
myocardial squeezing on the extent of retrograde flow to the ischemic region. In
their model, the squeezing pressure was set proportional to LVP and decreasing
contractility was simulated by a decreasing factor of proportionality. They found
myocardial squeezing to be necessary to cause effective retrograde perfusion from
the venous towards the capillary compartment. Retrograde flow increased with in-
creasing squeezing pressure, while very strong squeezing again reduced retrograde
flow. On theoretical grounds, their modeling approach of contractility does not
seem unreasonable, given that the interaction between the coronary vessels and the
myocardium currently seems indeed best explained by the combined effect of LVP-
derived interstitial pressure (CEP) and contraction-induced intramyocyte pressure
(shortening-induced intracellular pressure).[93, 120] Uncertainty exists, however, for
the exact contributions of the two mechanisms. It has been estimated that the effect
of contractility on ECP was at least 50% of that of the LVP.[120] Consequently,
although it is reasonable to assume that reduced contractility lessens retrograde flow
during CSO, its relative impact remains difficult to estimate.
With one exception, the published models of CSO did not include arterial collaterals
between the non-ischemic and ischemic territory. Yet, although Beyar included col-
laterals on the arterial level, his investigation in this respect was limited to but one
level of collateral flow (10% of normal antegrade flow). Therefore, the role of different
levels coronary collaterals in the anti-ischemic effect of CSO remained unexplored.
With regard to a proposed augmentation of collateral flow by CSO, the model by
Beyar predicted the opposite: collateral flow to the ischemic bed was reduced by
CSO.
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The model of this thesis provided valuable additional insight in the variables deter-
mining the effect of CSO. First of all and importantly, however, it could reproduce
the salient physiologic specifics of coronary pressure and flow during ischemic and
non-ischemic conditions, with the collateral circulation being an integral part of the
model. Secondly, the model could reproduce quantitative and qualitative pressure
and flow patterns during CSO, in particular retrograde flow during CSO and the
characteristic form of venous pressure. In this respect, the model can be seen on par
with prior published computer models on the subject.
With regard to the influence of myocardial squeezing on retrograde flow, this model
in essence reaffirms prior findings: a decrease in contractility modeled via a reduc-
tion in ECP lead to a concomitant decrease in retrograde flow to the ischemic region.
The model did not investigate stronger squeezing than the physiologically assumed.
The novel finding of this computer model is the influence of the extent of collateral
function on the anti-ischemic effect of CSO. The model predicted retrograde flow to
the ischemic region to be positively correlated with the prescribed collateral flow.
Assuming constant contractility, a modest increase in mean retrograde flow during
a 10s cycle of CSO was predicted, for example a 25% increase at a collateral flow of
0.25 ml/min/g relative to no collateral function. Importantly, though, contractility
in an ischemic region is reduced as a function of its remaining blood flow, in the
case of total occlusion as a function of its collateral supply. Therefore, the combina-
tions of reduced contractility and levels of collateral flow were also examined. The
model predicted retrograde flow to be strongly affected by the combination of more
reduced contractility with poorer collateral function compared to more preserved
contractility with better collateral function. Specifically, assuming a reduction of
ECP to half of normal with total ischemia (zero collateral flow), retrograde flow was
60% of that with normal contractility. Conversely, assuming preserved contractility
with a collateral flow of 0.20 ml/min/g, retrograde flow was twice as high compared
to the former constellation. In this comparison, the differential effect of arterialized
collateral blood flow compared to retrograde venous blood flow low in oxygen has to
be taken into account. In other words, the same rate of arterial coronary blood flow
is more effective in reducing myocardial ischemia, than venous blood retroperfusate,
where oxygen extraction is conceivably much lower.
Regarding the well-documented effect of antegrade flow inhibition, the model pre-
dicted the same for collateral blood flow, which was more reduced at higher collateral
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flows and showed a curvilinear relation with ECP. To summarize, the findings of the
computer model are in agreement with the clinical study. The prediction of low
retrograde flow at low collateral function is consistent with the observed absence of
an ischemia-reducing effect with CSO. With sufficient collateral function, the model
predicted an increase in retrograde flow, which did however not translate in a further
reduction in ischemia in the clinical study, given that it was abolished by collaterals
in the first place. Retrograde flow had an ischemia-reducing effect at intermediate,
but insufficient levels of collateral function. Given these points, the bell-shaped re-
lation between ischemia reduction and collateral function seen in the clinical study
is compatible with the mathematical model.
Role of coronary collaterals: implications for clinical application
Intermittent coronary sinus occlusion (ICSO) has recently been reinvestigated as an
adjunct to PCI in patients with acute mycoardial ischemia. A preliminary, uncon-
trolled safety and feasibility study included 19 patients undergoing PCI of a LAD
culprit lesion with anterior ST-segment elevation myocardial infarction (STEMI). In
patients successfully treated with (pressure-controlled) ICSO, there was greater in-
farct size reduction compared with matched historic controls.[121] Of note, the study
excluded patients with cardiogenic shock. By the same token, an interim analysis
of an ongoing controlled, but not randomized trial in patients with acute coronary
syndrome showed a significant reduction in infarct size of 10.6% points in patients
undergoing ICSO relative to patients not undergoing the intervention. Furthermore,
a reduction in microvascular obstruction was observed.[122]
In the context of the findings from our clinical study and the prediction by the
mathematical model, it might be worthwhile to additionally evaluate the influence
of collateral status on the effectiveness of ICSO in this setting. As a first approx-
imation, an evaluation by the angiographic Rentrop score would provide a simple
approach to gauge collateral function, given its ready availability during coronary
angiography.
Similarly, but in the setting of chronic ischemia, the clinical use of a coronary sinus
reducer stent, can be likened to a form of incomplete CSO, leading to chronic as op-
posed to intermittent elevation of CSP. A preliminary safety feasibility study [50] and
the following randomized, sham-controlled clinical study[52] showed symptomatic
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improvement in a majority, but not all patients undergoing the device implantation
for refractory angina. The mechanism of ”recruitment of collateral flow” purported
by the authors is however inconsistent with the notion of increased CSP leading to a
flow diversion from non-ischemic to ischemic zones augmented by collateral function
indirectly. Clinically, this notion might have implications for patient selection both
in the acute and chronic setting of myocardial ischemia. In other words, patients
with minimal collateral function might conceivably derive less benefit from CSI com-
pared to patients with higher levels of collateral function. In the setting of acute
myocardial ischemia this consideration in particular applies to patients with cardio-
genic shock, where poor collateral function is more common.[123, 124] In patients
with chronic myocardial ischemia, such as in the setting of CTO, collateral function
is typically much higher[125] and the effect of CSP elevation might therefore be more
beneficial.
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Code
Listing 1: Matlab code for the main function of the model
1 c l e a r v a r s except argnum doplot i teratemode ; close a l l ; clc
2
3 i f nargin < 1
4 argnum = 1 ;
5 doplot = 0 ;
6 e l s e i f nargin <2
7 doplot = 0 ;
8 end
9
10 %% ge t parameters from separa t e e x c e l f i l e
11
12 warning o f f
13 param tbl = readtab l e ( f u l l f i l e (pwd, ’ param double2c minimi 5 . x l sx
’ ) ) ;
14 warning on
15
16 % se t param names and va l u e s
17
18 t b l l e n g t h = find ( c e l l f u n (@(x ) isempty ( x ) , param tbl { : , 1} ) , 1 ) 1 ; %
exc lude empty rows
19
20 i f isempty ( t b l l e n g t h )
21 t b l l e n g t h = length ( param tbl { : , 1} ) ;
22 end
23
24 for i = 1 : t b l l e n g t h
25 for k = 1 : ( width ( param tbl ) 1 )
26 A r g l i s t {k } . ( char ( param tbl { i , 1} ) ) = param tbl { i , k+1};
27 end
117
28 end
29
30 %% check parameters
31
32 i f nargin < 1
33 Arg = Arg l i s t {1} ;
34 else
35 Arg = Arg l i s t {argnum } ;
36 end
37
38 %% ge t input : LVP and pao
39
40 [ time , LVP, pao , BPM] = l i n e a r d r i v e l o a d s e t u p 2 (0 ,Arg . beat s n ) ; %
genera te pu l se s , n=Arg . b ea t s n
41
42 % per iod
43 per iod = 60/BPM; % [ s ]
44
45 % LVP dot , ECP dot
46 [ dLVPdt ] = c e n t r a l d i f f (LVP, time ) ;
47
48 % ECP = LVP∗ l v p s c a l e ;
49
50 ECP L1 = LVP∗Arg . l v p s c a l e ∗Arg . gamma L1 ;
51 ECP L2 = LVP∗Arg . l v p s c a l e ∗Arg . gamma L2 ;
52
53 [ dECPdt L1 ] = c e n t r a l d i f f (ECP L1 , time ) ;
54 [ dECPdt L2 ] = c e n t r a l d i f f (ECP L2 , time ) ;
55
56 input = { time , pao , LVP, ECP L1 ,ECP L2 , BPM} ;
57
58 % r i g h t a t r i a l p re s sure
59
60 pRA = repmat (700 , length ( pao ) ,1 ) ;
61 pex1 = LVP;
62 pex2 = pRA;
63
64 %% i n i t i a l s t a t e
65
66 % i n i t i a l c ond i t i on s
118
67 p 0 = [ Arg . p0 aepi1 , Arg . p0 ai1 , Arg . p0 cap1 , Arg . p0 aepi2 , Arg .
p0 ai2 , Arg . p0 cap2 , Arg . p0 ven , . . .
68 Arg . V0 aepi L1 ∗1e 6 , Arg . V0 ai L1 ∗1e 6 , Arg . V0 cap L1∗1e 6 , Arg .
V0 aepi L2 ∗1e 6 , Arg . V0 ai L2 ∗1e 6 , Arg . V0 cap L2∗1e 6 , Arg .
V0 vepi ∗1e 6 ] ;
69
70 t span = [ time (1 ) , time (end) ] ;
71
72 %% so l v e r , ode15s
73
74 opt ions = odeset ( ’Mass ’ ,@( t , p ) mass ( t , p , Arg , time , ECP L1 , ECP L2 ,
pex1 , pex2 ) , ’ RelTol ’ ,Arg . RelTol ) ; % se t op t i ons f o r s o l v e r
75
76 %% node names
77
78 p nodes = {
79 ’ L1aepi ’
80 ’ L1ai ’
81 ’ L1cap ’
82 ’ L2aepi ’
83 ’ L2ai ’
84 ’ L2cap ’
85 ’ Lvepi ’
86 } ;
87
88 q l a b e l s = {
89 ’ RL1aepi ’ ; % 1
90 ’RL1ai ’ ; % 2
91 ’RL1cap ’ ; % 3
92 ’ RL2aepi ’ ; % 4
93 ’RL2ai ’ ; % 5
94 ’RL2cap ’ ; % 6
95 ’ RL1vepi ’ ; % 7
96 ’ RL2vepi ’ ; % 8
97 ’RL1ex ’ ; % 9
98 ’RL2ex ’ ; %10
99 ’ Rcai ’ ; %11
100 ’Rcven ’ ; %12
101 ’Rex2 ’ ; %13
102 ’RCS ’ ; %14
103 } ;
119
104
105 r l a b e l s = {
106 ’ RL1aepi ’ ; % 1
107 ’RL1ai ’ ; % 2
108 ’RL1cap ’ ; % 3
109 ’ RL2aepi ’ ; % 4
110 ’RL2ai ’ ; % 5
111 ’RL2cap ’ ; % 6
112 ’ RL1vepi ’ ; % 7
113 ’ RL2vepi ’ ; % 8
114 ’RL1ex ’ ; % 9
115 ’RL2ex ’ ; %10
116 ’ Rcai ’ ; %11
117 ’Rcven ’ ; %12
118 ’Rex2 ’ ; %13
119 ’RCS ’ ; %14
120 } ;
121
122 v l a b e l s = {
123 ’ L1aepi ’ % 1
124 ’ L1ai ’ % 2
125 ’ L1cap ’ % 3
126 ’ L2aepi ’ % 4
127 ’ L2ai ’ % 5
128 ’ L2cap ’ % 6
129 ’ Lven ’ % 7
130 } ;
131
132 %% so l v e system fo r p r e s su re s and volumes
133
134 [T, P] = ode15s (@( t , p ) rhs ( t , p , Arg , time , LVP, ECP L1 , ECP L2 ,
dECPdt L1 , dECPdt L2 , pao , pRA, pex1 , pex2 ) , t span , p 0 , opt ions ) ;
135
136 %% ca l c u l a t e f l ow s in nodes
137
138 [T, Q, V, r , c , c r a t i o ] = f l ows (T, P, pao , Arg , LVP, dECPdt L1 ,
dECPdt L2 , time , ECP L1 , ECP L2 , pex1 , pex2 ) ;
139
140 %% p l o t t i n g
141
142 i f doplot == 1
120
143
144 x l im f i g (1 ) = 1 ; % [ sec ]
145 x l im f i g (2 ) = T(end) ;
146
147 lw = 1 . 5 ; % l i n ew i d t h
148 f s l a b e l = 18 ; % fon t s i z e f o r a x i s l a b e l s
149
150
151 %% f i g u r e 1 : p r e s su re s coronary L1
152
153 hf1 = f igure ( ) ;
154
155 xlim ( x l im f i g )
156
157 hold on ; grid on ;
158
159 t i t l e 1 = t i t l e ( [ param tbl ( : , argnum+1) . P rope r t i e s . VariableNames , ’ L1 ’
] ) ;
160
161 for k = [ 1 : 3 , 7 ]
162 i f k == 3 % p l o t aor t i c , r i g h t a t r i a l and LV pres sure
163 plot ( time ,pRA/133 .3 , ’ c ’ , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , ’P RA
’ ) ; hold on ;
164 plot ( time , pao /133 .3 , ’ c ’ , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , ’ P ao
’ ) ; hold on ;
165 % p l o t ( time ,LVP/133.3 , ’ r ’ , ’ l i n ew id th ’ , lw , ’DisplayName ’ , ’
LVP’ ) ; ho ld on ;
166 end
167
168 i f k == 1
169 plot (T, P( : , k ) /133 .3 , ’ . ’ , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’
P ’ , p nodes {k } ] ) ; hold on ;
170 e l s e i f k == 2
171 plot (T, P( : , k ) /133 .3 , ’ ’ , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’
P ’ , p nodes {k } ] ) ; hold on ;
172 e l s e i f k == 3
173 plot (T, P( : , k ) /133 .3 , ’ : ’ , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’ P
’ , p nodes {k } ] ) ; hold on ;
174 else
175 plot (T, P( : , k ) /133 .3 , ’ : ’ , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’ P
’ , p nodes {k } ] ) ; hold on ;
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176 end
177
178 end
179
180 xlabel ( ’ time t [ s ] ’ , ’ FontSize ’ , f s l a b e l )
181 ylabel ( ’ p r e s su r e [mmHg] ’ , ’ FontSize ’ , f s l a b e l )
182
183 xlim ( x l im f i g )
184 set (gca , ’ FontSize ’ ,16)
185
186 l eg1 = legend ( ’ DynamicLegend ’ ) ;
187 set ( leg1 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
188 set ( t i t l e 1 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
189
190 %% f i g u r e 2 : p r e s su re s coronary L2
191
192 hf2 = f igure ( ) ;
193
194 xlim ( x l im f i g )
195
196 hold on ; grid on ;
197
198 t i t l e 2 = t i t l e ( [ param tbl ( : , argnum+1) . P rope r t i e s . VariableNames , ’ L2 ’
] ) ;
199
200 for k = 4 :7
201 i f k == 4 % p l o t a o r t i c pre s sure
202 plot ( time ,pRA/133 .3 , ’ c ’ , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , ’P RA
’ ) ; hold on ;
203 plot ( time , pao /133 .3 , ’ c ’ , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , ’ P ao
’ ) ; hold on ;
204 % p l o t ( time ,LVP/133.3 , ’ r ’ , ’ l i n ew id th ’ , lw , ’DisplayName ’ , ’
LVP’ ) ; ho ld on ;
205 end
206 plot (T, P( : , k ) /133 .3 , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’ P ’ ,
p nodes {k } ] ) ; hold on ;
207 end
208
209 xlabel ( ’ time t [ s ] ’ , ’ FontSize ’ , f s l a b e l )
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210 ylabel ( ’ p r e s su r e [mmHg] ’ , ’ FontSize ’ , f s l a b e l )
211
212 xlim ( x l im f i g )
213 set (gca , ’ FontSize ’ ,16)
214
215 l eg2 = legend ( ’ DynamicLegend ’ ) ;
216 set ( leg2 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
217 set ( t i t l e 2 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
218
219 %% f i g u r e 3 : f l ow s
220
221 hf3 = f igure ( ) ;
222 xlim ( x l im f i g )
223
224 hold on ; grid on ;
225
226 lw = 1 . 2 ;
227
228 t i t l e 3 = t i t l e ( param tbl ( : , argnum+1) . P rope r t i e s . VariableNames ) ;
229 set ( t i t l e 3 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
230
231 %%
232 sp (1 ) = subplot ( 6 , 1 , 1 : 2 ) ;
233
234 xlim ( x l im f i g )
235 set (gca , ’ FontSize ’ ,16)
236 hold on ; grid on ;
237
238 for k = [ 1 : 3 ]
239 plot (T, Q( : , k ) ∗1 e6 /100∗60 , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’ I ’ ,
q l a b e l s {k } ] ) ; hold on ;
240 end
241
242 ylabel ( ’ A r t e r i a l Flow [ ml/min ] per g ’ )
243 l e g 3 1 = legend ( ’ DynamicLegend ’ ) ;
244 set ( l eg3 1 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
245
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246 %%
247 sp (2 ) = subplot ( 6 , 1 , 3 : 4 ) ;
248
249 xlim ( x l im f i g )
250 set (gca , ’ FontSize ’ ,16)
251 hold on ; grid on ;
252
253 for k = [ 1 1 : 1 2 ]
254 plot (T, Q( : , k ) ∗1 e6 /100∗60 , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’ I ’ ,
q l a b e l s {k } ] ) ; hold on ;
255 end
256
257 ylabel ( ’ C o l l a t e r a l Flow [ ml/min ] per g ’ )
258 l e g 3 1 = legend ( ’ DynamicLegend ’ ) ;
259 set ( l eg3 1 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
260
261 %%
262 sp (3 ) = subplot ( 6 , 1 , 5 : 6 ) ;
263
264 xlim ( x l im f i g )
265 set (gca , ’ FontSize ’ ,16)
266 hold on ; grid on ;
267
268 % for k = [ 7 : 1 3 ]
269 for k = [ 7 , 9 , 1 1 : 1 4 ]
270 i f k == 12
271 plot (T, Q( : , k ) ∗1 e6 /200∗60 , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’
I ’ , q l a b e l s {k } ] ) ; hold on ;
272 else
273 plot (T, Q( : , k ) ∗1 e6 /100∗60 , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’
I ’ , q l a b e l s {k } ] ) ; hold on ;
274 end
275 end
276
277 xlabel ( ’ time t [ s ] ’ , ’ FontSize ’ , f s l a b e l )
278 ylabel ( ’ Venous Flow [ ml/min ] per g ’ , ’ FontSize ’ , f s l a b e l )
279 set (gca , ’ FontSize ’ ,16)
280
281 l i nkax e s ( sp , ’ x ’ )
282
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283 l e g 3 2 = legend ( ’ DynamicLegend ’ ) ;
284 set ( l eg3 2 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
285
286 %% f i g u r e 3 : volumes
287
288 hf3 = f igure ( ) ;
289
290 hold on ; grid on ;
291
292 lw = 1 . 5 ;
293
294 t i t l e 3 = t i t l e ( param tbl ( : , argnum+1) . P rope r t i e s . VariableNames ) ;
295
296 for k = [ 1 : 7 ]
297 plot (T, V( : , k ) , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’V ’ , v l a b e l s {k
} ] ) ; hold on ;
298 end
299
300 xlabel ( ’ time t [ s ] ’ , ’ FontSize ’ , f s l a b e l )
301 ylabel ( ’Volume [ ml ] ’ , ’ FontSize ’ , f s l a b e l )
302
303 xlim ( x l im f i g ) ;
304 set (gca , ’ FontSize ’ ,16)
305
306 l eg3 = legend ( ’ DynamicLegend ’ ) ;
307 set ( leg3 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
308 set ( t i t l e 3 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
309
310 %% f i g u r e 4 : r e s i s t a n c e s
311
312 hf4 = f igure ( ) ;
313
314 hold on ; grid on ;
315
316 lw = 1 . 5 ;
317
318 t i t l e 4 = t i t l e ( param tbl ( : , argnum+1) . P rope r t i e s . VariableNames ) ;
319
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320 for k = [ 2 : 1 3 ]
321 plot (T, r ( : , k ) , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’ r ’ , r l a b e l s {k
} ] ) ; hold on ;
322 end
323
324 set (gca , ’ FontSize ’ ,16)
325
326 xlabel ( ’ time t [ s ] ’ , ’ FontSize ’ , f s l a b e l )
327 ylabel ( ’ r e s i s t a n c e [ Pa s / mˆ3 ] ’ , ’ FontSize ’ , f s l a b e l )
328
329 xlim ( x l im f i g )
330
331 l eg4 = legend ( ’ DynamicLegend ’ ) ;
332 set ( leg4 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
333 set ( t i t l e 4 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
334
335 %% f i g u r e 5 : compl iances
336
337 hf5 = f igure ( ) ;
338
339 hold on ; grid on ;
340
341 lw = 1 . 5 ;
342
343 t i t l e 5 = t i t l e ( param tbl ( : , argnum+1) . P rope r t i e s . VariableNames ) ;
344
345 for k = [ 1 : 7 ]
346 plot (T, c ( : , k ) , ’ l i n ew id th ’ , lw , ’ DisplayName ’ , [ ’ c ’ , v l a b e l s {k
} ] ) ; hold on ;
347 end
348
349 xlabel ( ’ time t [ s ] ’ , ’ FontSize ’ , f s l a b e l )
350 ylabel ( ’ compliance [mˆ3 / Pa ] ’ , ’ FontSize ’ , f s l a b e l )
351
352 xlim ( x l im f i g )
353 set (gca , ’ FontSize ’ ,16)
354
355 l eg5 = legend ( ’ DynamicLegend ’ ) ;
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356 set ( leg5 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
357 set ( t i t l e 5 , ’ I n t e r p r e t e r ’ , ’ none ’ ) ; % turn o f f I n t e r p r e t e r to avoid
s u b s c r i p t when us ing ’ ’
358
359
360 end
361
362 disp ( ’ ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ’ )
363 disp ( ’ done ’ )
364 disp ( ’ ∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗∗ ’ )
365
366 end
367
368 %
369
370 %% func t i on f o r input o f r i g h t hand s i d e ( ode15s )
371
372 function [ M dpdt ] = rhs ( t , p , Arg , time , LVP, ECP L1 , ECP L2 , dECPdt L1 ,
dECPdt L2 , pao , pRA, pex1 , pex2 )
373
374 % in t e r p o l a t e input data
375
376 pa = interp1 ( time , pao , t ) ;
377 lvp = interp1 ( time , LVP, t ) ;
378
379 e cp l 1 = interp1 ( time , ECP L1 , t ) ;
380 e cp l 2 = interp1 ( time , ECP L2 , t ) ;
381
382 ecpdo t l 1 = interp1 ( time , dECPdt L1 , t ) ;
383 e cpdo t l 2 = interp1 ( time , dECPdt L2 , t ) ;
384
385 pra = 700 ;
386
387 pex1 = interp1 ( time , pex1 , t , ’ pchip ’ ) ;
388 pex2 = interp1 ( time , pex2 , t , ’ pchip ’ ) ;
389
390 % ca l c u l a t e v a r i a b l e r e s i s t a n c e s
391
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392 [ r , R1 , R2 , R3 , R4 , R5 , R6 , R7 , R8 , R9 , R10 , R11 , R12 , R13 , R14 , v , v1 ,
v2 , v3 , v4 , v5 , v6 , v7 ] = r e s i s t a n c e s ( t , p , ecp l1 , ecp l2 , Arg , 0 ,
pex1 , pex2 ) ;
393
394 % ca l c u l a t e v a r i a b l e compl iances
395
396 [ ˜ , C1 , C2 , C3 , C4 , C5 , C6 , C7 , ˜ ] = compl iances ( t , p , e cp l1 , ecp l2 ,
Arg , 0 , v3 , v6 , v7 , v ) ;
397
398 % ca p i l l a r y p re s su r e s
399
400 i f Arg . p forced
401 p (3 ) = ( p (10) / C3 ) + ecp l 1 ;
402 p (6 ) = ( p (13) / C6 ) + ecp l 2 ;
403 end
404
405 % venous pre s sure
406
407 i f Arg . p forced
408 p (7 ) = ( v7 ∗ Arg . ch i ven ˆ 2 ∗ exp(Arg . s igma ven ∗( v7 Arg . V0 vepi ) )
) ∗133 . 3 ;
409 end
410
411 % pres sure f o r venous c o l l a t e r a l s
412
413 p3 cven = Arg . p cv en f a c t o r ∗ p (3) + 1333 ;
414 p6 cven = Arg . p cv en f a c t o r ∗ p (6) + 1333 ;
415
416 % de f i n e r i g h t hand s i d e
417 M dpdt = zeros (14 ,1 ) ; % i n i t i a l i z e
418
419 M dpdt (1 ) = 1/R1∗ ( pa p (1 ) ) 1/R2∗ (p (1 ) p (2 ) ) ;
% node 1
420 M dpdt (2 ) = 1/R2∗ (p (1 ) p (2 ) ) 1/R3∗ (p (2 ) p (3 ) ) 1/R11∗(p (2 ) p
(5 ) ) + C2∗ e cpdo t l 1 ;
% node 2
421
422 i f Arg . cven
423 M dpdt (3 ) = 1/R3∗ (p (2 ) p (3 ) ) 1/R7∗(p (3 ) p (7 ) ) 1/R9∗(p (3 )
pex1 + Arg . p o f f c a p ) 1/R12∗( p3 cven p (6) ) + C3∗ e cpdo t l 1 ;
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% node 3 wi th c o l l a t e r a l
424 else
425 M dpdt (3 ) = 1/R3∗ (p (2 ) p (3 ) ) 1/R7∗(p (3 ) p (7 ) ) 1/R9∗(p (3 )
pex1 + Arg . p o f f c a p ) + C3∗ e cpdo t l 1 ;
% node 3
426 end
427
428 M dpdt (4 ) = 1/R4∗ ( pa p (4 ) ) 1/R5∗ (p (4 ) p (5 ) ) ;
% node 4
429 M dpdt (5 ) = 1/R5∗ (p (4 ) p (5 ) ) 1/R6∗ (p (5 ) p (6 ) ) + 1/R11∗(p (2 ) p
(5 ) ) + C5∗ e cpdo t l 2 ;
% node 5
430
431 i f Arg . cven
432 M dpdt (6 ) = 1/R6∗ (p (5 ) p (6 ) ) 1/R8∗(p (6 ) p (7 ) ) 1/R10∗(p (6 )
pex1 + Arg . p o f f c a p ) + 1/R12∗( p3 cven p (6) ) + C6∗ e cpdo t l 2 ;
% node 6 wi th c o l l a t e r a l
433 else
434 M dpdt (6 ) = 1/R6∗ (p (5 ) p (6 ) ) 1/R8∗(p (6 ) p (7 ) ) 1/R10∗(p (6 )
pex1 + Arg . p o f f c a p ) + C6∗ e cpdo t l 2 ;
% node 6
435 end
436
437 M dpdt (7 ) = 1/R7∗ (p (3 ) p (7 ) ) + 1/R8∗(p (6 ) p (7 ) ) 1/R13∗(p (7 )
pex2 + Arg . p o f f v en ) 1/R14∗(p (7 ) pra ) ;
% node 7
438 M dpdt (8 ) = 0 ;
% volume in C1
439 M dpdt (9 ) = C2∗ e cpdo t l 1 ;
% volume in C2
440 M dpdt (10) = C3∗ e cpdo t l 1 ;
% volume in C3
441 M dpdt (11) = 0 ;
% volume in C4
442 M dpdt (12) = C5∗ e cpdo t l 2 ;
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% volume in C5
443 M dpdt (13) = C6∗ e cpdo t l 2 ;
% volume in C6
444 M dpdt (14) = 0 ;
% volume in C7
445
446 end
447
448 %
449
450 %% func t i on f o r input o f mass matrix ( ode15s )
451
452 function [M] = mass ( t , p , Arg , time , ECP L1 , ECP L2 , pex1 , pex2 )
453
454 e cp l 1 = interp1 ( time , ECP L1 , t , ’ pchip ’ ) ;
455 e cp l 2 = interp1 ( time , ECP L2 , t , ’ pchip ’ ) ;
456
457 [ r , R1 , R2 , R3 , R4 , R5 , R6 , R7 , R8 , R9 , R10 , R11 , R12 , R13 , R14 , v , v1 ,
v2 , v3 , v4 , v5 , v6 , v7 ] = r e s i s t a n c e s ( t , p , ecp l1 , ecp l2 , Arg , 0 ,
pex1 , pex2 ) ;
458
459 [ c , C1 , C2 , C3 , C4 , C5 , C6 , C7 , c r a t i o ] = compl iances ( t , p , e cp l1 ,
e cp l2 , Arg , 0 , v3 , v6 , v7 , v ) ;
460
461 % mass matrix
462
463 %1 %2 %3 %4 %5 %6 %7 %8 %9 %10 %11 %12 %13
%14
464 M = [C1 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 ,
0 ; % node 1
465 0 , C2 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 ,
0 ; % node 2
466 0 , 0 , C3 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 ,
0 ; % node 3
467 0 , 0 , 0 , C4 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 ,
0 ; % node 4
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468 0 , 0 , 0 , 0 , C5 , 0 , 0 , 0 , 0 , 0 , 0 , 0 , 0 ,
0 ; % node 5
469 0 , 0 , 0 , 0 , 0 , C6 , 0 , 0 , 0 , 0 , 0 , 0 , 0 ,
0 ; % node 6
470 0 , 0 , 0 , 0 , 0 , 0 , C7 , 0 , 0 , 0 , 0 , 0 , 0 ,
0 ; % node 7
471 C1 , 0 , 0 , 0 , 0 , 0 , 0 , 1 , 0 , 0 , 0 , 0 , 0 ,
0 ; % volume in C1
472 0 , C2 , 0 , 0 , 0 , 0 , 0 , 0 , 1 , 0 , 0 , 0 , 0 ,
0 ; % volume in C2
473 0 , 0 , C3 , 0 , 0 , 0 , 0 , 0 , 0 , 1 , 0 , 0 , 0 ,
0 ; % volume in C3
474 0 , 0 , 0 , C4 , 0 , 0 , 0 , 0 , 0 , 0 , 1 , 0 , 0 ,
0 ; % volume in C4
475 0 , 0 , 0 , 0 , C5 , 0 , 0 , 0 , 0 , 0 , 0 , 1 , 0 ,
0 ; % volume in C5
476 0 , 0 , 0 , 0 , 0 , C6 , 0 , 0 , 0 , 0 , 0 , 0 , 1 ,
0 ; % volume in C6
477 0 , 0 , 0 , 0 , 0 , 0 , C7 , 0 , 0 , 0 , 0 , 0 , 0 ,
1 ] ; % volume in C7
478
479 end
480
481 % sub func t i on f o r ins tan taneous r e s i s t a n c e s
482
483 function [ r , R1 , R2 , R3 , R4 , R5 , R6 , R7 , R8 , R9 , R10 , R11 , R12 , R13 , R14
, v , v1 , v2 , v3 , v4 , v5 , v6 , v7 ] = r e s i s t a n c e s ( t , p , e cp l1 , ecp l2 ,
Arg , arrayfun , pex1 , pex2 )
484
485 % re s i s t a n c e s
486
487 R1 0 = Arg . RL1aepi ;
488 R2 0 = Arg . RL1ai ;
489 R3 0 = Arg . RL1cap ;
490
491 R4 0 = Arg . RL2aepi ;
492 R5 0 = Arg . RL2ai ;
493 R6 0 = Arg . RL2cap ;
494
495 R7 0 = Arg . RL1vepi ;
496 R8 0 = Arg . RL2vepi ;
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497 R9 0 = Arg . RL1ex ;
498 R10 0 = Arg . RL2ex ;
499
500 R11 0 = Arg . Rcai ;
501 R12 0 = Arg . Rcven ;
502 R13 0 = Arg . RLex ;
503
504 r f a c t o r = Arg . r f a c t o r ;
505
506 % unpack arguments end
507
508 i f ˜ arrayfun
509
510 % f i r s t coronary
511
512 v1 = p (8) ∗1 e6 ; % volume in C1 , from [m3] to [ ml ]
513 v2 = p (9) ∗1 e6 ; % volume in C2 , from [m3] to [ ml ]
514 v3 = p(10) ∗1 e6 ; % volume in C3 , from [m3] to [ ml ]
515
516 % second coronary
517
518 v4 = p(11) ∗1 e6 ; % volume in C4 , from [m3] to [ ml ]
519 v5 = p(12) ∗1 e6 ; % volume in C5 , from [m3] to [ ml ]
520 v6 = p(13) ∗1 e6 ; % volume in C6 , from [m3] to [ ml ]
521
522 % ep i c a r d i a l ve in
523
524 v7 = p(14) ∗1 e6 ; % volume in C7 , from [m3] to [ ml ]
525
526 % re s i s t a n c e s
527
528 R1 = R1 0 ;
529 R2 = R2 0 ;
530
531 % prevent emptying o f compartments
532
533 i f p (2) p (3 ) > 0
534 R3 = R3 0 + ( r f a c t o r ∗ p (9) ) ˆ 2 ; % p (9) i s volume in C2
535 else
536 R3 = R3 0 + ( r f a c t o r ∗ p (10) ) ˆ 2 ; % p(10) i s volume in C3
537 end
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538
539 R4 = R4 0 ;
540 R5 = R5 0 ;
541
542 i f p (5) p (6 ) > 0
543 R6 = R6 0 + ( r f a c t o r ∗ p (12) ) ˆ 2 ; % p(12) i s volume in C5
544 else
545 R6 = R6 0 + ( r f a c t o r ∗ p (13) ) ˆ 2 ; % p(13) i s volume in C6
546 end
547
548 i f p (3) p (7 ) > 0
549 R7 = R7 0 + ( r f a c t o r ∗ p (10) ) ˆ 2 ; % p(10) i s volume in C3
550 else
551 R7 = R7 0 + ( r f a c t o r ∗ p (14) ) ˆ 2 ; % p(14) i s volume in C7
552 end
553
554 i f p (6) p (7 ) > 0
555 R8 = R8 0 + ( r f a c t o r ∗ p (13) ) ˆ 2 ; % p(13) i s volume in C6
556 else
557 R8 = R8 0 + ( r f a c t o r ∗ p (14) ) ˆ 2 ; % p(14) i s volume in C7
558 end
559
560 % ex t ra o u t l e t L1 ( t h e b e s i an )
561
562 i f p (3) pex1 > 0
563 R9 = R9 0 + ( r f a c t o r ∗ p (10) ) ˆ 2 ;
564 else
565 R9 = R9 0 ;
566 end
567
568 % ex t ra o u t l e t L2 ( t h e b e s i an )
569
570 i f p (6) pex1 > 0
571 R10 = R10 0 + ( r f a c t o r ∗ p (13) ) ˆ 2 ; % p(13) i s volume in C6
572 else
573 R10 = R10 0 ;
574 end
575
576 R11 = R11 0 ;
577
578 % venous c o l l a t e r a l
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579
580 i f p (6) p (3 ) > 0
581 R12 = R12 0 + ( r f a c t o r ∗ p (13) ) ˆ 2 ; % p(13) i s volume in C6
582 else
583 R12 = R12 0+ ( r f a c t o r ∗ p (10) ) ˆ 2 ; % p(10) i s volume in C3
584 end
585
586 % ex t ra o u t l e t
587
588 i f p (7) pex2 > 0
589 R13 = R13 0 + ( r f a c t o r ∗ p (14) ) ˆ 2 ; % p(14) i s volume in C7 ;
590 else
591 R13 = R13 0 ;
592 end
593
594 % in t e rm i t t e n t CS occ l u s i on
595
596 i f t < 15 % reach steady s t a t e
597 R14 = Arg . RCS nonoccl ;
598 e l s e i f t < 25
599 R14 = Arg . RCS occl ;
600 e l s e i f t < 30
601 R14 = Arg . RCS nonoccl ;
602 e l s e i f t < 40
603 R14 = Arg . RCS occl ;
604 e l s e i f t < 45
605 R14 = Arg . RCS nonoccl ;
606 e l s e i f t < 55
607 R14 = Arg . RCS occl ;
608 e l s e i f t <= 60
609 R14 = Arg . RCS nonoccl ;
610 end
611
612 r = [ ] ;
613 v = [ ] ;
614 v r a t i o = [ ] ;
615
616 else
617 for k = 1 : length ( t )
618
619 %% volumes
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620
621 % f i r s t coronary
622
623 v (k , 1 ) = p(k , 8 ) ∗1 e6 ; % volume in C1 , from [m3] to [ ml ]
624 v (k , 2 ) = p(k , 9 ) ∗1 e6 ;
625 v (k , 3 ) = p(k , 1 0 ) ∗1 e6 ;
626
627 % second coronary
628
629 v (k , 4 ) = p(k , 1 1 ) ∗1 e6 ; % volume in C3 , from [m3] to [ ml ]
630 v (k , 5 ) = p(k , 1 2 ) ∗1 e6 ;
631 v (k , 6 ) = p(k , 1 3 ) ∗1 e6 ;
632
633 % ep i c a r d i a l ve in
634
635 v (k , 7 ) = p(k , 1 4 ) ∗1 e6 ;
636
637 %% re s i s t a n c e s
638
639 % f i r s t coronary
640
641 r (k , 1 ) = R1 0 ;
642 r (k , 2 ) = R2 0 ;
643
644 % prevent emptying o f C2 , a r t e r i a l in t ramyocard ia l compartment
645
646 i f p(k , 2 ) p(k , 3 ) > 0
647 r (k , 3 ) = R3 0 + ( r f a c t o r ∗ p(k , 9 ) ) ˆ 2 ;
648 else
649 r (k , 3 ) = R3 0 + ( r f a c t o r ∗ p(k , 1 0 ) ) ˆ 2 ;
650 end
651
652 % prevent emptying o f C3 , c a p i l l a r y compartment
653
654 i f p(k , 3 ) p(k , 7 ) > 0
655 r (k , 7 ) = R7 0 + ( r f a c t o r ∗ p(k , 1 0 ) ) ˆ 2 ;
656 else
657 r (k , 7 ) = R7 0 + ( r f a c t o r ∗ p(k , 1 4 ) ) ˆ 2 ;
658 end
659
660 % second coronary
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661
662 r (k , 4 ) = R4 0 ;
663 r (k , 5 ) = R5 0 ;
664
665 % prevent emptying o f C5 , a r t e r i a l in t ramyocard ia l compartment
666
667 i f p(k , 5 ) p(k , 6 ) > 0
668 r (k , 6 ) = R6 0 + ( r f a c t o r ∗ p(k , 1 2 ) ) ˆ 2 ;
669 else
670 r (k , 6 ) = R6 0 + ( r f a c t o r ∗ p(k , 1 3 ) ) ˆ 2 ;
671 end
672
673 % prevent emptying o f C6 , c a p i l l a r y compartment
674
675 i f p(k , 6 ) p(k , 7 ) > 0
676 r (k , 8 ) = R8 0 + ( r f a c t o r ∗ p(k , 1 3 ) ) ˆ 2 ;
677 else
678 r (k , 8 ) = R8 0 + ( r f a c t o r ∗ p(k , 1 4 ) ) ˆ 2 ;
679 end
680
681 % ex t ra o u t l e t L1 ( t h e b e s i an )
682
683 i f p(k , 3 ) pex1 (k ) > 0
684 r (k , 9 ) = R9 0 + ( r f a c t o r ∗ p(k , 1 0 ) ) ˆ 2 ;
685 else
686 r (k , 9 ) = R9 0 ;
687 end
688
689 % ex t ra o u t l e t L2 ( t h e b e s i an )
690
691 i f p (6) pex1 (k ) > 0
692 r (k , 1 0 ) = R10 0 + ( r f a c t o r ∗ p(k , 1 3 ) ) ˆ 2 ; % p(13) i s volume in
C6
693 else
694 r (k , 1 0 ) = R10 0 ;
695 end
696
697 r (k , 1 1 ) = R11 0 ;
698
699 % venous c o l l a t e r a l
700
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701 i f p (6) p (3 ) > 0
702 r (k , 1 2 ) = R12 0 + ( r f a c t o r ∗ p (13) ) ˆ 2 ; % p(13) i s volume in
C6
703 else
704 r (k , 1 2 ) = R12 0 + ( r f a c t o r ∗ p (10) ) ˆ 2 ; % p(10) i s volume in
C3
705 end
706
707 % coronary s inus
708
709 % prevent emptying o f C7 , venous compartment
710
711 i f p(k , 7 ) pex2 (k ) > 0
712 r (k , 1 3 ) = R13 0 + ( r f a c t o r ∗ p(k , 1 4 ) ) ˆ 2 ;
713 else
714 r (k , 1 3 ) = R13 0 ;
715 end
716
717 % in t e rm i t t e n t CS occ l u s i on
718
719 i f t ( k ) < 15 % reach steady s t a t e
720 r (k , 1 4 ) = Arg . RCS nonoccl ;
721 e l s e i f t ( k ) < 25
722 r (k , 1 4 ) = Arg . RCS occl ;
723 e l s e i f t ( k ) < 30
724 r (k , 1 4 ) = Arg . RCS nonoccl ;
725 e l s e i f t ( k ) < 40
726 r (k , 1 4 ) = Arg . RCS occl ;
727 e l s e i f t ( k ) < 45
728 r (k , 1 4 ) = Arg . RCS nonoccl ;
729 e l s e i f t ( k ) < 55
730 r (k , 1 4 ) = Arg . RCS occl ;
731 e l s e i f t ( k ) <= 60
732 r (k , 1 4 ) = Arg . RCS nonoccl ;
733 end
734
735 end
736
737 R1 = [ ] ;
738 R2 = [ ] ;
739 R3 = [ ] ;
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740 R4 = [ ] ;
741 R5 = [ ] ;
742 R6 = [ ] ;
743 R7 = [ ] ;
744 R8 = [ ] ;
745 R9 = [ ] ;
746 R10 = [ ] ;
747 R11 = [ ] ;
748 R12 = [ ] ;
749 R13 = [ ] ;
750 R14 = [ ] ;
751
752 v1 = [ ] ;
753 v2 = [ ] ;
754 v3 = [ ] ;
755 v4 = [ ] ;
756 v5 = [ ] ;
757 v6 = [ ] ;
758 v7 = [ ] ;
759
760 end
761
762 end
763
764 % sub func t i on f o r ins tan taneous compl iances
765
766 function [ c , C1 , C2 , C3 , C4 , C5 , C6 , C7 , c r a t i o ] = compl iances ( t , p ,
e cp l1 , ecp l2 , Arg , arrayfun , v3 , v6 , v7 , v )
767
768 % unpack arguments s t a r t
769
770 % compl iances
771
772 C1 0 = Arg . CL1aepi ;
773 C2 0 = Arg . CL1ai ;
774 C3 0 = Arg . CL1cap ;
775
776 C4 0 = Arg . CL2aepi ;
777 C5 0 = Arg . CL2ai ;
778 C6 0 = Arg . CL2cap ;
779
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780 C7 0 = Arg . CLvepi ;
781
782 % re f e r ence volumes
783
784 V0 vepi = Arg . V0 vepi ;
785 sigma ven = Arg . sigma ven ;
786
787 % unpack arguments end
788
789 i f ˜ arrayfun
790
791 C1 = C1 0 ;
792 C2 = C2 0 ;
793
794 i f Arg . C cap var == 0
795 C3 = C3 0 ;
796 else
797 C3 = C3 0 ∗ (1 + Arg . s igma cap ∗ v3 ) . ˆ 1 ∗ exp ( Arg . s igma cap ∗(
v3 Arg . V0 cap L1 ) ) ; % volumes in [ ml ]
798 end
799
800 C4 = C4 0 ;
801 C5 = C5 0 ;
802
803 i f Arg . C cap var == 0
804 C6 = C6 0 ;
805 else
806 C6 = C6 0 ∗ (1 + Arg . s igma cap ∗ v6 ) . ˆ 1 ∗ exp ( Arg . s igma cap ∗(
v6 Arg . V0 cap L2 ) ) ;
807 end
808
809 C7 = C7 0 ∗ (1 + sigma ven ∗ v7 ) . ˆ 1 ∗ exp ( sigma ven ∗( v7 V0 vepi )
) ;
810
811 c = [ ] ;
812 c r a t i o = [ ] ;
813
814 else
815 for k = 1 : s ize ( t , 1 )
816
817 % f i r s t coronary
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818
819 c r a t i o (k , 1 ) = 1 ;
820 c r a t i o (k , 2 ) = 1 ;
821
822 i f Arg . C cap var == 0
823 c r a t i o (k , 3 ) = 1 ;
824 else
825 c r a t i o (k , 3 ) = (1 + Arg . s igma cap ∗ v (k , 3 ) ) ˆ 1 .∗ exp ( Arg .
s igma cap ∗ ( v (k , 3 ) Arg . V0 cap L1 ) ) ; % volumes in [ ml
] ;
826 end
827
828 % second coronary
829
830 c r a t i o (k , 4 ) = 1 ;
831 c r a t i o (k , 5 ) = 1 ;
832
833 i f Arg . C cap var == 0
834 c r a t i o (k , 6 ) = 1 ;
835 else
836 c r a t i o (k , 6 ) = (1 + Arg . s igma cap ∗ v (k , 6 ) ) ˆ 1 .∗ exp ( Arg .
s igma cap ∗ ( v (k , 6 ) Arg . V0 cap L2 ) ) ; % volumes in [ ml
] ;
837 end
838
839 % compliance f o r venous segment i s volume dependent
840
841 c r a t i o (k , 7 ) = (1 + sigma ven ∗ v (k , 7 ) ) ˆ 1 .∗ exp ( sigma ven ∗ (
v (k , 7 ) V0 vepi ) ) ; % volumes in [ ml ]
842 end
843
844 c ( : , 1 ) = C1 0 .∗ c r a t i o ( : , 1 ) ;
845 c ( : , 2 ) = C2 0 .∗ c r a t i o ( : , 2 ) ;
846 c ( : , 3 ) = C3 0 .∗ c r a t i o ( : , 3 ) ;
847 c ( : , 4 ) = C4 0 .∗ c r a t i o ( : , 4 ) ;
848 c ( : , 5 ) = C5 0 .∗ c r a t i o ( : , 5 ) ;
849 c ( : , 6 ) = C6 0 .∗ c r a t i o ( : , 6 ) ;
850 c ( : , 7 ) = C7 0 .∗ c r a t i o ( : , 7 ) ;
851
852 C1 = [ ] ;
853 C2 = [ ] ;
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854 C3 = [ ] ;
855 C4 = [ ] ;
856 C5 = [ ] ;
857 C6 = [ ] ;
858 C7 = [ ] ;
859 end
860
861 end
862
863 % func t i on f o r output o f node f l ow s and volumes
864
865 function [T, Q, v , r , c , c r a t i o ] = f l ows (T, P, PAO, Arg , LVP, dECPdt L1
, dECPdt L2 , time , ecp l1 , ecp l2 , pex1 , pex2 )
866
867 % in t e r p o l a t e inpu t s
868 pao = interp1 ( time , PAO, T, ’ pchip ’ ) ;
869 lvp = interp1 ( time , LVP, T, ’ pchip ’ ) ;
870 pex1 = interp1 ( time , pex1 , T, ’ pchip ’ ) ;
871 pex2 = interp1 ( time , pex2 , T, ’ pchip ’ ) ;
872 pra = 700 ;
873
874 decpdt l 1 = interp1 ( time , dECPdt L1 , T, ’ pchip ’ ) ;
875 decpdt l 2 = interp1 ( time , dECPdt L2 , T, ’ pchip ’ ) ;
876
877 % ge t v a r i a b l e r e s i s t a n c e s
878 [ r , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , v , v1 , v2 , v3 , v4 , v5 , v6
, v7 ] = r e s i s t a n c e s (T, P, ecp l1 , ecp l2 , Arg , 1 , pex1 , pex2 ) ;
879
880 % ge t v a r i a b l e compl iances
881 [ c , ˜ , ˜ , ˜ , ˜ , ˜ , ˜ , c r a t i o ] = compl iances (T, P, ecp l1 , ecp l2 , Arg ,
1 , v3 , v6 , v7 , v ) ;
882
883 %% f l ows
884
885 Q( : , 1 ) = ( pao P( : , 1 ) ) . / r ( : , 1 ) ;
886 Q( : , 2 ) = (P( : , 1 ) P( : , 2 ) ) . / r ( : , 2 ) ;
887 Q( : , 3 ) = (P( : , 2 ) P( : , 3 ) ) . / r ( : , 3 ) ;
888
889 Q( : , 4 ) = ( pao P( : , 4 ) ) . / r ( : , 4 ) ;
890 Q( : , 5 ) = (P( : , 4 ) P( : , 5 ) ) . / r ( : , 5 ) ;
891 Q( : , 6 ) = (P( : , 5 ) P( : , 6 ) ) . / r ( : , 6 ) ;
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892
893 Q( : , 7 ) = (P( : , 3 ) P( : , 7 ) ) . / r ( : , 7 ) ;
894 Q( : , 8 ) = (P( : , 6 ) P( : , 7 ) ) . / r ( : , 8 ) ;
895
896 Q( : , 9 ) = (P( : , 3 ) pex1 + Arg . p o f f c a p ) . / r ( : , 9 ) ;
897 Q( : , 1 0 ) = (P( : , 6 ) pex1 + Arg . p o f f c a p ) . / r ( : , 1 0 ) ;
898
899 Q( : , 1 1 ) = (P( : , 2 ) P( : , 5 ) ) . / r ( : , 1 1 ) ;
900
901 i f Arg . cven
902 disp ( ’ c a l c u l a t i n g venous c o l l a t e r a l f low ’ )
903 Q( : , 1 2 ) = ( (P( : , 3 ) ∗Arg . p cv en f a c t o r +1333 Arg . p o f f c v en ) (P
( : , 6 ) ∗Arg . p cv en f a c t o r +1333 Arg . p o f f c v en ) ) . / r ( : , 1 2 ) ;
904 end
905 % Q( : , 1 2 ) = [ ]
906
907 Q( : , 1 3 ) = (P( : , 7 ) pex2 ) . / r ( : , 1 3 ) ; % Arg . p o f f v e n
908 Q( : , 1 4 ) = (P( : , 7 ) pra ) . / r ( : , 1 4 ) ;
909
910 end
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Listing 2: Matlab code for the input to the main function
1 function [T, LVP, pao , BPM] = l i n e a r d r i v e l o a d s e t u p 2 ( showplot , N puls )
2 %
3 % This i s a MATLAB m f i l e
4 %
5 % Fi l e : l i n e a r d r i v e l o a d s e t u p 2 .m
6 % Author : David Hasler , Michael S t o l l e r ( some mod i f i c a t i on s )
7 % Date : 2 016 06 21
8 % Last Change : 2 017 01 14
9 % In s t i t u t e : ARTORG and Cardio logy , Bern Un i v e r s i t y Hosp i ta l , Bern ,
10 % Swi t z e r l and
11 % Topic : Load on l i n e a r dr ive , LPM sys temic c i r c u l a t i o n , tomo
p iv se tup 2.0
12 %
13 % Descr ip t i on :
14 % The load on the l i n e a r d r i v e screw used in the pump of the f l ow loop
can
15 % be determined by the l i n e a r momentum equat ion ( Impu l s sa t z ) . To
determine
16 % the load from the pre s sure on the c y l i n d e r su r f a c e a lumped parameter
17 % lumped paR ameter model (LPM) i s app l i e d . To t h i s puR pose , the LPM
18 % ’ f l ow l o o p s e t u p 2 .m’ i s ex tended at the LV node wi th a compliance in
19 % s e r i e s wi th an iner tance and a r e s i s t a n c e . This group
20 % rep r e s en t s the par t from the pump to the LV ( f e ed in g tube , LV champer )
.
21 % The i n l e t f l ow p r o f i l e i s g i ven by ’LPM input XYZ . t x t ’ which i s a f i l e
22 % conta in ing f l ow ra t e va l u e s (mˆ3/ s ) o f a normal ized f l ow p r o f i l e wi th
23 % a s p e c i f i c waveform .
24 %
25 % Changelog :
26 % removed h y s t e r e s i s o f v a l v e opening ( mi t ra l and ao r t i c ) and reduced
27 % aor t i c v a l v e r e s i s t a n c e
28 % 04.01 .17 us ing c e n t r a l d i f f f unc t i on f o r d i f f e r e n t i a t i o n
29 %
30 %
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31 % References :
32 % Ste r g i opu l o s , 1999 , ”Tota l a r t e r i a l ine r tance as the f ou r t h e lement o f
the
33 % windke s s e l model ”
34 %
35 %
36 c l e a r v a r s except showplot N puls ;
37 close a l l ; clc
38
39 % check input arguments
40
41 i f nargin <1
42 showplot = 0 ;
43 N puls = 20 ;
44 e l s e i f nargin <2
45 N puls = 20 ;
46 end
47
48 %
49 % PAR aMETERS
50 %
51 g = 9 . 8 1 ;
52
53 % f l u i d
54 rho = 1050 ;
55 mu = 0 . 0 0 4 ;
56
57 % re f e r ence pre s su r e s
58 p atm = 0 ; % . . . 0 i f on ly i n t e r e s t e d in r e l a t i v e pre s sure
59 h 1 = 0 . 2 1 ; % water l e v e l h e i g h t in r e f e r ence open r e s e r v o i r
( d e f a u l t i s 0 .4 m)
60 p r e f 1 = p atm + rho∗g∗h 1 ;
61
62 % re s i s t a n c e
63 R a = 8e06 ; % [Pa s / mˆ3] S t e r g i o pu l o s (1999) 7464800
64 R p = 1 .5 e08 ; % [Pa s / mˆ3] S t e r g i o pu l o s (1999) 105307000
65 RMV = 10∗133 .3/0 . 0002 ; % [Pa s / mˆ3]
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66 R AV = 1∗133 . 3/0 . 0002 ; % [Pa s / mˆ3]
67
68 d f = 0 . 0 2 5 ; l f = 0 . 2 ;
69 R f = 128∗mu∗ l f /( d f ˆ4∗pi ) ;
70
71 % iner tance
72 L Ster = 7e05 ; % [Pa s ˆ2 / mˆ3] S t e r g i o pu l o s (1999) 679830
73
74 d a = 0 . 0 2 5 ; l a = 0 . 2 ;
75 L a = rho∗ l a /( d a ˆ2/4∗pi ) ; % acc e l e r a t e d f l u i d in a o r t i c tube
76
77 L f = rho∗ l f /( d f ˆ2/4∗pi ) ; % acc e l e r a t e d f l u i d in f e ed in g tube
78
79 % compliance
80 d C = 0 . 1 1 4 ;
81 h C = 0 . 1 2 ;
82 p C 0 = 101325; V C 0 = d Cˆ2/4∗pi∗h C ;
83 K = p C 0∗V C 0 ; % for a i r chamber
84
85 C A = 1e 0 9 ; % Ste r g i o pou l o s (1999) 9.1522880 e 0 9
86 C LV = 1e 1 0 ;
87 C m = 1e 0 9 ; % Compliance o f LV membrane
88
89 % pu l s e per iode
90 BPM = 60 ;
91 T = 60/BPM;
92
93 % aor t i c f l ow mean peak v e l o c i t y
94 u bar = 0 . 7 ;
95
96 % pi s t on
97 d p = 0 . 1 ;
98 muN = 50 ; % Coulomb f r i c t i o n p i s t on head [N]
99 m = 0 . 5 ; % Total mass o f s l i d e , suppor t and p i s t on [ kg ]
100
101 %
102 % Waveform
103 %
104 wf data = importdata ( ’ LPM input phys N100 . txt ’ ) ’ ;
105 wf = repmat ( wf data ( 1 :end 1 ) ,1 , N puls ) ;
106
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107 % time domain
108 time = linspace (0 , T∗N puls , ( length ( wf data ) 1) ∗N puls ) ;
109
110 % pi s t on k inemat ic s
111 v p = d a ˆ2/d p ˆ2∗ u bar ∗wf ;
112 a p = c e n t r a l d i f f ( v p , time ) ;
113
114 % f low ra t e
115 Q = v p∗d p ˆ2/4∗pi ;
116 Q dot = c e n t r a l d i f f (Q, time ) ;
117 Q ddot = c e n t r a l d i f f (Q dot , time ) ;
118
119 %
120 % TIME INTEGR aTION
121 %
122 % pack arguments s t a r t
123 Arg . p r e f 1 = p r e f 1 ;
124 Arg . R a = R a ;
125 Arg . R p = R p ;
126 Arg . R f = R f ;
127 Arg .RMV = RMV;
128 Arg .R AV = R AV;
129 Arg . L a = L a ;
130 Arg . L f = L f ;
131 Arg .K = K;
132 Arg .C A = C A ;
133 Arg .C LV = C LV ;
134 Arg .C m = C m;
135 % pack arguments end
136
137 % i n i t i a l s t a t e
138 p 0 = [ p r e f 1 , p r e f 1 , 0 , p r e f 1 , 0 , V C 0 , p r e f 1 , p r e f 1 ] ;
139
140 t span = [ time (1 ) , time (end) ] ;
141 opt ions = odeset ( ’Mass ’ ,@( t , p ) mass ( t , p , Arg ) , . . .
142 ’ MassSingular ’ , ’ no ’ , . . .
143 ’ RelTol ’ ,1 e 5 ) ;
144
145 [T, P] = ode15s (@( t , p ) rhs ( t , p , Arg , time , Q, Q ddot ) , t span , p 0 ,
opt ions ) ;
146
146
147 LVP = P( : , 1 ) ;
148 pao = P( : , 2 ) ;
149
150 %
151 % CARDIAC OUTPUT
152 %
153 Qa = zeros ( length (T) ,1 ) ;
154 s1 = zeros ( length (T) ,1 ) ;
155 s2 = zeros ( length (T) ,1 ) ;
156 for i = 1 : length (T)
157 t = T( i ) ;
158 p = P( i , : ) ;
159
160 Qa( i ) = f low ( t , p , Arg ) ;
161
162 [R1 , R2 ] = va lve s ( t , p , Arg ) ;
163
164 s1 ( i ) = RMV/R1 ;
165 s2 ( i ) = R AV/R2 ;
166 end
167
168 %
169 % LOAD ON LINEAR DRIVE
170 %
171
172 p z = pchip (T, P( : , 8 ) , time ) + Q∗R f ;
173
174 % l i n e a r momentum
175 F A = m∗a p + p z ∗d p ˆ2/4∗pi + muN∗sign ( v p ) ;
176
177 % torque
178 l s l i d e = 0 . 1 ;
179 M = l s l i d e ∗( p z ∗d p ˆ2/4∗pi + muN∗sign ( v p ) ) ;
180
181 %
182 % PLOTS
183 %
184
185 i f showplot
186
187 hf1 = f igure (1 ) ;
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188 f s = 15 ;
189
190 subplot 311 ; hold on ; lw = 1 . 5 ;
191 plot (T, P( : , 1 ) /133 .3 , ’ c o l o r ’ , [ 0 . 9 , 0 . 1 , 0 . 1 ] , ’ l i n ew id th ’ , lw )
192 plot (T, P( : , 2 ) /133 .3 , ’ c o l o r ’ , [ 0 . 5 , 0 . 5 , 0 . 5 ] , ’ l i n ew id th ’ , lw )
193 ylabel ( ’ p r e s su r e [mmHg] ’ , ’ f o n t s i z e ’ , f s )
194 legend ( ’ p {LV} ’ , ’ p A ’ , ’ l o c a t i o n ’ , ’ s outheas t ’ )
195 grid on ;
196
197 subplot 312 ; hold on ;
198 plot (T, Qa∗1e03 , ’b ’ , ’ l i n ew id th ’ , lw )
199 plot ( time , Q∗1e03 , ’ b ’ )
200 ylabel ( ’ f low R ate [ l / s ] ’ , ’ f o n t s i z e ’ , f s )
201 legend ( ’Q A ’ , ’Q p ’ , ’ l o c a t i o n ’ , ’ s outheas t ’ )
202 grid on ;
203
204 subplot 313 ;
205 plot (T, s1 , ’ k ’ , . . .
206 T, s2 , ’m’ )
207 xlabel ( ’ time t [ s ] ’ , ’ f o n t s i z e ’ , f s )
208 ylabel ( ’ va lve s ’ , ’ f o n t s i z e ’ , f s )
209 ylim ( [ 0 , 1 . 1 ] )
210 legend ( ’MV’ , ’AV’ , ’ l o c a t i o n ’ , ’ s outheas t ’ )
211
212
213 hf2 = f igure (2 ) ;
214 f s = 15 ;
215
216 subplot 311 ; hold on ; lw = 1 . 5 ;
217 plot (T, P( : , 1 ) /133 .3 , ’ c o l o r ’ , [ 0 . 9 , 0 . 1 , 0 . 1 ] , ’ l i n ew id th ’ , lw )
218 plot (T, P( : , 2 ) /133 .3 , ’ c o l o r ’ , [ 0 . 5 , 0 . 5 , 0 . 5 ] , ’ l i n ew id th ’ , lw )
219 plot (T, P( : , 8 ) /133 .3 , ’ c o l o r ’ , [ 0 . 7 , 0 . 3 , 0 . 1 ] , ’ l i n ew id th ’ , lw )
220 ylabel ( ’ p r e s su r e [mmHg] ’ , ’ f o n t s i z e ’ , f s )
221 legend ( ’ p {LV} ’ , ’ p A ’ , ’ p z ’ , ’ l o c a t i o n ’ , ’ s outheas t ’ )
222 grid on ;
223
224 subplot 312 ; hold on ;
225 plot ( time , F A , ’ r ’ , ’ l i n ew id th ’ , lw )
226 ylabel ( ’ load [N] ’ , ’ f o n t s i z e ’ , f s )
227 grid on ;
228
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229 subplot 313 ; hold on ;
230 plot ( time , M, ’ r ’ , ’ l i n ew id th ’ , lw )
231 ylabel ( ’ load [N] ’ , ’ f o n t s i z e ’ , f s )
232 ylabel ( ’ time [ s ] ’ , ’ f o n t s i z e ’ , f s )
233 grid on ;
234 end
235
236 % save
237 % or i en t landscape
238 % f i l l p a g e
239
240 % fi l ename = ’ Se t up 2 f l ow l oop ou t pu t ’ ;
241 % pr in t ( hf1 , f i lename , ’ dpdf ’ ) ;
242 %
243 % fi l ename = ’ Se tup 2 l oad ou tpu t ’ ;
244 % pr in t ( hf2 , f i lename , ’ dpdf ’ ) ;
245
246 end
247
248 %
249
250 function [ f ] = rhs ( t , p , Arg , time , Q, Q ddot )
251
252
253 % unpack arguments s t a r t
254 p r e f 1 = Arg . p r e f 1 ;
255 L a = Arg . L a ;
256 L f = Arg . L f ;
257 K = Arg .K;
258 % unpack arguments end
259
260 % in t eR po l a t e input data
261 f low = pchip ( time , Q, t ) ;
262 f low ddot = pchip ( time , Q ddot , t ) ;
263
264 [ R MV t , R AV t ] = va lve s ( t , p , Arg ) ;
265
266 % de f i n e r i g h t hand s i d e
267 f = zeros ( 8 , 1 ) ;
149
268
269 f (1 ) = f low + 1/R MV t∗(p (1 ) p r e f 1 ) + 1/R AV t∗(p (1 ) p (2 ) ) ;
270 f (2 ) = p (3) ;
271 f (3 ) = 1/L a ∗(p (2 ) p (4 ) ) ;
272 f (4 ) = p (5) ;
273 f (5 ) = 1 / L a ∗(p (2 ) p (4 ) ) 2∗p (6) ˆ3/Kˆ2∗p (5) ˆ2 ;
274 f (6 ) = p (6) ˆ2/K∗p (5) ;
275 f (7 ) = f low ;
276 f (8 ) = f low ddot ;
277
278 end
279
280 %
281
282 function [M] = mass ( t , p , Arg )
283
284 % unpack arguments s t a r t
285 R a = Arg . R a ;
286 R p = Arg . R p ;
287 R f = Arg . R f ;
288 L f = Arg . L f ;
289 K = Arg .K;
290 C A = Arg .C A ;
291 C LV = Arg .C LV ;
292 C m = Arg .C m;
293 % unpack arguments end
294
295 [ R MV t , R AV t ] = va lve s ( t , p , Arg ) ;
296
297 % mass matrix
298 M = [ C LV, 0 , 0 , 0 , 0 , 0 ,
0 , 0 ;
299 0 , 1 , 0 , 0 , 0 , 0 ,
0 , 0 ;
300 1/R AV t , ( 1 / R AV t + 1/R a ) , C A , 1/R a , 0 , 0 ,
0 , 0 ;
301 0 , 0 , 0 , 1 , 0 , 0 ,
0 , 0 ;
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302 0 , 1/R a , 0 , ( 1 / R a + 1/R p) , p (6 ) ˆ2/K,
0 , 0 , 0 ;
303 0 , 0 , 0 , 0 , 0 , 1 ,
0 , 0 ;
304 C m, 0 , 0 , 0 , 0 , 0 , C m, 0 ;
305 0 , 0 , 0 , 0 , 0 , 0 , 1 / L f , 1/ L f ] ;
306
307 end
308
309
310 %
311
312 function [ R MV t , R AV t ] = va lve s ( t , p , Arg )
313
314 % unpack arguments s t a r t
315 p r e f 1 = Arg . p r e f 1 ;
316 RMV = Arg .RMV;
317 R AV = Arg .R AV;
318 % unpack arguments end
319
320
321 % l im i t pre s sure d i f f e r e n c e ( opening / c l o s u r e time o f v a l v e s )
322 dp hat MV = 5∗133 . 3 ;
323 dp hat AV = 5∗133 . 3 ;
324
325 % va l v e r e s i s t a n c e
326
327 % mitR al v a l v e
328 dp MV = ( p r e f 1 p (1 ) ) ;
329
330 i f dp MV < 0 ;
331 T1 = 0 ;
332 % hy s t e r e s i s commented out :
333 % e l s e i f (0 <= dp MV) && (dp MV < dp hat MV) % smoothostep
334 % T1 = 1/R MV∗(6∗(dp MV/dp hat MV)ˆ5 . . .
335 % 15∗(dp MV/dp hat MV)ˆ4 . . .
336 % + 10∗(dp MV/dp hat MV)ˆ3 ) ;
337 %
338 else
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339 T1 = 1/RMV;
340 end
341
342
343 % aor t i c v a l v e
344 dp AV = (p (1) p (2 ) ) ;
345
346 i f dp AV < 0 ;
347 T2 = 0 ;
348 % hy s t e r e s i s commented out :
349 % e l s e i f (0 <= dp AV) && (dp AV < dp hat AV ) % smoothostep
350 % T2 = 1/R AV∗(6∗(dp AV/dp hat AV )ˆ5 . . .
351 % 15∗(dp AV/dp hat AV )ˆ4 . . .
352 % + 10∗(dp AV/dp hat AV )ˆ3 ) ;
353 else
354 T2 = 1/R AV;
355 end
356
357 R MV t = 1/T1 ;
358 R AV t = 1/T2 ;
359
360 end
361
362 %
363
364 function [Qa ] = f low ( t , p , Arg )
365
366 % aor t i c hear t v a l v e r e s i s t a n c e
367 [ R MV t , R AV t ] = va lve s ( t , p , Arg ) ;
368
369 % aor t i c f l ow
370 Qa = (p (1) p (2 ) ) /R AV t ;
371
372 end
373
374 %
375
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376 function [ dxdt ] = d i f f e r e n t i a t e (x , t )
377
378 N = length ( x ) ;
379 dxdt = zeros ( s ize ( x ) ) ;
380
381 for i = 1 :N
382
383 i f i == 1
384 dxdt ( i ) = (x (2 ) x (1 ) ) /( t (2 ) t (1 ) ) ;
385 e l s e i f i == N
386 dxdt ( i ) = (x (N) x (N 1 ) ) /( t (N) t (N 1 ) ) ;
387 else
388 dxdt ( i ) = (x ( i +1) x ( i 1 ) ) /( t ( i +1) t ( i 1 ) ) ;
389 end
390 end
391
392
393 end
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Listing 3: Input to the function linear˙drive˙load˙setup˙2
1 0.000000
2 0.014800
3 0.054400
4 0.111600
5 0.179200
6 0.250000
7 0.331520
8 0.428560
9 0.529840
10 0.624080
11 0.700000
12 0.754720
13 0.795760
14 0.827440
15 0.854080
16 0.880000
17 0.904720
18 0.925360
19 0.942640
20 0.957280
21 0.970000
22 0.980800
23 0.989200
24 0.995200
25 0.998800
26 1.000000
27 0.984800
28 0.942400
29 0.877600
30 0.795200
31 0.700000
32 0.568749
33 0.398248
34 0.223371
35 0.078997
36 0 . 0 0 0000
37 0 . 0 3 4252
38 0 . 0 6 7634
39 0 . 1 0 0133
40 0 . 1 3 1737
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41 0 . 1 6 2432
42 0 . 1 9 2205
43 0 . 2 2 1044
44 0 . 2 4 8935
45 0 . 2 7 5866
46 0 . 3 0 1823
47 0 . 3 2 6794
48 0 . 3 5 0766
49 0 . 3 7 3726
50 0 . 3 9 5660
51 0 . 4 1 6557
52 0 . 4 3 6402
53 0 . 4 5 5184
54 0 . 4 7 2888
55 0 . 4 8 9503
56 0 . 5 0 5015
57 0 . 5 1 9412
58 0 . 5 3 2680
59 0 . 5 4 4806
60 0 . 5 5 5778
61 0 . 5 6 5582
62 0 . 5 7 4206
63 0 . 5 8 1637
64 0 . 5 8 7862
65 0 . 5 9 2867
66 0 . 5 9 6641
67 0 . 5 9 9169
68 0 . 6 0 0439
69 0 . 6 0 0177
70 0 . 5 9 6879
71 0 . 5 9 0484
72 0 . 5 8 1203
73 0 . 5 6 9244
74 0 . 5 5 4819
75 0 . 5 3 8137
76 0 . 5 1 9407
77 0 . 4 9 8841
78 0 . 4 7 6647
79 0 . 4 5 3037
80 0 . 4 2 8219
81 0 . 4 0 2404
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82 0 . 3 7 5802
83 0 . 3 4 8622
84 0 . 3 2 1075
85 0 . 2 9 3370
86 0 . 2 6 5718
87 0 . 2 3 8328
88 0 . 2 1 1411
89 0 . 1 8 5176
90 0 . 1 5 9833
91 0 . 1 3 5593
92 0 . 1 1 2664
93 0 . 0 9 1258
94 0 . 0 7 1584
95 0 . 0 5 3852
96 0 . 0 3 8272
97 0 . 0 2 5054
98 0 . 0 1 4408
99 0 . 0 0 6543
100 0 . 0 0 1671
101 0.000000
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